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Abstract.
The insertion sequence IS6110 has been shown to be present only in members of the 
Mycobacterium tuberculosis complex.
In this report, probes derived from a copy of IS6110 from M. tuberculosis, namely 
IS986, have been employed to fingerprint M. tuberculosis, BCG and M.bovis. 
BCG vaccine strains Brazil, Japan and Russia are shown to possess two copies of the 
insertion sequence at the sites BCG, and BCG2 respectively, while the rest of the BCG 
substrains possess only one copy which is present at BCG,. M.tuberculosis isolates 
from Tanzania were seen to vary widely in their restriction fragment length 
polymorphism (RFLP) patterns, but groupings of these isolates were achieved 
employing the MolMatch analysis program. Some rare but widely distributed isolates 
of M.tuberculosis were analyzed and their relation to BCG assessed by employing 
Southern blots of restriction digests and the polymerase chain reaction. These strains 
were initially thought to have IS6110 at the BCG2 position, but PCR analysis 
indicated it might be at the BCG, position.
186110 typing of M.bovis strains from animal and human sources indicated most of 
these strains possessed only single copy of IS 6110 which was mainly located at BCG,, 
although a few strains had IS6110 located at the BCG2 position (but on rare 
occasions, at a position between BCG, and BCG2), while the isolates with multicopies 
had two or three copies. Strains from human origins were also observed to be more 
likely to harbor multiple copies of 186110 than those from an animal origin.
Experimental demonstration of transposition of 18986 was also achieved, giving a 
range of structures from cointegrates, to genuine transposition and other structures not 
defined by conventional transposition models.
These results have been analyzed and their significance fully discussed in the ensuing 
chapters.
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Chapter 1.
GENERAL INTRODUCTION
1.0 Introduction
This report will be concerned with the fingerprinting/typing of some members of the 
M.tuberculosis complex employing gene probes. Exercises carried out to 
demonstrate transposition of an insertion element found exclusively in the 
M.tuberculosis complex have also been done.
But it is only fair to begin by paying tribute to some great names in microbiology.
1.1. Microbiology. (In Retrospect.)
T have had several gentlewomen in my house, who were keen on seeing the 
little eels in vinegar; but some o f them were so disgusted at the 
spectacle, that they vowed they’d never use vinegar again. But what i f  
one should tell such people in the future that there are more animals 
living in the scum on the teeth in a man’s mouth, than there are men in 
the whole kingdom. ’ This is an extract from a letter by Antonie van Leeuwenhoek 
(1632-1723), the Dutch merchant who made the first microscope. With his simple 
microscope, man could see animalcules (tiny animals) he did not know existed. The 
microbial world was discovered. Armed with the microscope, scientists could now 
study in depth the nature of disease causing organisms, hence the science of 
microbiology was born.
The discovery of microorganisms as disease causing agents.
Louis Pasteur first hinted on the idea that microorganisms were involved as 
aetiological agents when he termed microbial induced spoilage during the fermentation 
process as ’diseases’ of beer and wine. In 1845, M.J. Berkeley proved that the potato 
blight in Ireland was caused by a fungus. Bassi, A. (1836) showed the specific 
association of some fungi with the disease of silkworms. This was an early indication 
that microbial diseases were not limited to plants only.
Louis Pasteur’s work on abiogenesis (spontaneous generation) proved that
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microorganisms were present in air. Pasteur’s work greatly influenced the work of 
Joseph Lister (1864). Lister set out to eliminate the incidence of surgical sepsis, by 
carrying out procedures which prevented the access of microorganisms into surgical 
wounds. Lister’s procedures included sterilization of surgical equipment, use of 
disinfectant dressings, conduct of surgical procedures under a spray of disinfectant to 
prevent airborne infection. These procedures greatly reduced the incidence of surgical 
sepsis, and also provided indirect evidence for the germ theory of disease. Between 
1863 and 1868, C.J. Davaine, working on the disease anthrax, showed that rod­
shaped elements present in diseased animals were absent in healthy ones. He also 
showed that healthy animals inoculated with blood containing the rod-like elements 
came down with the disease.
In 1876, Robert Koch carried out the work of Davaine further by growing the rods 
in sterile serum medium and reinfecting healthy mice with the culture. The mice 
came down with the disease and the organisms could be isolated from the diseased 
animals. Before the works of Davaine and Koch became known, J. Henle, 1843., 
had laid down the criteria necessary to establish the causal relationship between a 
specific microorganism and a specific disease. The criteria are;
1. The microorganism must be present in every case of the disease.
2. The microorganism must be isolated from the diseased host and grown in pure 
culture.
3. On inoculating a healthy susceptible host with the pure culture, the specific disease 
must be produced in the host.
4. The experimental organism must be recoverable from the experimentally infected 
host.
The above criteria are now known as Koch’s postulates because it was Robert Koch 
who first applied them experimentally.
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Although Koch’s postulates have proved invaluable in many cases, they do not seem 
to be applicable in others. One example is Mycobacterium leprae which is an 
obligate parasite. Hence, it cannot be obtained in pure culture. Only the nine banded 
armadillo has proved to be a very successful life host for the propagation of 
M. leprae, but this does not make it a good model for studying the effects of 
M. leprae in relation to human infections.
Similar exercises by Pasteur and his co-workers confirmed Koch’s work. Through 
their endeavours, the germ theory of disease was firmly established. Robert Koch 
then continued with the isolation, cultivation and characterization of the causative 
agents of major infectious diseases of man. In 1882, he discovered Mycobacterium 
tuberculosis, the causative agent of tuberculosis, and a year later, he discovered 
Vibrio cholerae, the causal agent of cholera.
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1.2 MYCOBACTERIACEAE.
This is a family of bacteria in which the relationship between the different members 
of the family ranges from close to very diverse, as reflected in factors which include 
virulence, habitat, rate of growth, nutritional requirements, antigenicity and genetic 
relatedness. The family Mycobacteriaceae consists of one genus, Mycobacterium, 
a name assigned by Lehmann and Newmann in 1896.
1.2.1 Some general properties of members of the genus Mycobacterium.
The name Mycobacterium means fungus bacterium. This name should not be taken 
to imply Mycobacterium species are related to any fungus. The name simply 
highlights the fact that members of this genus exhibit a mould-like growth on the 
surface of a liquid medium.
Members of the mycobacteriaceae are non motile, non spore forming bacilli. They 
are aerobes (but to varying degrees) as exemplified by members of the 
M. tuberculosis complex (table 1.1).
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Table 1.1: Some Properties of Members of the M. tuberculosis Complex that 
Facilitate Their Identification and Differentiation.
Species and 
Variants.
Susceptibility
toTCH
Pyrazinamide
Susceptibility
Nitratase Oxygen
Preference
M.tuberculosis(i
)
Classical(a)
Asian(a)
Resistant
Sensitive
Sensitive
Sensitive
Positive
Positive
Aerobic
Aerobic
M. afficanum(i) 
Africa 1(a) 
Africa 11(a)
Sensitive
Sensitive
Sensitive
Sensitive
Negative
Positive
MA
MA
M. bovis(\) 
Classical bovine(a) 
BCG
Sensitive
Sensitive
Resistant
Resistant
Negative
Negative
MA
Aerobic
Footnotes:
MA (Microaerophilic)
(i). In a review of nomenclature, Skerman et al, (1980) produced a list containing 41 
species of mycobacteria, including M.africanum, M.bovis and M.tuberculosis.
(a). Variants of M.tuberculosis complex as seen by Collins et al, (1982).
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1.2.11 Staining Properties.
In 1882, Paul Ehrlich discovered the property of acidfastness in Mycobacteria. This 
implies members of the genus Mycobacteria resist decolorization by weak mineral 
acids when stained with an arylmethane dye e.g carbulfuchsin, hence they are termed 
acid fast. This is the principle behind the commonly used Ziehl-Neelsen stain.
Some caution has to be exercised when interpreting an acid fast staining result with 
respect to mycobacterial species. This is because acidfastness is not a property unique 
to mycobacterial species.
Bacterial spores are usually strongly acid fast while some members of the genera 
Nocardia, Corynebacteria and Rhodococcus exhibit a weak acid fast property. 
Young rapidly growing cultures, especially those of saprophytic species of 
mycobacteria, may be partially acid fast or non-acid fast.
Spheroplast mutants will normally be non acid fast. But they will resemble the parent 
wild type strain biochemically. This indicates acidfastness depends on maintaining 
the integrity of the cell wall.
Mutants of mycobacteria which contain nocardomycolic acid in their cell wall are not 
acid fast. Nocardomycolic acid is chemically similar to mycolic acid but with a 
shorter chain length. The cell wall of these mutants has been shown to be chemically 
similar to normal mycobacteria (Hawley et al, 1977). This may imply the length of 
the carbon chain has a part to play in the staining property of the cell.
In terms of the gram stain, the Mycobacteria are considered gram positive, but they 
are difficult to stain. Because of this staining difficulty, they have been described as 
gram-neutral or ghost footprints (Trifiro et al, 1990).
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1.2.12 Occurrence.
The Mycobacteria are omnipresent. They can be found as saprophytes in soil and 
occur in air as well as in water. They can be found as pathogens or harmless 
inhabitants of humans and animals. Until recently, only two members of this genus, 
M. tuberculosis and M.leprae (both being well known pathogens) have attracted 
a great deal of attention. With the discovery of their role as opportunistic agents of 
disease in immunocompromised patients, other members of the genus 
Mycobacterium, for example M.avium, have also grown in prominence.
1.2.13 Morphology and growth characteristics.
Some members of the family mycobacteriaceae are pigment producers (chromogens) 
while others are non chromogenic. Chromogenic strains which produce pigment in 
the presence of light are called photochromogens. Others produce pigments in the 
dark and are called scotochromogens.
The members of the genus Mycobacterium are either slow growers or fast growers. 
M.fortuitum has a generation time of about 2.5 hours while M.tuberculosis has 
a generation time of about 18 hours, yet M.paratuberculosis exhibits an even 
slower growth rate. A feature of the growth of mycobacterial species in liquid 
medium is that they clump and form aggregates of cells which sediment. Members 
of the M. tuberculosis complex exhibit the highest degree of clumping while others 
like M.smegmatis and M. avium exhibit less clumping of cells in liquid medium. The 
degree of clumping seems to be related to the growth rate of the organism. The 
greater the degree of clumping, the slower the growth. Addition of tween 80 to a 
concentration of 0.05% facilitates a dispersed growth.
Bovine serum albumin (BSA) is usually added to media for growth of many 
mycobacterial species. It improves growth by neutralizing free fatty acids which 
might be toxic to the cell. It can also serve as a source of aminoacids hence'" 
benefiting nitrogen metabolism of the cell.
The mycobacterial species all have a complex lipid rich cell wall similar to that found
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in corynebacteria and nocardia. This complex cell wall structure is probably 
responsible for the property of acidfastness.
Variations in size and shape occurs among the different members of the genus and 
within species. On solid media, colonial morphology ranges from single smooth 
colonies of M. smegmatis, and M. avium, to the crusty single colonies of 
M.tuberculosis, on to the spreading colonies of some members of M. bovis BCG. 
The variation in colonial morphology highlights the presence of extracellular 
substances which may vary from one strain to another, an example being the 
peptidoglycolipids called mycoside C (Kim et al, 1976). The property of variation 
associated with mycoside C has been employed in agglutination tests to serotype 
species of M. avium (Shaefer, 1965). Mycosides have also been identified as phage 
receptors in some mycobacteria (Bisso et al, 1976, Furuchi and Tokunaya, 1972). 
Therefore, the presence of different mycosides could give an indication of the phage 
type of that strain.
Cellular morphology ranges from rods (M.tuberculosis), curved rods 
(M.microti), through coccobacillary (M.avium) to ovoid and filamentous forms. 
Young cultures of M.smegmatis may also appear as filaments.
Treatment of mycobacterial cultures with factors that interfere with cell wall synthesis 
could lead to the isolation of cell wall deficient forms or spheroplasts (bacterial cell 
in which the shape determining integrity of the cell wall has been lost).
Treatment of M.tuberculosis cultures with lysozyme and EDTA gave wall deficient 
forms which could be maintained on suitable media (Thacore et al, 1963., Willett et 
al, 1966). Further studies revealed that the spheroplasts of M.tuberculosis obtained 
in pure culture seemed to be non pathogenic unless they reverted to the wild type 
bacilli (Ratnam et al, 1976), indicating the virulence of M.tuberculosis is closely 
associated with components of the cell wall.
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1.2.14 The mycobacterial cell wall.
With the discovery that the mycobacterial cell wall was responsible for adjuvant 
activity in Freund’s complete adjuvant, more effort was invested in elucidating the 
chemical nature of the wall as well as its structure.
The cell wall of mycobacteria has been shown to be a bilayered structure, in contrast 
to the single layer structure found in gram positive bacilli (Edwards, 1970). In thin 
sections, it is seen to comprise an inner membrane, a middle bilayer wall and an 
outer diffuse capsular layer (which comprises a fibrous capsule-like material and a 
mycoside layer (Barksdale and Kim, 1977).
Although there are species variation with respect to the wall, the wall structure can 
be generally described as comprising a cross linked peptidoglycan backbone to which 
are linked polysaccharide side chains esterified at their distal ends with mycolic acids 
(Rogers et al, 1981).
The major polysaccharide in the cell wall is arabinogalactan, which has been shown 
to be structurally similar in M. tuberculosis, M.phlei, and BCG (Kotani et al, 
1971). This arabinogalactan cross reacts with antisera prepared against corynebacteria, 
nocardia, as well as mycobacteria, and appeared to be a major antigen in these 
bacteria. This might have an influence on the staining properties of these organisms, 
since all of them tend to stain acid fast, albeit to varying degrees.
The mycobacterial peptidoglycan normally contains the aminoacids D-alanine, 1- 
alanine, diaaminopimelic acid and D-isoglutamine. Other aminoacids which include 
serine (Yabu and Huempfner, 1974) and methionine (Yabu and Takahashi, 1977), 
have been found to replace normal constituents of the mycobacterial cell wall. A 
corresponding alteration of colonial morphology was observed. This change in 
colonial morphology might have been interpreted as being due to a mutational event 
rather than simple incorporation of the foreign aminoacid. The foreign amino acid 
can be obtained from the growth medium and incorporated in the peptidoglycan 
backbone. Such a change can have far reaching effects on the antigenicity of that 
particular cell, hence on its pathogenicity. But the transfer of such a property to 
daughter cells cannot occur.
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Lipids. The total lipid content of the BCG cell wall was found to be over 60% of 
the weight of the cell wall (Kotani et al, 1959). If this stands as an example for all 
species of mycobacteria, then the lipid content of the mycobacterial cell wall is 
definitely high.
This high lipid content is responsible for the hydrophobic behavior of the cell and 
may also confer resistance to chemical injury. The high lipid content might be 
responsible for the slow growth rate of mycobacteria by restricting uptake of oxygen 
and nutrients into the cell. It might also play a role in resisting dehydration and for 
survival under adverse conditions ( Barksdale and Kim, 1977).
In addition to lipids, the mycobacterial envelope is rich in non-lipid polymers such 
as peptidoglycan, polysaccharides, and proteins.
Mycolic acids. These are fatty acids attached as esters to arabinose residues of 
arabinogalactan (Azuma et al, 1969). They form the outermost region of the 
mycobacterial cell wall and are probably responsible in part for the lipophilic behavior 
of the cells. Mycolic acids also occur in nocardia and corynebacteria (Etemadi, 1967) 
but they all vary in size. Mycolic acids of mycobacteria are of the highest molecular 
weight, followed by nocardiomycolic acids, while the corynomycolic acids are the 
smallest of these mycolic acids. Some mutants of mycobacteria have been seen to 
possess nocardiomycolic acids (Hawley et al, 1977). This probably indicates a close 
relation between the two genera.
Since different groups of mycobacteria possess different mycolic acids, mycobacterial 
strains can thus be classified based on the composition of their mycolic acids.
Peptides. Peptides are known to be associated with the cell wall and they give strong 
tuberculin reactivity. It is not clear whether these peptides are covalently bonded to 
the wall, or they are in a transient state on their way to the exterior. One peptide, 
a polyglutamic acid, is known to be covalently attached to the cell wall of 
M. tuberculosis and related species. This peptide has more L- glutamate than D- 
glutamate residues. The D- glutamate residues are the only ones normally associated
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with the peptidoglycan, forming a 1:1 ratio with diaminopimelic acid. The occurrence 
of a greater amount of poly L-glutamic acid in the wall of virulent M. tuberculosis 
strains than is the case with M.bovis BCG (Wietzerbin at al, 1975), and its absence 
in M.smegmatis and M.phlei, highlights this polymer as a possible virulence factor. 
As virulence is a multifactorial entity, a possible interaction of L-glutamate with other 
factors makes this assumption look plausible. One must not oversee the possibility 
that the property of virulence and the presence of high amounts of poly L-glutamate 
residues in strains of M.tuberculosis is coincidental.
1.2.15 Mycobacterial Genetics.
Mycobacterial species have genome sizes ranging from 3.1xl09 to 4.5xl09 daltons. 
A deviation from this genome size range can be seen in the case of M. leprae , 
M.tuberculosis and M.bovis BCG which have genomic sizes of 2.2xl09 daltons, 
2.5xl09 daltons and 2.8xl09 daltons respectively (Bradley, 1973).
Mycobacterial species have a high percentage G+C which ranges from 64% to 71% 
(Baess and Mansa, 1978), but two exceptions are M.leprae and M.lufu which have 
% G+C values of 58% and 61% respectively (Clark-Curtiss et al, 1985).
From DNA-DNA reassociation studies (Grosskinsky et al, 1989), members of the 
M. tuberculosis complex show homologies of between 78% and 97% with the 
genomic DNA of M. tuberculosis strain 37H. Chromosomal DNA from fast 
growing species exhibited 4% to 26% homology to M. tuberculosis DNA 
(Grosskinsky et al, 1989). This indicates that a good degree of homology is apparent 
within the M. tuberculosis complex while a lower degree of homology is apparent 
with other mycobacterial species, possibly indicating an early split of the 
M. tuberculosis complex from the rest of the mycobacterial species. It may also 
imply members of the M. tuberculosis complex do not have a common ancestral 
origin with other mycobacterial species, but they happen to share some common 
features by coincidence. M. leprae DNA showed little homology with any
mycobacterial species employed, hence highlighting the possibility that M.leprae 
might be a distinct evolutionary entity.
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Kieser et al. (1986) have shown that mycobacterial DNA can act as promoters more 
efficiently in Streptomyces lividans than in E.coli. This probably highlights 
S.lividans as a suitable species for studying mycobacterial genes. Streptomyces 
and mycobacteria are both known to have a high G+C content, a property which is 
taken to mean they are a primitive species. An evidence to implicate these genera as 
being ancient has been put forward by Anderson and Kurland, (1990). They indicated 
biosphere studies showed glycine, valine, aspartic acid, glutamic acid and alanine 
(which are all coded for by G+C rich codons) were most abundant in primitive times. 
But since its mainly the third base which is G/C rich in mycobacteria (A. Patki [1990] 
Phd thesis), this assumption may not hold for this species.
Sequence comparison data of 16S RNA from different mycobacteria have been used 
to generate similarity values (Stahl et al,1990). The similarity values show 
mycobacteria to be a related group distinct from corynebacteria. Slow growing 
species are seen to define a distinct line of evolutionary descent while fast growers 
seem to be polyphyletic. The similarity tree places M.bovis, M.kansasii and the 
MAIS group as being 98.8% related.
Bercovier et al. (1986), armed with the knowledge that ribosomal RNA genes are 
highly conserved in procaryotes, and showing considerable homology, generated 
probes from the E.coli rrnB operon to detect the number of rRNA genes present in 
mycobacterial species. The studies show that mycobacteria possess a small number 
of ribosomal RNA genes in relation to their size. The slow growers exemplified by 
M.tuberculosis and M.intracellulare, possess one rRNA operon while the fast 
growers, represented by M.phlei and M.smegmatis possess two rRNA operons. 
E.coli was shown to possess seven rRNA operons. The studies indicate the number 
of rRNA operons is linked to the rate of growth.
Genetic variation among strains occurs through mutation and recombination. In 
nature, these mutations could be spontaneous, arising as a result of misincorporation 
of bases (base substitution), or frameshift mutation (deletions or insertions of bases) 
during DNA replication and the failure of the repair system to correct the mistake.
12
Mutations may be silent, implying no apparent change is observed. Conversely, 
mutations affecting vital biochemical pathways may create auxotrophic mutants which 
require the addition of certain growth supplements. This may be the reason for the 
existence of obligate parasites like M.leprae. The small size of the M.leprae 
genome suggests it might have lost (or never had) the genes involved in vital 
biochemical pathways, hence its total dependence on a host for survival, yet such 
defects have not been identified.
Although mutations cause strain alterations in every case, interspecific differentiation 
is associated with a wide mutation spectrum while intraspecific variants differ by few 
mutations (Grange, 1973).
In common with other bacteria, mycobacteria possess elements with the ability to 
move within the genome, generating insertional mutants, deletions and other 
recombination events which cause strain variations. These elements may be simple 
insertion sequences or more complex transposons. Transposons may carry certain 
traits which they confer on the new host (see chapter 4).
A further source of variation are extrachromosomal elements (which are capable of 
autonomous replication) called plasmids. They have been isolated from M. avium, 
M.intracellure, M.scrofulaceum (Crawford et al, 1990), M.fortuitum (Martin 
et al, 1990a). These plasmids may confer on the host strain properties such as drug 
resistance, the ability to utilize certain substrates, resistance to mercury.
Although these elements have not been isolated in members of the M. tuberculosis 
complex, some extrachromosomal bands have been detected in drug resistant strains 
of M. tuberculosis (Zainuddin and Dale, 1990). The failure to isolate these 
extrachromosomal bands may mean they represent plasmid forms other than covalent 
circular molecules. They may be linear or single stranded plasmids.
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1.3 Some Common Mycobacteria.
1.3.1 Mycobacteria not Associated with human illness.
These organisms are mainly saprophytes and they include M. gordonae, M.phlei, 
and M.smegmatis. M.gordonae and M.phlei are usually found on plants, in the 
soil and in water, while M.smegmatis can be found in human sebaceous secretions. 
Hence an acid fast positive result from a specimen associated with the skin may not 
indicate the presence of a pathogenic mycobacteria. M.phlei and M.smegmatis are 
also important due to their employment in genetic and biochemical studies.
1.3.2 Mycobacteria of Aetiological Significance.
1.3.21 Mycobacterium- Avium~Intracellulare(MAl) complex.
These are slow growing mycobacteria which exhibit soft, smooth colonies with little 
color, but they are usually classified as non-chromogens. They can be found in air, 
soil and water. They normally infect birds, but infrequently cause diseases in humans 
and animals, where they operate as opportunistic pathogens. Disease condition is 
manifested in immunocompromised humans like old people and AIDS patients 
(Roberts et al, 1987), and it is commonly a disseminated infection.
They show resistance to most antituberculous agents, hence treatment regimens 
employ up to six drugs.
Members of the MAI group are known to carry a variety of similar plasmids which 
can be employed in typing these strains (Hellyer et al, 1991), but RFLP typing is 
mainly directed at the chromosome.
1.3.22 M. scrqfulaceum.
This is a scotochromogen occasionally found in water and as saprophytes in humans 
with chronic lung disease. It causes cervical lymphadenitis in small children, which
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can be cured by removal of the affected lymph node. Resistance to antituberculosis 
drugs is common. It is sometimes grouped into the same complex as M.avium- 
intracellulare, in which case the complex is known as MAIS. It can be 
differentiated from M.avium by agglutination tests and RFLP typing.
1.3.23 M.paratuberculosis.
This is a very slow growing species. It requires the iron chelating agent mycobactin, 
which it cannot synthesize. M.paratuberculosis is known to cause chronic 
hypertrophic enteritis (Johne’s disease) in cattle, and uncommonly, in other ruminants 
(Vary et al, 1990., Jawetz et al, 1989). Although there is .no direct evidence of its 
involvement in human disease, it has been implicated in Crohn’s disease (chronic 
granulomatous inflammation of large and small intestine). It is closely related to 
M.avium, showing less than 2% base substitution (McFadden et al, 1987a).
1.3.24 M.kansasii.
This is a photochromogen with extremely limited pathogenicity for animals, producing 
only a local lesion. In man, it can produce pulmonary and systemic disease 
indistinguishable from that produced by M.tuberculosis, indicating it is probably 
a heterogeneous species.
1.3.25 M. marinum.
It is a photochromogen and an opportunist species which occurs in water. It may 
infect fish but can also produce superficial skin lesions (also known as swimming pool 
granulomas) in humans.
1.3.26 M.ulcerans.
This is a very slow growing non-chromogenic species with a growth temperature 
range between 31°C and 34°C. It is thought to be a saprophyte as infection has been 
frequently encountered close to rivers and swampy areas. It is the cause of Buruli 
ulcer.
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1.3.27 Mycobacterium fortuitum-chelonei complex.
These are non-pigmented rapidly growing saprophytes found in the soil and water. 
Colonies on Lowenstein-Jensen medium appear rough and large, often similar to 
M.tuberculosis colonies. They are usually harmless but can produce superficial 
and systemic disease in humans. The most common clinical manifestation is an 
abscess. M.fortuitum (also known as the frog tubercle bacillus) and M.chelonae 
(the turtle bacillus), are antigenically distinct species with different phage patterns.
1.3.28 M. leprae.
M.leprae is the causative agent of leprosy. Although this organism was first 
described in 1874 by the Norwegian, Gerhard A. Hanson, attempts to cultivate it in 
vitro have been met with failure.
M. leprae is a unique member of the mycobacteria in that it is an obligate parasite. 
So far, man has been able to propagate it only on living tissue, where they are 
arranged singly or in bundles and appear as straight to curved rods. It grows very 
slowly, with an estimated generation time of about 12 days, and optimum growth 
occurring at about 30°C.
Initially, man was thought to be the only natural host, but the discovery of 
spontaneously infected armadillo and monkeys in the wild might change this 
assumption (Groothius, D.G., 1989).
Kadza et al. (1980) have isolated non-cultivable acid fast bacilli from sphagnum moss 
vegetation in Norway by propagation of the bacilli in mouse footpads. This indicates 
non-culturable mycobacteria exist in nature and might also be an indication of the 
origins of M. leprae.
The lesions due to M. leprae infection involve the cooler parts of the body which 
include the skin, nose, pharynx, eyes, testicles. The bacilli also colonise the 
superficial nerves and Schwann cells. The superficial nerves can be seriously affected 
giving rise to conditions which include nerve infiltration and thickening with resultant 
anaesthesia, neuritis, cold hands, trophic ulcers, bone reabsorption and shortening of
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digits (characteristic of chronic lepromatous condition [below]). Disfiguration may 
occur due to skin infiltration and nerve damage.
Experimental work on M. leprae may be carried out by generating the bacilli in mice 
foot pads where they produce a local granulomatous lesion with limited multiplication 
of the bacilli. In order to obtain the bacilli in large amounts, another system had to 
be employed. Such a system is found in the nine banded armadillo. The nine banded 
armadillo (with a body temperature ranging from 30°C to 35°C) is highly susceptible 
to infection with M.leprae, and the infection is characterized by dissemination of the 
disease to all organs, a situation which is not typical of leprosy in humans.
Identification of the bacilli involves the employment of human tissue derived from 
scrapings of the skin, mucous membrane (nasal septum), and biopsy of the earlobe. 
M.leprae also produces a specific surface lipid called phenolic glycolipid I. 
Monoclonal antibodies have been produced and employed to detect the presence of 
this lipid (Hunter et al., 1981, Cho et al., 1983).
Although there are several intermediate forms of leprosy, the disease can be divided 
into two main types namely; tuberculoid (neural) and lepromatous (progressive) forms 
of leprosy.
Tuberculoid (neural) leprosy.
This form of the disease occurs in persons with effective immune reactions. The 
course of infection is non progressive. It is characterized by macula lesions on skin, 
loss of sensation on parts of the skin which can be surrounded by nodules. Acid fast 
bacilli are not easily detected, but in extreme cases, bacilli can be detected in nasal 
secretions, fluids and biopsies obtained from other cool sites such as the earlobe and 
fingers. Skin biopsies show mature granuloma formation in the dermis consisting of 
epitheloid cells, giant cells and an extensive infiltration of lymphocytes (helper T- 
cells). A positive lepromin test is apparent at this stage of the disease. Recovery may 
be spontaneous, but chemotherapy is usually employed.
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Lepromatous leprosy.
This is a progressive and malign form of leprosy. It is characterized by a deficient 
cell-mediated immune response. The skin is infiltrated with suppressor T-cells and 
a negative lepromin test is evident. Epitheloid and giant cells are absent while 
lymphocytes are rare and their distribution is diffuse. Numerous bacilli can be found 
within the macrophages and Schwann cells (macrophages associated with the nervous 
system), coupled with continuous bacteraemia. The damage to the nerve structure is 
less severe than in tuberculoid leprosy. There is infection of the skin cells and the 
characteristic formation of disfiguring nodules all over the body. Deformation of the 
hand may occur, accompanied by tissue necrosis. Changes in the severity of the 
disease condition is unpredictable. Although a tuberculoid condition can change into 
a lepromatous condition, it is not a common occurrence.
Transmission of leprosy.
Leprosy is not very contagious. Although a few patients develop clinical symptoms, 
it is possible that many contacts develop subclinical infections. Transmission from 
person to person is via prolonged intimate contact with heavy shedders of the bacilli. 
The mode of shedding includes nasal secretions and exudates from the lesions. The 
onset of leprosy is insidious, and the time from infection to appearance of symptoms 
takes several years. Patients may die from leprosy due to the complications involved, 
rather than the disease itself.
Leprosy is a very difficult disease to cure. In the early days, chaulmoogra oil was 
employed in treating cases of leprosy. Presently, prolonged treatment with the 
sulphone drug dapsone or its long acting analogue acedapsone is being employed to 
arrest the progress of the disease. But dapsone resistant strains are being reported 
(Pearson et al, 1977). The WHO recommended multidrug therapy in combinations 
such as rifampicin with clofaximine (and its analogues) to be employed in treating 
cases exhibiting drug resistance to dapsone.
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Prevention and control of leprosy.
Early diagnosis and treatment of patients coupled with prophylaxis to close dependents 
can serve to curb the incidence of leprosy. Education about the disease will also help 
both patients and their close associates to be able to manage cases of leprosy. 
Although no effective vaccine has been produced against M. leprae, there are reported 
cases of BCG providing 50% protection against leprosy (Fine et al, 1986). Other 
vaccine trials involving killed M.leprae and BCG applied in concert are also being 
carried out.
1.3.29 Mycobacterium tuberculosis complex
This complex comprises Mycobacterium tuberculosis, M.africanum, M.bovis, 
M.bovis BCG, and M.microti. They are a group of closely related species of which 
the representative species is M. tuberculosis.
M. tuberculosis was first described by Robert Koch in 1882. It mainly infects 
humans, but transmission of the bacilli from man to pet is possible. Overt disease 
is apparent among primates, parrots and canaries (Groothius, 1989.)
It mainly causes pulmonary disease, but sometimes infects other parts of the body. In 
the case of pulmonary infections, acid fast bacilli can be detected in sputum and 
bronchial washings, albeit in small numbers.
M. tuberculosis can resist drying for long periods and it is also more resistant to 
chemical agents than other mycobacteria. These properties are in part due to its 
hydrophobic cell wall and clumpy growth. Many antimicrobial agents like penicillin 
have no apparent effect on M. tuberculosis (and usually little effect on other 
mycobacteria) hence can be used to select for these organisms.
The cellwall of M.tuberculosis is highly immunogenic, consisting of lipoprotein 
and lipopolysacharides. It can induce delayed type hypersensitivity in animals and 
humans, and may confer resistance to further infection.
The purified protein derivative (PPD) from culture filtrates of mycobacteria is used 
in testing for the presence of mycobacterial antigens. PPD elicits species specificity
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at low concentrations but cross reactivity to antigens of other mycobacterial species 
at high concentrations. The reaction to PPD is of the delayed type hypersensitivity 
although immediate reactions (4-6 hours) have been observed (Jawetz et al, 1989., 
Beck, 1991).
Virulent strains of M. tuberculosis often form serpentine cords. They possess a cord 
factor known as trehalose 6 ’6 ’ dimycolate which inhibits leucocyte migration, causes 
chronic granulomas, and can serve as an adjuvant.
M. africanum.
This species was first described by Castets, Boisvert and Rist in 1969. It causes 
pulmonary tuberculosis in humans. In Western Europe, it is commonly found among 
the immigrant population, particularly of African origin. It has properties 
intermediate to both M.tuberculosis and M.bovis (table 1.1). It is sensitive to 
pyrazinamide, and microaerophlic.
M.bovis.
This is the bovine tubercle bacillus, causing tuberculosis in cattle. It infects man 
through drinking of contaminated milk. The tonsils, cervical lymph nodes and 
intestines may become infected. In the case of chronic infection, deformation of the 
spine may result, leading on to the development of a hump-back by the infected 
individual. Pasteurization of milk, coupled with tuberculin testing of cattle has 
reduced the incidence of this form of tuberculosis in some parts of the world.
M.bovis BCG.
This is the vaccine strain used to protect against the development and spread of 
tuberculosis. It is an attenuated strain of an organism usually referred to as M.bovis 
(isolated by Nocard in 1902 from tuberculous mastitis of a heifer), although the actual 
identity of the parent strain is unknown.
It was prepared by subculturing the parent M.bovis strain through 231 three weekly 
transfers on 5% glycerinated beef-bile potato medium.
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BCG was first introduced in 1921 by Calmette and Guerin, the two Frenchmen who 
prepared the vaccine and over the years, genotypic and phenotypic variations have 
resulted in various substrains, with resultant effects being changes in immunogenic 
and reactogenic properties. The efficacy of BCG as a vaccine has been observed to 
vary between 0% in Chingleput (South India ) to 80% in Britain (Abou-Zeid et al, 
1987a., Grange et al, 1990). These differences are thought to be due to previous 
exposure to environmental mycobacterial strains. But one cannot rule out the 
possibility of variations of the vaccine strains employed in some trials as being a 
factor in the successes and failures. It is thought that vaccination of neonates before 
they become sensitized by environmental mycobacteria increases the level of 
protection (Grange et al, 1990).
Lugosi, (1992) has put forward some reasons for the apparent failures of some BCG 
vaccine trials.
1. Different BCG substrains differ in the residual virulence which determines 
immunogenicity and reactogenicity.
2. Due to the different production methods employed in different laboratories, 
variations in BCG viable units per dose may result.
3. Quantitative bioassay methods are not being used for statistical quality control of 
the vaccine.
4. BCG vaccine products are applied in various demographical, epidemiological and 
socioeconomic conditions with different vaccination policies.
5. Inadequate biostatistical models are employed to analyze its effectiveness and 
adverse reactions.
The benefits of the immunostimulatory effects of BCG can be seen in cases beyond 
prevention of tuberculosis. It has also been observed that vaccination of neonates 
reduces the risk of developing malignancies in the future. It is explained that the 
resultant cell mediated immunity gained from vaccination with BCG serves as a 
weapon to destroy embryonic remnants which may give rise to malignancies (Grange 
et al, 1990). The BCG vaccine has also been employed as an immunostimulant in
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immunotherapy of cases of neoplasia. The most promising results were obtained with 
cases involving cancer of the bladder.
M.microti (Vole bacillus).
It infects the field mouse producing a chronic disease which resembles tuberculosis. 
It resembles M. tuberculosis in both phage typing and the immunological responses 
it elicits. It is not known to cause overt disease in man, hence was employed as a 
vaccine strain in the 1940s.
Tuberculosis.
The disease tuberculosis has been around as long as mankind can remember. It has 
been estimated that one third of the world’s population is infected with tuberculosis, 
with an annual death count of about three million, most of which occur in the 
developing world. In 1991, eight million new cases were reported. Most people 
infected with M. tuberculosis do not come down with overt disease because the 
infection may be dormant, or their immune system is capable of containing its spread. 
With continuous increase in cases of HIV and AIDS, an increase in tuberculosis cases 
is expected because of reactivation of dormant infections. Consequently, the death toll 
from TB is expected to rise dramatically.
Although tuberculosis was being considered a disease of the developing world, 
attitudes are changing with the recent scare occurring in the USA which is 
summarized by the words of P.Brown (1992): "The west thought it had conquered 
tuberculosis. But collapsing public health systems and increasing poverty have given 
the disease a chance to fight back". An even more dreadful situation is the 
occurrence of ’superbugs’ which are strains resistant to all eleven drugs employed in 
the treatment of patients with tuberculosis. It is up to the clinicians, epidemiologists, 
microbiologists and the world at large to cooperate in controlling tuberculosis, or be 
controlled by it.
Initially, it was thought to be a disease of the respiratory system only. But findings 
have unveiled it as a multisystemic disease affecting almost every part of the body.
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The main route of infection is oral/respiratory, but wound contamination has also been 
implicated.
Types of Tuberculosis.
When M. tuberculosis becomes established in some part of the body, there is the 
resultant disease. The symptoms will depend on the part affected and may resemble 
the symptoms of diseases caused by other agents (Domingo et al, 1990., Ormerod, 
1989). The different types of tuberculosis include:
Respiratory tuberculosis which is evident when the lungs are infected. It is the most 
common form of TB. Coughing is the most apparent symptom. Other cases of 
tuberculosis, although rare, include penile tuberculosis (Annobil et al, 1990), 
tuberculosis of the breast (Domingo et al, 1990), tubercular meningitis (Humphries 
et al, 1990), hepatic tuberculosis (Shyr-Ming et al, 1990), tuberculosis of the bone 
(Ormerod et al, i989) and infections of the lymph nodes. All these rare forms of 
tuberculosis would usually present symptoms not normally associated with 
tuberculosis. In the case of the bone TB, it was initially thought to be a case of 
disseminated carcinoma. Hence reliable and rapid screening methods are being 
sought.
Progress of Tuberculosis. Infections due to M. tuberculosis are usually acquired 
through the nasal/oral route although rare portals like broken skin do exist. Whereas 
some infected individuals do not come down with the disease, others are subsequently 
killed by tuberculosis. Some predisposing factors for the development of the disease 
include alcoholism, congenital or acquired immunodeficiency, immunosuppressive 
drugs, diabetes, malnutrition, old age, and stress.
The first step to infection via the nasal/oral route is by inhalation of the bacilli and 
their subsequent migration to the alveoli in the lungs. Ingestion of milk contaminated 
with M.bovis may lead to establishment of the bacilli in the tonsils and intestine, 
subsequently causing disease.
In the alveoli, the bacilli are phagocytized by macrophages. They may be destroyed
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by the macrophages. If they survive, they gain protection within the macrophages 
and multiply. Subsequent lysis of macrophages results in the release of bacilli which 
may trigger the disease process. The resultant disease due to infection with 
M.tuberculosis is due to complex immunological reactions mounted by the body’s 
defence mechanism against the invading bacilli, which may lead to destruction of the 
bacilli and even host tissue in severe cases (See Immunology of mycobacterial disease: 
Grange, (1988); and Owen et al, (1988) for details on immunological responses.) 
Hypersensitivity reaction against bacilli released from lysed macrophages leads to the 
formation of a tubercle which comprises tissue cells, disintegration products of bacilli 
and leucocytes, some live bacilli and a necrotic centre. Necrosis of the tubercle leads 
to the formation of a caseous lesion with a cheese-like constituency.
There are two types of lesions associated with the tuberculosis disease process: 
Exudative and Productive lesions.
Exudative lesions are usually seen in lung tissue and are characterized by acute 
inflammatory reaction, edema fluid, polymorphonuclear leucocytes and monocytes 
around the bacilli. Productive lesions are characterized by chronic granuloma, 
caseation, tubercle formation.
If the caseous lesions heal, they become calcified and form Ghon complex. The 
caseous lesion may also undergo liquefaction, creating a suitable environment for 
bacterial multiplication. This will lead to spread of the bacilli to the lymph nodes and 
lymphatics, resulting in widespread dissemination of the pathogen.
The lesions may even erode blood vessels. A subsequent rupture of the lesion 
releases the bacilli into the blood stream giving rise to a condition called miliary 
tuberculosis. The body’s defences are now overwhelmed. Miliary tuberculosis is 
characterized by symptoms which include weight loss, coughing blood, and weakness. 
A characteristic of miliary tuberculosis is wide spread dissemination of the bacilli with 
the result being the appearance of other rare forms of tuberculosis (Jawetz et al, 1989, 
Grange, 1988).
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Prevention and Treatment of Tuberculosis Infection.
The use of the BCG vaccine to counter or control the spread of infection is only valid 
if the individual was vaccinated prior to infection by M. tuberculosis. The success 
of immunotherapy employing killed suspensions of M.vaccae have been reported in 
Kuwait (Stanford, J.L., 1989), but this method of treatment is not yet widespread. 
Hence chemotherapy is the best option that is widely available in a situation where 
the bacilli have established a foothold in the host.
The drugs of choice for the treatment of tuberculosis are isoniazid, rifampicin, 
streptomycin, ethambutol and pyrazinamide. The strategy normally employed for 
treating cases of tuberculosis is by employing drugs in concert. This strategy is vital 
if one is to prevent the occurrence of drug resistant strains. Chemotherapy is usually 
a long term program covering at least six months and even as long as one year. This 
long term treatment course is vital because some bacilli are normally shielded from 
contact with the drug by the macrophages. Subsequent death and lysis of the 
macrophages will inevitably expose the bacilli to the drug.
Isoniazid (INH). This is a common agent employed in the therapy and control of 
mycobacterial infections due to M.tuberculosis and M.bovis, against which it has 
a high activity. It is a bactericidal agent and requires active growth of the organism 
to be highly effective. It is thought to inhibit mycolic acid synthesis and this is 
accompanied by loss of acid fastness.
Some strains develop resistance to isoniazid and this is accompanied by reduction or 
loss of catalase and peroxidase activity (Dunbar et al, 1959). Genetic studies on 
isoniazid resistance in M. tuberculosis and M.smegmatis revealed the involvement 
of the kat G gene which encodes both catalase and peroxidase, and this gene is 
similar to that found in E.coli (Zhang et al, 1992b). Subsequent studies revealed 
M. tuberculosis strains which have lost kat G were resistant to INH. But other 
events such as insertions or point mutations may lead to reduced/loss of catalase
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activity, hence conferring resistance to INH.
Despite being highly successful, INH has been associated with psychotic behavior in 
some patients, hence close patient supervision is required (Madan et al, 1989).
Rifampicin. This drug is very active against M.tuberculosis and is also effective 
against M. leprae. It interferes with transcription and RNA elongation by binding to 
the 8-subunit of DNA dependent RNA polymerase, leading to inhibition of RNA 
synthesis. This subsequently leads to the inhibition of protein and DNA synthesis. 
Telenti et al.(1993) have analyzed the rpoB gene (which encodes the RNA polymerase 
8 -subunit) in some M.tuberculosis isolates and discovered that rifampicin resistant 
phenotypes exhibited mutations which were clustered in a region of eight codons. 
These mutations gave rise to amino acid substitutions, resulting in conformational 
changes and defective binding of the drug. Rifampicin resistant M. leprae also have 
mutations within rpoB with one serine residue most commonly affected (Honore et 
al, 1993).
In the treatment of cases of tuberculosis, it is usually employed in concert with 
isoniazid as resistance quickly develops when used alone. It is more bacteriostatic 
than bactericidal for mycobacteria. Side effects include impairment of liver function, 
and thrombocytopenia.
Streptomycin. This is an aminoglycoside antibiotic that can either be bactericidal or 
bacteriostatic. It inhibits protein synthesis by binding to the ribosomes (Vogel et al, 
1970). Growth of the organism is necessary for its bactericidal action. 
Hypersensitivity to streptomycin may result in skin rashes and fever. It can cause 
impairment of the nervous system.
Ethambutol. The mechanism of action of this drug is not known. It is usually 
employed in concert with isoniazid. Visual disturbance is the commonest side effect 
associated with this drug.
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Cycloserine is active against a wide range of bacteria. It inhibits the utilization of D- 
alanine, thereby inhibiting peptidoglycan synthesis. It is normally employed as a 
second line drug for the treatment of tuberculosis. It is a neurotoxic drug hence 
rarely employed in treatment regimes.
Neomycin and kanamycin are also aminoglycoside antibiotics which inhibit protein 
synthesis by binding to the 30S ribosomal subunit. Their use in chemotherapy is rare, 
due to the toxicity of neomycin in particular.
Para-aminosalicyclic acid (PAS). It is thought to inhibit dihydropteroate synthetase. 
Severe gastrointestinal disturbances are associated with this drug.
Problems with Chemotherapy.
In addition to the adverse side effects already covered, there are other difficulties 
encountered when administering chemotherapy.
In addition to the protective shield provided by the macrophages, caseous material 
may also interfere with drug action.
Development of drug resistance. This is a common problem which frequently arises 
from drug overuse and non-compliance by the patient. Due to the length of the course 
of treatment, patients may start feeling better at one stage and may decide to miss out 
on doses or prematurely terminate the treatment course. The patient will still carry 
the pathogen and remain a potential source of infection. Such a situation creates an 
environment with mutational pressures in favor of development of drug resistance. 
In some cases, strains may develop resistance to more than one drug. Patients may 
either contract this drug resistant strain from an external source, or the strain may 
develop resistance through prolonged exposure to the drug inside the patient.
The application of two or more drugs in concert will help to eradicate drug resistant 
strains, but the decision on which drugs to employ will have to take into consideration 
the areas of residence of the bacilli, the side effects of the drug as well as the problem
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of drug resistance.
Some drugs are known to penetrate into certain areas in effective concentrations while 
others do not achieve high concentrations. Isoniazid is known to penetrate into the 
cerebrospinal fluid a short time after administration and reaches high concentrations 
(Fletcher, 1953.), whereas rifampicin does not appear to cross into the cerebrospinal 
fluid (CSF) in high concentrations. The highest concentration attainable for 
rifampicin is just about its minimum inhibitory concentration (MIC), hence its 
contribution to therapy will at the most be marginal in infections involving the CSF 
(Humphries et al, 1990).
Another problem confronting chemotherapy of tuberculosis infections is the slow 
growth of the organism. M. tuberculosis has a generation time of about 18 hours. 
There is also the presence of metabolically inactive non-proliferating persisters in 
chronic lesions which are not sensitive to drug action, but they can be reactivated to 
start growing and subsequently cause tissue destruction. These slow dividing and 
non proliferating strains pose a problem since many antibiotics are only active against 
actively dividing cells.
Different species of mycobacteria exhibit different Minimum Inhibitory Concentration 
values for drugs. Members of the M. avium-intracellulare complex are resistant 
to all antituberculous drugs at concentrations which inhibit wild M. tuberculosis 
strains (Truffot-Pernot et al, 1991). This implies there is the need for new drugs 
which can penetrate the site of infection in adequate amounts. It also shows the 
importance of proper identification of the organism before commencement of 
chemotherapy, as application of inadequate amounts of the drug may easily lead to the 
appearance of drug resistant strains.
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1.4 Some Methods Employed in the Identification of Mycobacterial Species.
This section will concentrate on members of the M.tuberculosis complex, but the 
same methods are also applicable to other mycobacterial species. Special references 
may be made regarding other species were appropriate. The methods already covered 
will not be looked at in detail.
The methods employed in identifying mycobacteria include microscopy, biochemical 
methods, immunological methods, gene detection systems, physical identification 
(based on pigmentation, colonial morphology), assessment of growth under different 
conditions which include growth on nutrient agar, growth at different temperatures. 
Usually, more than one method is employed to confirm the identity of a particular 
isolate. In certain situations like the case in paucibacillary infection, failure to detect 
or isolate the pathogen does not rule out its presence. It simply shows the low 
sensitivity of the detection system.
See Chadwick, (1982), Grange, (1988) for details.
1.4.1 Microscopy.
The first step in the identification procedure involves the collection of specimens from 
the patients. If pulmonary tuberculosis is suspected, the specimens could be sputum, 
bronchial washings, or laryngeal swabs. Other specimens for detection of 
mycobacteria include urine, blood, pus, biopsies, cerebrospinal fluid, stools, bone 
marrow. Although blood, bone marrow, stool, urine are not suitable for routine 
microscopy, they can be employed to isolate the organism in culture.
The specimen is then fixed, stained and viewed under the oil immersion lens. 
Identification of mycobacteria using a microscope normally depends on a staining 
technique which will be able to differentiate mycobacteria from other organisms. One 
widely used staining technique is the acid fast staining technique. Mycobacterial 
species will appear pink to red under the microscope.
To avoid false positives which result from contamination of one slide by another, it 
is advisable to refrain from blotting the smears.
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In order to carry out culturing of the bacilli from a specimen, one has to carry out 
decontamination procedures (see Grange, 1988., Groothius, 1989 for details). This 
is vital due to the presence of contaminants which include fungi and other bacteria. 
If they are not eliminated, these contaminants will rapidly overgrow the medium, 
hence suppressing the growth of the mycobacterial species. Since mycobacteria are 
relatively resistant to acids, alkalis and some disinfectants compared to other 
microorganisms, these chemicals are applied in the decontamination procedure.
The Lowenstein-Jensen (L-J) culture media is usually employed in the isolation of 
mycobacterial species. It is an egg-based medium which contains asparagine, glycerol 
and mineral salts. The dye, malachite green, is also incorporated to serve both as an 
inhibitory agent to certain bacteria, and to give a better background against which the 
colonies can be easily spotted.
For work other than primary isolation of mycobacteria, other media which include 
Dubos 7H9 broth and 7H10 agar can be employed. Appropriate growth supplements 
may be added to these media depending on the specific requirements of the organism.
1.4.2 Biochemical Techniques.
They include tests for niacin production, catalase or peroxidase activity, nitrate 
reduction, tellurite reduction and arylsulphatase test.
The biochemical activities are usually recorded as production of a color, production 
of a gas, growth or failure to grow.
These tests indicate a broad range of activities carried out by the members of the 
mycobacteriaceae. Some cross species reactions are evident, but nonetheless, these 
tests may aid in identification procedures. The number of different tests needed for 
the full confirmation of a species makes this scheme laborious and expensive. See 
table 1 .2  for a summary of results on identification methods for mycobacteria, and 
table 1.1 for further classification of members of the M.tuberculosis complex.
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Table 1.2: Identification procedures for Mycobacteria.
Test
M. tuberculosis. M.bovis. Atypical
Mycobacteria.
INH sen. INH res.
Acid fast + + + + :
Colonial
Morphology
R R D R, S, D.
Growth on 
Nutrient Agar
- - - + or -
Pigmentation B B B B, Y, O.
Niacin
Production
+ + -
Catalase + - + +
Peroxidase + - + or - -
Growth on 
PNP
- - - +
Growth at 
25°C
- “ +
Chadwick, (1982).
B(Buff), Y(Yellow), O(Orange).
* M.bovis strains may give a weak niacin reaction, but generally , it is negative. 
The rapid growers are generally the only atypical mycobacteria to grow on nutrient 
agar.
PNP(Para-Nitrobenzoic acid)
R(Rough), S(Smooth), D(Dysgonic).
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1.4.3 Immunoassay Methods.
This procedure has been employed in serotyping and it involves serodiagnosis of 
antigenic components of the bacilli and also detection of bacilli in other specimens 
using immunological techniques like enzyme-linked immunosorbent assay (ELISA) 
(Grange, 1989) and latex agglutination tests. There is also the tuberculin test which 
can be employed to test for the presence of mycobacterial antigens in an individual. 
While modern immunoassay methods have overcome the problem of sensitivity, there 
is the problem of specificity to be solved. No single species specific antigen of 
M.tuberculosis has been shown to be significantly elevated in all cases of the 
disease. There is also the problem of antigenic cross reactions among mycobacterial 
species and with species of other genera (Grange, 1989). In general, serological and 
immunological tests (other than skin testing) are not widely used in the diagnosis of 
tuberculosis.
1.4.4 Identification of specific products of metabolism.
Analysis of lipid composition by thin layer chromatography has revealed four main 
mycobacterial mycolates which can distinguish between mycobacterial species. These 
mycolate groupings are exemplified by M.avium, M.tuberculosis, M.fortuitum, 
M.chelonae. M.tuberculosis and M.bovis presented a characteristic pattern of 
alpha- methoxy and keto mycolates (Minnilcen et al, 1980).
The detection of tuberculostearic acid by a combination of gas chromatography and 
mass spectrophotometry (Grange, 1989) is sensitive and specific for M.tuberculosis 
but patients on amikacin have been observed to give false positive results.
Analysis of protein profiles by SDS-PAGE has also been shown to differentiate 
between mycobacterial species. Both intra-strain (in the case of BCG) and
interspecies (in the case of M.tuberculosis and BCG) differentiation have been 
observed. (Abou-zeid et al, 1986., 1988).
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1.4.5 BACTEC detection system (developed by Johnson and Johnson) is a
radiometric method for detection of microorganisms. The bacilli are grown in a 
special 7H12 broth, utilizing 14C substrates hence producing radioactive labelled C02 
in the space above the broth. The amount of radioactive-labelled C02 is measured and 
assigned a growth index. A growth index greater than ten is regarded as positive. 
The positive attribute to this method is that it is quicker with an average detection 
time of about 10 days compared to 17 days for conventional culture techniques.
1.4.6 Genomic Detection Systems.
1.4.61 Gene Probe Detection System.
This test was developed by GEN-PROBE and involves the hybridization of single 
stranded 125I-labelled DNA probes with complementary ribosomal RNA giving a 
DNA-RNA hybrid. The double stranded hybrid is then separated from the single 
stranded molecules and the amount of radioactivity emitted by the DNA-RNA hybrid 
is measured. The result is calculated as % of input probe that has hybridized. A 
hybridization of 10% is regarded as positive. The advantages of this method include 
its automation and its high specificity for members of the M.tuberculosis complex. 
But it does not differentiate between the members of the M. tuberculosis complex.
1.4.62 Other probes and the PCR.
Labelled nucleic acid probes can be used to detect complementary DNA strands bound 
onto a solid support like a nylon membrane. This method can be used, in concert 
with an appropriate restriction enzyme, to generate characteristic restriction fragment 
length polymorphism (RFLP) patterns which can be employed to effect species and 
strain differentiation. In a situation where the amount of DNA in the sample is 
minute, the polymerase chain reaction (PCR) can be employed to amplify particular 
sequences, employing primers derived from the region flanking the DNA fragment of 
interest. The PCR product may then be detected with the labelled probe, implying 
the sensitivity of the labelled probes can be enhanced by PCR.
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The sensitivity of both nucleic acid probes and immunoassays is put at about 104 
organisms per millilitre and this can also be achieved by careful microscopy (Daniel, 
1989). Despite the successes of these detection methods, there exist some inherent 
problems which include high cost of machinery and training of man power, instability 
of reagents, false results and low specificity in some cases. But the problems of false 
results and low specificity are encountered to a lesser extent using gene probes.
1.5 Typing Schemes for Mycobacterial species.
Typing schemes are procedures which when employed, will generate data which can 
be applied in fields such as epidemiology and nomenclature. The objectives of typing 
schemes is to group isolates according to similarities they share. The groupings 
defined by one typing scheme will usually differ to that defined by another scheme. 
This implies the scheme of choice will depend on the specific needs of the researcher.
1.5.1 Serotvping. (See immunoassay methods, above).
Serotyping has been widely applied in characterizing members of the M. avium 
complex (Wolinsky and Schaefer, 1973) compared to other mycobacteria. But other 
more specific typing schemes have shown that some strains classified as 
M.intracellulare are actually M. avium (McFadden et al, 1987b).
1.5.2 Phage Typing.
This scheme relies on the ability of certain bacteriophages to lyse members of the 
M. tuberculosis complex and other mycobacteria. These phages are termed 
mycobacteriophages and they are known to be common in the environment. 
Mycobacteriophages may differ in host range, morphology, antigenic structure, and 
plaque morphology.
In order to infect a cell, there must be suitable phage receptors on the cell surface 
for the phages to adhere to the cell, and the cell must lack systems that restrict the 
phage DNA.
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Table 3 shows the result of employing eight mycobacteriophages (DS6 A, AG1, GS4E, 
BG1, PH, BK1, D34, 33D) to type M.tuberculosis and BCG. M.tuberculosis 
can be divided into four phage types A,I,B,C while BCG is seen to form a separate 
phage type (Grange, 1982).
Phage typing is also seen to define geographical locations of the bacilli. Phage type 
B is common to Europe and America. Phage type I is common to Asia. Most of the 
strains from Hongkong, Japan and Central Africa were of phage type A. M.bovis 
strains were also seen to belong to type A, and differed from BCG in being 
susceptible to phage 33D. Despite its proven ability to type strains, phage typing is 
not widely used due to problems of discriminating power and reproducibility.
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Table 1.3. Major Bacteriophage Types of M tuberculosis complex.
Phage
type
DS6 A AG1 GS4E BG1 PH BK1 D34 33D
A + + - - - - - +
I + + + + + - - +
B + + + + + + - +
C + + + + + + +
BCG + + - - - - - -
Source: Grange ( 988). Mycobacterial diseases
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1.5.3 Genomic Typing.
One part of this report will cover exercises based on the genomic typing scheme as 
applied to members of the M.tuberculosis complex.
This scheme relies on the generation of unique restriction fragment length 
polymorphism (RFLP) patterns for different strains. The RFLP pattern generated for 
each isolate will depend on the distribution of the restriction sites for that 
endonuclease in the genome. Employing appropriate restriction endonucleases will 
yield characteristic patterns for different strains and species. Digestion of total 
genomic DNA with BstEII (Collins et al, 1985.) has revealed patterns which 
distinguish between members of the M.tuberculosis complex. The patterns also 
show a close relationship between M.tuberculosis, M.bovis and M.africanum 
while M.microti was shown to be a distant relative. DNA probes derived from BCG 
(Cooper et al, 1989) have been employed to show that although M.tuberculosis and 
M.bovis are closely related, they are genetically distinct. However, this probe could 
not distinguish between M.bovis strains.
Some species harbor unique sequences which are repeated many times in the genome. 
The number and location of these repeated sequences may vary with different isolates, 
hence these repeated sequences provide a suitable target for generating restriction 
fragment length polymorphisms.
Some of these repeated sequences known as insertion elements, have the ability to 
replicate and insert at various locations within the genome. They may also show 
species specificity.
The ability of the element to replicate and translocate may vary among strains within 
the same species, hence creating an ideal situation for generating unique RFLPs. 
RFLP patterns could then be employed in epidemiological analysis to define the origin 
and monitor the spread of particular strains of M.tuberculosis complex, hence 
enabling suitable management and control measures to be carried out. See chapter 3. 
In this study, the insertion sequence known as 186110 has been employed in typing 
members of the M.tuberculosis complex.
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1 .6 The Insertion Sequence IS6110.
Initial work on generating RFLP of mycobacterial genomic DNA was done by 
digesting the DNA with a restriction enzyme, separation of the resultant fragments on 
a gel followed by staining the gel with ethidium bromide. By analysis of the variation 
in the banding patterns, species differentiation could be achieved (Patel et al, 1986). 
But the method is not specific enough to differentiate reliably between strains of a 
particular species.
The use of total chromosomal DNA probes (Roberts et al, 1987) is much more 
sensitive and some strain differentiation can be achieved, but cross hybridization 
between species is a problem.
The employment of cloned DNA fragments as probes gives more specific and clearer 
results. Repetitive sequences are commonly used for this purpose (Eisenhach et al,
1988., Reddi et al, 1988., Zainuddin et al, 1989., Hermans et al, 1990). Some 
repetitive sequences, although capable of species and strain differentiation, are not 
highly specific (Reddi et al, 1988) whereas others show high species specificity 
(Hermans et al, 1990., Thierry et al, 1990b).
One such repetitive sequence has been reported by Zainuddin and Dale (1989), 
Eisenhach et al,(1988). It has been cloned and sequenced by McAdam et al.(1990), 
and an almost identical sequence has been reported by Thierry et al. (1990 a,b). It has 
been found only in members of the M.tuberculosis complex, hence having a great 
potential for employment in typing and detection of members of the M.tuberculosis 
complex. This repeated sequence has been observed to be a member of the IS3 family 
of insertion elements and it has been christened IS986 (McAdam et al, 1990). It is 
1358bp in size with 30bp inverted repeats at the ends.
Thierry et al, (1990 a,b) have named the element they isolated IS6110. Because 
IS986 and 186110 are similar elements, an agreement was reached to refer to this 
class of elements as 186110, unless a specific copy was inferred (van Embden et al, 
1993).
The probes employed in this project for the analysis of DNA from members of the
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M. tuberculosis complex have been obtained from parts of IS986.
The occurrence of many copies of IS 6110 in some members of the M. tuberculosis 
complex indicated this element had the ability to duplicate itself and insert the 
daughter copy at a new location. This phenomenon is known as transposition (see 
chapter 4.)
Experimental demonstration of transposition of IS6110ot IS986 has not been hitherto 
established. The second part of this report will be describing attempts to demonstrate 
transposition of IS986. IS986 has been shown to exhibit three identifiable open 
reading frames (ORF). ORFal, ORFa2, and ORFb are on one strand while ORFc is 
found on the complementary strand. ORFal and ORFa2 are separated by a frame 
shift, while ORFb is thought to code for the transposase.
Demonstration of such an event will pave the way for generating gene couriers (based 
on the IS9S6 transposition system) which will be able to deliver foreign genes into 
mycobacterial species. This may have far reaching effects in vaccine development and 
the study of gene expression in mycobacteria (England et al, 1991).
Such a system may also be employed in mutagenesis studies due to insertion of this 
IS9cS<5-based courier system.
Finally, the different methods employed in attempts to demonstrate transposition of 
IS986 will be highlighted, while the possibilities and shortfalls of the results obtained 
in these exercises will be discussed and compared with similar systems already 
achieved.
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Chapter 2
MATERIALS AND METHODS.
2.00 Part A. Materials.
2.01; Chemicals. Other Materials and Suppliers.
Amersham International Pic.
Hybond-N™ Nylon membranes, Radioactive nucleotides, Multiprime DNA labelling 
kit.
Applied Biosystems.
Reagents and other components for the synthesis of oligonucleotides.
BDH Chemicals Ltd.
Ammonium acetate (Analar), Ammonium persulphate, ortho-Boric acid (Analar), 
Calcium chloride 6 -hydrate, Glycine (Analar), D-Glucose, Dimethyldichlorosilane 
solution, Silane A-174, Propan-2-ol(Aristar), Liquid paraffin, Maltose, Sodium 
dihydrogen orthophosphate dihydrate, Disodium hydrogen orthophosphate, Sodium 
acetate anhydrous (Analar), Trisodium citrate (GPR™), Sucrose (Analar), Tween 80, 
Phenol (Analar).
Boerhinger Mannheim Biochemica.
Taq DNA polymerase from Thennus aquaticus BM, Calf intestine alkaline 
phosphatase (CIAP), DNA labelling and detection kit Non-radioactive.
Difco.
Bacto Middlebrook 7H9 broth (dehydrated), Bacto Mycobacteria 7H11 agar 
(dehydrated), Middlebrook OADC enrichment.
F.S.A. Laboratory supplies.
Acetic acid (glacial), Sodium hydroxide (pellets).
40
Fuji photo film Co.Ltd.
R.X X-ray film, Polaroid films-type 665 (positive\negative), type 667 (positive only.)
DOW chemical Co.
Saran-wrap.
Gibco-BRL.
Agarose(ultra-pure), DNA molecular weight markers, Cesium chloride(optical grade), 
E.coli DH5or™ maximum efficiency competent cells, Restriction enzymes and 10X 
react buffers, Ribonuclease A, Taq DNA polymerase, T4 DNA ligase.
Hay man Ltd.
Ethyl alcohol (99.86% v/v)
May and Baker.
Chloroform, Glacial acetic acid, Hydrochloric acid, Sodium chloride (AR).
New England Biolabs.
Sph I linker (phosphorylated).
Oxoid.
Agar Bacteriological (n°l), Nutrient broth, Nutrient agar, Tryptone, Yeast extract. 
Pharmacia.
Ribonuclease A (DNase-free.), pUC18, pUC19, pUC4k.
Sigma Chemicals Co.
Ampicillin, Bovine serum albumin (BSA) fraction V (nuclease-free), Brij-58, 
Chloramphenicol (crystalline), N,N-dimethylformamide (DMF), D-L-dithiothreitol 
(DTT), Deoxycholic acid, Ethidium bromide, Ethylene diaminotetracetic acid
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(EDTA), Ficoll type 400, Formamide, HEPES, Herring testis DNA (type XIV), 8 - 
hydroxyquinoline, Isoamyl alcohol, Kanamycin monosulphate, N-Laurosarcosine 
(Sodium salt), Lithium chloride (anhydrous), Lauryl sulphate(SDS) sodium salt, 
Lysozyme, Nalidixic acid (sodium salt), Polyvinylpyrollidone (PVP), Maleic acid, 2- 
mercaptoethanol, Methacryloxypropyl-trimethoxy silane, Dimethyl dichlorosilane, 
Protease (Proteinase K), Urea (ultra pure), Spermidine, Tween 80, Trizma base, 
Tween 20, Trimethoprim, N,N,N’N’-tetramethyl ethylenediamine (TEMED).
Stratech Scientific Ltd.
Geneclean II kit.
Whatman Laboratories Ltd.
Whatman 3MM filter paper.
United States Biochemicals(USB).
Sequenase version 2.0 DNA sequencing kit.
Northumbria Biologicals Ltd.(nbl).
IPTG (Isopropyl 8 -D-thiogalactopyranoside, X-gal (5-bromo-4-chloro-3-indolyl~fl-D- 
galactopyranoside, Restriction enzymes and 10X React buffers.
Gel tanks.
BRL H5, BRL H6 , BIORAD DNA SUB CELL™, Pharmacia GNA-100.
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2 .02; Strains employed.
A. Strains other than members of the M.tuberculosis complex.
E.coli DH5ce. F  ,<f>80dlacZChM15, £i (lacZYA-argF)U169,recAl,endAl,hsdRl7(rk- 
,mk+), supE44,lambda-,thi-l,gyrA,relA (BRL).
E.coli JM109. recAl supE44 endAl hsdRl7 gyrA96 relAl thi Ci(lac-proAB) 
F 7 traD36proAB + lacl HacZ(hM15] (Promega).
JD103: J53(R388) TpRSulR.
JD127: J62(R64drd) S m ^ ef.
JD157: J62 NalR.
2.03; Plasmids.
pUC18, pUC19, pUC4K (Pharmacia)
pAT153.
2.04; Culture Media.
Media and solutions were sterilised by autoclaving at 121°C (15 p.s.i) for 15 minutes 
or by filtration through a 0.2jum FlowPore D filter.
(i) Luria-Bertani (LB) medium (agar).
Bacto tryptone lOg
Bacto yeast extract 5g
NaCl lOg
water to 1 0 0 0ml, autoclaved.
LB agar contained 15g/litre of Bacto agar, autoclaved.
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(ii) 50x salts
MgS04.7H20  lOg
Citric acid lOOg
K2HP04 500g
NaNH4(HP04) . 4H20  175g
water to 1 0 0 0ml.
Autoclaved.
(iii) Minimal medium 
Bacto-agar 7.5g
Glucose l.Og
water to 500ml, Autoclaved.
10ml of 50x salts was added after autoclaving.
(iv). 2x TY medium (agar).
Bacto tryptone 16g
Bacto yeast extract lOg
NaCl 5g
water to 1 0 0 0ml.
2x TY agar contained 15g/litre of Bacto agar.
Autoclaved.
(v) Middlebrook 7H9 broth.(Difco).
4.7g of dehydrated 7H9 formula in 900ml of distilled water containing
0.1% Tween 80. Autoclaved. OADC enrichment was added to 10% prior to use.
(vi) Middlebrook 7H11 Agar. (Difco)
21g of dehydrated 7H11 formula in 900ml distilled water, dissolved by heating and 
autoclaved. OADC enrichment was added to 10% on cooling to 55°C. The plates 
were then poured.
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2.05; General Buffers and Solutions
(i) TE Buffer
Tris
EDTA
lOmM
ImM
pH 8.0 with HC1, autoclaved.
(ii) STE 
NaCl 
Tris 
EDTA
lOOmM
lOmM
ImM
pH 7.5 with HC1, autoclaved.
(iii). Sodium acetate 
3M Na acetate
pH 5.2 with glacial acetic acid.
Autoclaved
(iv) Ammonium acetate 
5M solution
Filter sterilised.
(v)a. Phenol/chloroform
Phenol:chloroform was prepared as a 1:1 (v:v) mixture, saturated with 1M 
Tris.HCl (pH 8.0) and stored in the presence of the antioxidant 8-hydroxyquinoline 
(0 . 1 % w/v).
(v)b. Chloroform:isoamyl alcohol (49:l,v:v).
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2.06; Enzyme Buffers
(i). lOx Kinase buffer
Tris-HCl (pH 7.5) 700mM
MgCl2 lOOmM
KC1 ImM
DTT 50mM
Spermidine ImM
EDTA ImM
(ii). lOx Calf intestinal alkaline phosphatase buffer 
Tris.HCl (pH 8.0). 500mM
MgCl2 lOmM
ZnCl2 ImM
(iii). lOx restriction endonuclease buffer.
DNA restriction endonuclease buffers were supplied with the enzyme and used 
according to the manufacturer’s instructions.
(iv) 5x ligase buffer.
Tris.HCl (pH 7.5). 250mM
MgCl2 50mM
ATP 5mM
DTT 5mM
PEG8000 25%
This buffer was supplied with T4 DNA ligase by BRL.
46
2.07; Solutions for Transformation of Escherichia coli
(i) SOC
Bacto tryptone 2% (w/v)
Bacto yeast extract 0.5% (w/v)
NaCl lOmM
KC1 2.5mM
MgCl2 20mM
MgS04 20mM
Glucose 20mM
pH 7.0
SOC was prepared and autoclaved in the absence of the magnesium salts and glucose. 
Filter sterilized magnesium salts and glucose were then added prior to use.
2.08; Solutions for DNA Electrophoresis.
(ia) lx TAE (Tris-acetate)
Tris-acetate 40mM
EDTA 2mM
pH to 8.0 with glacial acetic acid.
It was made as a 50X stock solution which was diluted to IX just before use.
(ib) lx  TBE (Tris-borate)
Tris-borate 89mM
Boric acid 89mM
EDTA 2mM
It was made as a 10X stock solution which was diluted just before use.
(ii) DNA loading buffer, (6 x). 
Bromophenol blue. 0.25% (w/v)
Xylene cyanol. 0.25% (w/v)
Sucrose. 40% (w/v)
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2.09; Solutions for DNA Hybridisation (Radioactive).
(i). Denaturing solution
NaCl 1.5M
NaOH 0.5M
(ii). Neutralising solution 
NaCl 1.5M
Tris.HCl pH (7.2) 1.0M
(iii). 20x SSC 
NaCl
Tri-sodium citrate 
Autoclaved.
(iv). Phosphate buffer (0.2M) pH 6.5 
Na2HP04 18.75 ml, 0.2M
NaH2P04 31.25 ml, 0.2M
Water 50ml
(v). 50x Denhardt’s solution 
Ficoll 5g
Polyvinylpyrrolidone 5g
Bovine serum albumin 5g
(Fraction V)
water to 500 ml. The stock solution was distributed in 20ml amounts and stored at - 
20°C.
3.0M
0.3M
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(vi). Prehybridisation/hybridisation solutions:
DNA hybridisations:
SSC 6 x
SDS 0.5% (v/v)
Denhardt’s solution 5x
EDTA lOmM
Phosphate buffer 4mM
(pH 6.5)
Denatured Herring testis DNA, 10/xg/ml.
2.10. Solutions for Plasmid Extraction from Bacteria.
(i).
Glucose 
EDTA pH 8.0 
Tris.HCl pH 8.0
(ii).
NaOH 0.2M
SDS 1.0% (w/v)
(iii). Potassium acetate (3M potassium 5M acetate). 
Prepared as follows:
60ml 5M potassium acetate
11.5 ml glacial acetic acid
28.5 ml water
(iv). Sucrose solution.
Sucrose 25 % (w/v)
Tris.HCl pH 8.0 0.05M
50mM 
lOmM 
25 mM
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(v) Brij-Doc solution.
Brij 58 1% (w/v)
Sodium deoxycholate 0.4% (w.v)
in lx TE pH 8.0
(vi). Isopropanol saturated with Caesium chloride (CsCl).
CsCl (10g) dissolved in STE (10ml). Isopropanol (100ml) was added and the mixture 
allowed to settle overnight.
2.2; Part B. Methods
2.2.1; Ethanol Precipitation of Nucleic Acid.
DNA was precipitated employing one of the following methods.
Method A. Addition of 0.1 volume of 3M sodium acetate (pH5.2) followed by two 
volumes of ethanol.
Method B. As for method A, except that an equal volume of isopropanol (2-propanol) 
was substituted for ethanol.
Method C. Addition of 0.01 volume of 5M sodium chloride solution followed by 2.0 
volumes of ethanol.
Method D. Ammonium acetate was added to a final concentration of 2.5M (i.e. 1 
volume of 5M ammonium acetate) followed by the addition of 3.0 volumes of ethanol. 
After the addition of ethanol (or isopropanol) the solutions were mixed and incubated 
on ice for 30 minutes (room temperature, 5mins., in the case of isopropanol) or for 
shorter time periods at -20°C or -70°C. The DNA was precipitated by centrifuging
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at lOOOOg for 20 mins. The DNA pellet was washed in 70% (v/v) ethanol and dried 
in a vacuum prior to resuspending in TE buffer pH 8.0 or distilled water. In the case 
of isopropanol, the DNA was re-precipitated using ethanol.
2.2.2; Extraction of Solutions of Nucleic Acid with Phenol-chloroform.
An equal volume of phenol-chloroform was added to the nucleic acid solution and 
mixed. The aqueous and organic phases were separated by centrifugation (lOOOOg, 
5 mins) and the aqueous phase was transferred to a fresh tube. The extraction 
procedure was repeated until the interphase was clear of debris. A final extraction 
was performed using an equal volume of chloroform in isoamyl alcohol.
2.2.3; Quantitation of Nucleic Acid in Aqueous Solution.
The concentration and purity of nucleic acid in aqueous solutions was estimated by 
measuring the u.v. absorbance of the solution over the wavelength range of 
220-300nm. A pure solution of DNA has a peak absorbance at 260nm, and a 
260nm/280nm ratio 1.8 (Sambrook et al., 1989). The concentration of nucleic acid 
was calculated employing A260= l  equivalent to 50jug/ml for double stranded DNA, 
while using the value A260= l  equivalent to 33jug/ml for oligonucleotides.
2.2.4; Agarose-gel Electrophoresis.
DNA Electrophoresis.
In general, gels were run at 100 volts for a time dependent on the gel dimensions 
and the agarose concentration. Gels were cast and run in lx TAE with samples 
loaded in 1 x loading buffer. After electrophoresis, gels were stained with ethidium 
bromide (0.5jug/ml) for 20minutes and DNA bands visualized under u.v. light.
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2.2.5; Extraction of Bands Separated on a Gel.
The geneclean kit (Geneclean II) prepared by BIO 101 was used for extracting DNA 
separated on a gel. The kit contains sodium iodide, glassmilk and new wash buffer. 
The DNA containing the fragment of interest was digested with the appropriate 
restriction enzyme. The digested DNA was then run on a gel alongside suitable DNA 
markers until good separation was effected. The gel was stained in ethidium bromide 
solution. The gel was well rinsed in distilled water and the bands were observed on 
an ultraviolet transilluminator. The band of interest was carefully excised from the 
rest of the gel slab and put into an microfuge tube. 600/fl of sodium iodide was 
added to lg of excised gel. This was incubated for 5 mins at 55°C to dissolve the gel. 
6 /ri of glass milk was added to the dissolved gel, mixed and incubated at room 
temperature for 15 mins. It was then centrifuged at lOOOOg for Imin. The 
supernatant was pipetted off and discarded. The precipitate was washed in 400/xl New 
wash buffer and centrifuged at lOOOOg for lmin. The supernatant was pipetted and 
discarded. Washing was done thrice. After the last wash, the DNA was extracted 
from the rest of the pellet by resuspending in 2 5 of TE buffer or distilled water. 
This was centrifuged at lOOOOg for lmin. The supernatant was collected into a clean 
microfuge tube. The extraction procedure was repeated three more times until the 
volume of the DNA solution was 100/zl. The DNA was then precipitated by adding 
3ul of 5M sodium chloride and 200/U cold absolute ethanol. This was mixed and 
incubated at -70° C for 15mins. The tube was centrifuged at lOOOOg for 12 mins at 
4° C. The supernatant was pipetted off and discarded. The pellet was washed in 
lOOjul 70% ethanol (without resuspension) and centrifuged. The supernatant was 
discarded and the pellet was dessicated under vacuum for 4 mins after which it was 
resuspended in an appropriate amount of TE buffer (pH 8.0) or distilled water and 
stored at -20°C prior to use.
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2.2 .6; Restriction Enzyme Digests.
Restriction enzymes were obtained from BRL and NBL, and the digests were 
performed according to the manufacturer’s instructions.
Restriction analysis was performed using approximately Ipg of DNA and 1-5 units 
of enzyme in a volume of I0~20pl. When analysing small DNA fragments, RNase 
A (0.1 mg/ml) was included in the digestion buffer. The digestion products were 
ethanol precipitated (in the case of large volumes) prior to electrophoresis.
2.2.61; End Filling of DNA Fragments.
This exercise was carried out to create blunt ended fragments for cloning. To Ipg 
of staggered-cut DNA, 2p\ of React buffer 3 (BRL), 2^ 1 of dNTP solution (containing 
each of the four dNTPs at a concentration of 1.25mM), and water was added to a 
volume of 19 1^. lp\ of klenow enzyme was then added and the mixture was mixed 
and incubated at room temperature (23°C) for 45mins. The end filled DNA fragments 
were then precipitated in ethanol, washed in 70% ethanol, resuspended in water and 
stored at -20°C until required.
2.2.7; DNA Ligations.
DNA ligations were performed using T4 DNA ligase according to the manufacturer’s 
instructions. Generally, ligations were carried out in a volume of 20pi, employing 
lOOng of a dephosphorylated vector at an insert: vector molar ratio of 2:1. Cohesive 
end ligations were incubated at 14°C while blunt end ligations were carried out at 9°C 
overnight.
Ligation products were either added directly to competent cells for transformation or 
stored at -2 0 °C.
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2.2.8; Alkaline Phosphatase Treatment.
The vector was treated with calf intestine alkaline phosphatase to prevent religation 
of the vector ends.
The digested vector was heat treated at 65°C for 5mins to inactivate the restriction 
enzyme. The vector was then precipitated in ethanol, washed in 70% ethanol and 
centrifuged at lOOOOg for lOmins at 4°C. The supernatant was discarded and the 
pellet was vacuum dried and resuspended in 16 1^ TE buffer pH 8.0. 2/xl of React 
buffer III (BRL) was added, followed by the addition of 2jul calf intestine alkaline 
phosphatase (CIAP). This was gently mixed and incubated at 37°C for 60mins, 
followed by inactivation of the enzyme at 65°C for lOmins. 180/xl of TE buffer pH
8.0 was added to the CIAP treated DNA which was then extracted once in an equal 
volume of phenol/chloroform and once in an equal volume of chloroform/isoamyl 
alcohol. The DNA was then ethanol precipitated, vacuum dried and resuspended in 
TE buffer pH 8.0.
2.2.9; Small Scale Plasmid Isolation.
This method was employed to isolate plasmids from E.coli strains. It has the 
advantage of being faster than the large scale method, and many cultures can be easily 
handled at the same time. On the other hand, there is the risk of some chromosomal 
DNA and RNA contamination.
A single colony of a plasmid-containing strain was inoculated into 10ml L-broth 
containing the appropriate antibiotic to select for the plasmid. The culture was 
incubated at 37°C for about 16 hours with shaking. 1.5ml of the culture was pipetted 
into a microfuge tube and centrifuged at 7000g for 5 mins. in a bench top centrifuge 
at room temperature. The supernatant was discarded and the pellet was resuspended 
in lOOjul lysis solution (25mM Tris.Cl pH.8.0, lOmM EDTA, 50mM glucose, 
lysozyme to a final concentration of 2mg/ml). The mixture was lightly vortexed to 
facilitate resuspension, followed by incubation on ice for 30 mins. 200^1 alkaline
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SDS (1% SDS [w/v], 0.2M NaOH.) was added followed by incubation on ice for 5 
mins. 150/ri 3M sodium acetate (pH.4 .8) was added to the suspension. The tube was 
gently inverted thrice to effect mixing of its contents, followed by incubation on ice 
for 60 mins.
The lysate was centrifuged at 7000g for 5 mins at room temperature. The supernatant 
was carefully collected, avoiding the pellet. 1ml of 99.86% ethanol (-20° C) was 
added to 400ptl of the supernatant. This was gently mixed and incubated at -70°C for 
15 mins. The suspension was centrifuged at 7000g for 5 mins at room temperature. 
The supernatant was carefully discarded and the pellet was resuspended in 100/xl 0 .1M 
ammonium acetate (pH. 6.0). An equal volume of phenol/chloroform was added to 
the suspension. The contents were mixed and centrifuged at 7000g for 5 mins at 
room temperature. This was to extract the water soluble DNA from insoluble 
proteins and other substances. lOO^ tl of the supernatant was collected, avoiding 
disturbance of the interphase material. 300^1 of 99.86% ethanol (-20°C) was added 
to the supernatant, followed by mixing and incubating at -70° C for 15 mins. The 
mix was centrifuged at lOOOOg for 5 mins at 4°C. The supernatant was discarded and 
the pellet was desiccated under vacuum for 5 mins., resuspended in distilled water 
or T.E buffer (pH.8.0) and stored at -20°C.
2.3.0; Miniprep Plasmid Preparatioitiunder 60mins.)
This method, comprising a phenol/chloroform and an ethanol precipitation step makes 
it a very easy and rapid method. Its shortfalls include the presence of chromosomal 
DNA and RNA. Successful elimination of chromosomal DNA (probably by treatment 
with exonuclease III) will highly enhance the usefulness of this method. RNase A 
treatment eliminates RNA. This method has been applied only to E.coli. cells. 
1.5ml 17 hour growing cells in 10ml L-broth was centrifuged at 7000g for 5mins at 
room temperature. The supernatant was decanted and the pellet was resuspended in 
50/di TEN buffer. 50/xl phenol/chloroform was added. The mixture was vigorously 
vortexed for about 30 seconds and centrifuged at 7000g for 6 mins at room
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temperature. 60pi of the supernatant was carefully collected. Ammonium acetate 
(5M) was added to give a final concentration of 2M, followed by adding 2 volumes 
of 99.86% ethanol (-20° C). The solution was well mixed and incubated on ice for 
15mins. It was then centrifuged at 7000g for 10 mins. at room temperature. The 
supernatant was discarded and the pellet was washed in 70% cold ethanol, desiccated 
under vacuum for 5 mins. and resuspended in 20pi sterile distilled water. The 
solution was stored at -20° C. DNase free-RNase was added (final concentration of 
50jug/ml) to the plasmid solution prior to digestion.
2.3.1; Large Scale Plasmid Preparation.
The Brij-Doc cleared lysate method was employed in the preparation of plasmids on 
a large scale. This method was used for strains of E.coli harboring plasmids.
METHOD:
A single colony of plasmid containing bacterial strain was used to inoculate 10ml of 
L-broth into which a suitable antibiotic had been incorporated to select for the 
plasmid. The broth culture was incubated at 37°C for 18 hours, with shaking. 1ml 
of the 18 hour broth culture was then used to inoculate 200ml L-broth in a 1000ml 
flask. This was then incubated at 37°C for 18 hours, with shaking. The broth 
culture was then centrifuged at 4000g for 15 mins at 4°C. The bacterial pellet was 
resuspended in 3.5ml of a solution containing 25% sucrose (w/v) in 0.05M Tris.Cl 
pH 8.0. The suspension was lightly vortexed to homogenize. 0.5ml of freshly 
prepared lysozyme solution (20mg/mllysozyme in 0.25M EDTA pH 8.0), was added 
to the bacterial suspension. This was incubated on ice for lOmins. 3.5ml 0.25M 
EDTA (pH 8.0) was added and the mixture incubated on ice for a further 5 mins. 
5ml of Brij-Doc (1% Brij 58, 0.4% Deoxycholate in 0.01M Tris.Cl, ImM EDTA 
pH 8.0) was then added. Lysis was facilitated by gently pipetting the bacterial 
suspension three times. The lysate was incubated on ice for 30 mins, then centrifuged 
at 16000g for 45 mins at 4°C. This is the clearing spin. The supernatant was then 
collected (avoiding the slimy pellet at the bottom of the tube) and kept on ice.
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Isolation of plasmid DNA was based on the difference in buoyant densities in the 
presence of ethidium bromide, between supercoiled plasmids and chromosomal DNA. 
A caesium chloride density gradient was employed to effect this separation. To 5ml 
of cleared lysate, 4.75g of cesium chloride was added. The suspension was gently 
mixed by slowly inverting the tube to ensure complete dissolution of the caesium 
chloride. Ethidium bromide solution(in water) was then added to a concentration of 
0.4/<g//d, followed by gentle mixing. The solution was loaded into a Beckman 
quickseal tube. The tube was then filled with paraffin oil and balanced against a 
similar tube to within 0.09 of a gram. Both tubes were heat sealed and centrifuged 
at 1 lOOOOg for 20 hours at 15°C (in the case of half gradients), or at 86500g for 40 
hours at 15°C for full gradients. The plasmid band, seen as the lower orange band 
when viewed under ultraviolet light, was extracted using a 21G needle and a 1ml 
syringe.
Plasmid Purification. The ethidium bromide was extracted in several changes of 
isopropanol saturated with cesium chloride in TES( 20mM Tris.Cl pH 8.0, ImM 
EDTA, 150mM Nacl). Extraction was stopped when a colorless solution was 
evident.
Precipitation of Plasmid DNA.
Isopropanol Precipitation. To 200/d caesium chloride/DNA solution, 250/d of 
water, 50/d of 3M sodium acetate (pH 5.2), and 500/d isopropanol was added. The 
solution was well mixed. If layering occurred, 50/d amounts of water was added to 
the tube and mixed until the layering was eliminated. The solution was incubated on 
the bench for 5 mins. It was then centrifuged at 7000g for 10 mins at room 
temperature in a bench top centrifuge. The supernatant was carefully pipetted out and 
discarded and the pellet was resuspended in 2 0 0 /d of sterile distilled water.
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Ethanol Precipitation. To the 200/xl plasmid solution, 2.5 volumes of 99.86% 
ethanol (-20°C), 1/10 volume 3M sodium acetate(pH 5.2) was added. This was well 
mixed and incubated at -70°C for 20 mins., followed by centrifuging lOOOOg for 
lOmins at 4°C. The supernatant was pipetted and discarded. The pellet was washed 
in 60ul of 70% ethanol, centrifuging at lOOOOg for 10 mins. at 4°C. The supernatant 
was discarded and the pellet was desiccated for 5 mins under vacuum. The pellet was 
resuspended in lOOpl TE buffer or sterile distilled water. Finally, the DNA 
concentration was estimated using a spectrophotometer.
2.3.2; Isolation of Total Genomic Mycobacterial DNA.
A 10ml 7H9 broth containing 1ml OADC was inoculated with a suitable 
mycobacterial culture. This was incubated at 37°C for 72 hours in the case of fast 
growers, or for up to 4 weeks in the case of slow growers.
Incubation was carried out in a shaker for all mycobacteria except the Category 3 
organisms which include M. tuberculosis. Glycine was then added to a final 
concentration of 2 %. The broth culture was then incubated for a further 24hrs (for 
fast growers), or for 48hrs (for slow growers). The Category 3 organisms were then 
incubated in a 70°C water bath for 30 mins. to kill the cells. The culture was 
harvested by centrifuging at lOOOg for 10 mins. The supernatant was decanted and 
the cells were transferred into 1.5ml microfuge tubes. This was centrifuged at 7000g 
for 2 mins. The remaining broth was then pipetted off and discarded. 300^1 of lysis 
solution (2mg/ml lysozyme in TE buffer pH 8.0, 0.3M sucrose, 50/ug/mlRNase) was 
added to the cells. This was lightly vortexed to resuspend the cells. The cells were 
then incubated at 37°C for 3hrs. 400/xl 5% SDS (in TE buffer pH 8.0) was added 
followed by gentle mixing. 30^1 proteinase K (5mg/ml) was added followed by 
gentle mixing and incubation at 37°C for 30 mins.
The DNA was separated from the protein by phenol/chloroform extraction, 
precipitated in ethanol, and washed in 70% ethanol. The pellet was then resuspended 
in 20 pi TE buffer pH 8.0 or in sterile distilled water.
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2.3.3; Transformation of Bacterial Cells (E.coli).
2.3.31; Preparation of Competent Cells.
A colony of a suitable transformation host such as E.coli strain JM109 was 
inoculated into 5ml L-broth and incubated at 37°C for 17 hrs in a shaker. lOOul of 
the culture was used to inoculate 25ml L-broth. This was incubated at 37°C in a 
shaker to an OD 600 value of between 0.5 and 0.6. This was usually achieved in 
about 2 hours 30 mins. The culture was then chilled on ice. Prechilled bottles and 
solutions were used henceforth. The chilled culture was transferred into a 10ml 
universal and centrifuged at 1600g for 5 mins. at 4°C. The supernatant was decanted 
and the pellet was resuspended in 10ml 0.1M magnesium chloride solution (aqueous). 
This was centrifuged at 1600g for 5mins at 4°C. The supernatant was decanted and 
the cells were resuspended in 10ml 0.1M calcium chloride solution (aqueous). This 
was incubated on ice for 30 mins. The cell suspension was then centrifuged at 1600g 
for 5 mins at 4°C. The supernatant was decanted and the competent cells were 
resuspended in 1.5ml 0.1M calcium chloride. The cells were stored on ice and 
usually used within 5 hours.
2.3.32; Transformation of Competent Cells.
An aliquot of 150/d of competent cells was put in a microfuge tube. A 50ng amount 
of transforming DNA (in terms of vector) was added to the tube and gently mixed. 
This was incubated on ice for 30 mins. The mix was then subjected to a heat shock 
treatment which involved incubation at 42°C for 1 min., immediately followed by 
incubation on ice for 30 mins. 300/d of L-broth was added to the tube. This was 
mixed and incubated in a water bath or shaker at 37°C for 55 mins. prior to plating 
to allow the expression of ampicillin or kanamycin resistance genes.
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2.3.33; Plating of Transformed Bacteria.
L-agar was melted and allowed to cool to 55°C. Ampicillin, isopropylthiogalactoside 
(IPTG), 3,4,5,bromochloroindolyl-B-d-galactoside were added to concentrations of 
50/tg/ml, 20/tg/ml, 11.9/tg/ml respectively. The agar was swirled to mix its contents. 
About 30ml amounts were poured per plate and allowed to set. The plates were then 
dried in the oven for about 10 mins.
Restriction of DNA for cloning was carried out as advised by the manufacturers of 
the enzyme. Ligations were carried out in a total volume of 20/d and incubated as 
described in 2.2.7. Ligation controls employed in transformation included: cut 
vector, vector cut and ligated, uncut vector, in addition to the vector/insert test ligate. 
Aliquots of these mixes were also run on the gel alongside ligated and unligated 
lambda Hindlll DNA.
2.3.4; Detection of DNA Bands on a Southern Blot.
The DNA to be detected was digested with the appropriate restriction enzyme. The 
resulting bands were separated on a 1% agarose gel which was stained in a 0.5/*gper 
ml ethidium bromide solution for 15mins. The gel was rinsed in distilled water and 
a photograph of the gel was taken using a u.v. trans-illuminator. The gel was then 
immersed in denaturing solution for 40 mins., rinsed in distilled water and immersed 
in neutralising solution for a further 30 mins. The DNA was then transferred onto 
a hybond-N membrane by the Southern blotting technique. 20X SSC was used as 
the transfer medium and the blotting was done for overnight. The filter was carefully 
rinsed in 2X SSC for 30 secs and allowed to dry in air for 10 mins. It was then 
baked under vacuum at 80°C for 2 hours to fix the DNA bands firmly onto the 
membrane. Detection of DNA bands on the nylon membrane was by two methods: 
The non-radioactive and the radioactive methods.
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2.3.41. The Non Radioactive Method.
The DNA labelling and detection kit was obtained from Boehringer Mannheim. The 
DNA probe was labelled by random primed incorporation of digoxigenin-labelled 
deoxyuridine triphosphate (dUTP). The dUTP was linked via a spacer arm to the 
steroid hapten digoxigenin. After hybridization to the target DNA, the hybrids were 
detected by enzyme-linked immunoassay employing an antibody-conjugate (anti 
digoxigenin alkaline phosphatase conjugate), and a subsequent enzyme catalyzed color 
reaction or a chemiluminescence reaction.
2.3.42; Labelling of Probes.
From lOng to 3/ig of DNA could be labelled per standard reaction. The DNA to be 
labelled was first linearized, then denatured by immersing in boiling water for 5 
mins., and immediately kept on ice or ice/alcohol for 5 mins. 2/d of hexanucleotide, 
2/d of deoxynucleotide triphosphates, 5/d of sterile distilled water, 1/d of Klenow 
enzyme, all making a total volume of 20/d, were added to the denatured DNA and 
incubated for at least 2 hours or for up to 24hours. The reaction was stopped by 
adding 2/d 0.25M EDTA. The labelled DNA was precipitated by adding 2/d 4M 
LiCl, 1/d glycogen, and 60/d cold absolute ethanol. This was mixed and incubated 
at -70° C for 30 mins. It was then centrifuged at lOOOOg for 10 mins. at 4° C. The 
supernatant was carefully discarded. The pellet was washed in 40/d 70% ethanol, 
followed by centrifuging at lOOOOg for 10 mins. at 4° C. The supernatant was 
carefully discarded, the pellet was desiccated for 5 mins. under vacuum and 
resuspended in 50/d TE buffer pH 8.0.
The labelled DNA was always denatured prior to use.
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2.3.43; Hybridization of Probe to DNA Bound on a Nylon Membrane.
The nylon membrane with the bound DNA was put in a hybridization bag (and heat 
sealed) or in a bottle. Prehybridization was carried out by adding 30ml of 
hybridization solution.
The hybridization solution for the color reaction comprised 5X SSC, 0.5g blocking 
reagent (supplied with the kit), 0.1% N-laurosarcosine sodium salt, 0.02% SDS in 
water; The blocking reagent was dissolved by heating the suspension at 6 8 °C (water 
bath) for 40 mins. with shaking. It was then kept at 55°C in a water bath until 
needed.
The hybridization solution for the chemiluminescence detection comprised 5X SSC, 
2.5% blocking reagent (added from the stock solution), 0.1 % (w/v) N-laurosarcosine 
sodium salt, 0.02% (w/v) SDS and 100/ig/ml herring sperm DNA. The herring sperm 
DNA was denatured prior to use.
The filter was incubated at 6 8 °C for 1 hour in a shaking water bath or rotating oven. 
After prehybridization, the hybridization solution in the bag was discarded and the 
labelled probe was added to 5ml fresh hybridization solution. This was added into 
the bottle or bag and incubated at 6 8 °C for 15 hrs. The probe was then poured into 
sterile plastic bottles and stored at -20°C to be re-used after renewed, denaturation. 
The membrane was washed in 100ml [2x SSC,0.1% SDS (w/v)] solution (aqueous) 
for 2 x 5 mins. at room temperature, followed by washing in 100ml [0. Ix SSC, 0.1 % 
SDS (w/v)] solution for 2 x 15 mins. at 68°C. These solutions were always warmed 
to the desired temperature before use.
2.3.44; Immunological Detection of DNA
Buffers and Solutions for Color Reaction:
Buffer 1: Tris.HCl(lOOmM), NaCl(150mM) pH 7.5 20°C (aqueous).
Buffer 2: This was prepared as a 10% stock solution comprising the blocking reagent 
in buffer 1. It was dissolved in a water bath at 6 8°C, then autoclaved and stored at
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4°C. The working concentration was 2%.
Buffer 3: Tris.HCl (lOOmM), NaCl (lOOmM), Magnesium chloride (50mM) pH 9.5, 
room temperature 20°C.
Buffer 4: Tris.HCl (lOmM), EDTA (ImM), pH 8.0 at room temperature.
Antibody conjugate: Freshly prepared. 1:5000ml in buffer 1, giving a concentration 
of 150mU per ml.
The Color solution: 45ul NBT, 35ul X-phosphate in 10ml of buffer 3. This was 
freshly prepared. All the following reactions are performed at room temperature with 
shaking or mixing, except for the color reaction.
Color Reaction.
The prepared filter was immersed in buffer 1 for two minutes. Buffer 1 was 
discarded. The filter was then covered in buffer 2 and incubated for 30 mins., 
shaking slowly. Buffer 2 was discarded and the filter was washed in buffer 1 for 2 
mins. Buffer 1 was discarded and a 20ml volume of diluted antibody conjugate was 
applied to the filter. This was incubated for 30 mins. with occasional mixing. The 
excess antibody conjugate solution was discarded. The filter was then washed in two 
changes of buffer 1 at slow speed for 15 mins each. After the final wash, buffer 1 
was discarded and the filter was equilibrated with 20ml of buffer 3 for 2 mins. The 
excess buffer 3 was discarded. A 10ml volume of color solution was added dropwise 
over the filter. The tray containing the filter was covered and promptly kept in the 
dark for the color precipitate to form. The color precipitate could be seen as early 
as 70 seconds. The reaction could be monitored every 2 hours. When desired bands 
were evident, the reaction was stopped by washing the filter in TE buffer (pH 8.0) 
for 4 mins. The filter was allowed to dry in air, and wrapped up with Saran wrap.
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2.3.45; Detection of DNA By The Chemiluminescence Method.
Buffers and Solutions.
Buffer I: Maleic acid (lOOmM); NaCl (150mM); pH 7.5 (20°C), adjusted with 
concentrated NaOH, autoclaved.
Washing buffer: Tween 20 (0.3%,v/v) in buffer I.
Blocking stock solution: blocking reagent, 10%(w/v), in buffer I, autoclaved and 
stored at 4°C.
Buffer II: Blocking stock solution diluted to 2 % in buffer I.
Buffer III was the same as buffer 3 (color reaction).
Antidigoxigenin alkaline phospatase conjugate (anti Dig.Ap conjugate) was involved 
in the catalysis of AMPPD.
AMPPD [3-(2’-spiroadamantane)-4-methoxy-4-(3-phosphoryloxy)-phenyl-l,2- 
dioxetane] is a chemiluminescent substrate for alkaline phosphatase which comes as 
a lOmg/ml stock solution. The working solution 0.235mM, was derived by diluting 
the AMPPD stock solution 1:100 in buffer III.
Method:
All the steps were carried out at room temperature in hybridization bottles (Hybaid) 
and the nylon membrane was never allowed to dry during treatment.
The filter was washed in washing buffer for three minutes. The washing buffer was 
discarded and the membrane was incubated in 2% blocking buffer (buffer II) for thirty 
minutes. Buffer II was discarded and the membrane was incubated for 30 minutes 
in a solution containing 1/10000 anti-DIG-Ap conjugate in buffer I. The filter was 
then washed in washing buffer twice, for twenty minutes each. After the last wash, 
the membrane was equilibrated in buffer III for two minutes followed by incubation 
in AMPPD solution for three minutes. Excess AMPPD solution was allowed to drip 
off. The membrane was then wrapped in Saran wrap, incubated at 37°C for three 
minutes and was then exposed to X-ray film for twenty minutes. Depending on the 
strength of the signal, further exposures were done.
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Reprobing of nylon membranes.
If the membrane was to be re-probed, it was not allowed to dry out before stripping 
the probe. The membrane was washed in distilled water twice for five minutes each, 
followed by washing in a solution containing 0.2M NaOH, 0.1% SDS (w/v) at 37°C 
for twenty minutes. It was finally rinsed in 2X SSC for 3 minutes. The membrane 
was either air-dried and stored or it was prehybridized and hybridized immediately 
with a further probe.
2.3.46; DNA Detection by the Radiolabelling Method.
Buffers and solutions.
Phosphate buffer pH 6 .6 : This was made by adding 18.75ml of 0.2M disodium 
hydrogen phosphate to 31.25ml 0.2M sodium dihydrogen orthophosphate at room 
temperature (23°C).
Herring testis DNA: Herring testis DNA having a stock concentration of lOmg per 
ml was made by adding 4.38ml of sterile distilled water to 43.8mg of herring testis 
DNA. This was passed through a 19 gauge needle 75 times. It was then put in 
boiling water for 10 mins. and allowed to cool slowly. It was then distributed in 1ml 
amounts and stored at -20°C. The DNA was denatured before use by heating in 
boiling water for 10 mins. and chilling on ice for 6  mins.
100X Denhardt’s solution: It was made of 2% (w/v) bovine serum albumin (BSA), 
2% (w/v) ficoll™, 2 % (w/v) polyvinyl pyrollidone (PVP); made up in sterile 
distilled water. It was distributed in 10ml amounts and stored at -20°C. 
Prehybridization buffer: It comprised 6 X SSC, 4mM phosphate buffer (pH 6 .6), 5X 
Denhardt’s solution, lOmM EDTA(pH 8.0), lOOjug per ml herring testis DNA, 0.5% 
SDS.
Labelling of Probe.
** Handling of radioactivity was carried out behind a screen in the designated area**
Labelling was by random hexanucleotide primer extension. The kit and labelling 
instructions were supplied by Amersham. The labelling reaction consisted of the
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following, added in the order they appear: Primer- 5/tl, Labelling buffer- 10/d, 
water- 18/d, freshly denatured probe (25ng)-10/d, Label:(50/tCi)- 5/d, Klenow 
enzyme-2/d. The total volume was 50/d. The contents were stirred and incubated at 
37°C for 2 hours on a heating block with a lead top over the tube. The reaction was 
carried out in screw capped tubes for safety reasons. After the labelling reaction was 
over, the probe was denatured by incubating in boiling water for 4 mins., followed 
by chilling on ice for 5 mins. before adding to the blot.
Prehybridization.
The filter was soaked in 6X SSC, wrapped around a tube and carefully unwound in 
the hybridization bottle, avoiding the formation of bubbles. After elimination of the 
residual bubbles, 10ml hybridization solution was added to the filter and incubated for 
2 hours at 65°C, in a rotating oven. All of the labelled probe was then added to the 
hybridization solution in the bottle and incubated at 65°C for a further 12 hours. 
Washing of the Filter.
The filter was first washed in a solution containing 6X SSC, 0.1% SDS, twice at 
65°C for 15 mins each. A second wash was done in 3X SSC, 0.1% SDS, twice at 
65°C for 15mins each. This was the low stringency wash. The filter was rinsed in 
0. IX SSC, wrapped in Saran wrap and a photographic film was exposed over the 
filter for 2 hours. The film was developed. If the signal was very high, a third wash 
of higher stringency was carried out. The third wash was done in a solution 
containing 0.1X SSC, 0.1% SDS, twice at 65°C for 15 mins. each. The filter was 
rinsed in a 0.1X SSC solution, wrapped in Saran wrap and exposed to a photographic 
film for 3 hours. The film was then developed and the banding pattern analyzed. 
Removal of the Probe.
This was done as advised by Amersham. The blot was incubated in 0.4M sodium 
hydroxide solution at 45°C for 30 mins. The solution was replaced by another 
solution made up of 0.1% SDS, 0.1X SSC, 0.2M tris.HCl (pH 7.5) followed by 
incubation at 45°C for 15 mins. The filter was then monitored for the presence of 
radioactivity. The probe removal process was repeated with longer incubation periods
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if radioactivity was detected. Care was taken to ensure the filter did not dry out 
before the probe was removed as this would make the removal of the probe difficult.
2.3.5; The Polymerase Chain Reaction (PCR)
The procedure was adapted from Perldn Elmer Cetus specifications for running a PCR 
reaction. A mixture having each of the four deoxynucleotide triphosphates (dNTP) 
to a final concentration of 1.25mM was made. To make up ten PCR mixes, 310/d 
of sterile distilled water, 80/d of dNTP mix, 50/d 10X buffer, 10/d WI detergent 
were added in the order they appear. This was mixed and distributed in 45/d 
amounts. 50/d of liquid paraffin was added to each mix which was used the same day 
or stored at -20°C for up to three weeks.
To each mix, 2/d of primer (300ng per /d), 1/d of Taq polymerase (2.5 units), and 
2/d of template DNA (0.5ng per /d) was added. This was centrifuged at 7000g for 
2 secs (pulse spin). The outside of the tube was lightly greased and the tube was 
slotted into the programmed heating block.
2.3.51; Heating Block Program.
The heating block was set to do three main steps. The first step was an initial 
denaturation of the template DNA at 94°C for 2 mins, once.
Step II: This comprised three sub-steps viz: Annealing of the primer to the template 
DNA at 60°C for 1 min, followed by an extension reaction at 72°C for 2 mins and 
finally by the denaturation step at 94°C for 1 min. Step II was repeated 29 times i.e. 
30 cycles.
Step III: This comprised annealing of the primer to the template DNA at 60°C for 2 
mins followed by an extension process at 72°C for 7 mins. Step III was a single 
cycle. At the end of the run, the temperature was held at 4°C until the tubes were 
retrieved. The paraffin oil was discarded, the PCR product was run on an agarose 
gel and the DNA band(s) of interest was then isolated.
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2.3.52; Precautionary Moves in the Running of a PCR Reaction.
Elimination of products due to non-specific binding or due to contaminating DNA was 
the aim of introducing some precautionary steps. Binding of primer to template DNA 
will depend on the degree of homology between the primer and the template. If a 
primer binds strongly to the specific template, one can use high annealing 
temperatures of up to 6 8 °C to eliminate the problem of non-specific binding. In a 
situation where non specific products were observed, the annealing temperature was 
adjusted such that while the product of interest was being synthesized, the synthesis 
of extraneous sequences was kept to a minimum.
In order to prevent contamination by extraneous DNA material from sources which 
include aerosols, gloves, or contaminated stocks like buffers, primers, 
deoxynucleotides, some basic guidelines were observed:
All the exercises involved in preparation for running a PCR reaction were carried out 
in an air flow cabinet. The cabinet was cleaned with hycolin and the air flow system 
was switched on for 10 mins. prior to commencing work. All the manipulations 
involving stock solutions were carried out to completion before the template DNA was 
being handled. Gloves used in the cabinet were not taken out if they were to be re­
used. The gloves were changed from time to time during the exercise.
Control reactions were also included to help explain the failures of the PCR. The 
control reactions comprised the PCR mix plus enzyme; PCR mix plus primers and 
enzyme; PCR mix plus template and enzyme; PCR mix plus enzyme, primers, and a 
template that is known to be effectively primed by the primer. The PCR mix 
comprised the buffer, dNTPs, and WI detergent.
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2.3.6; Sequencing with Sequenase.
DNA sequencing was carried out as described in the protocol by United States 
Biochemical (USB). The template DNA was first denatured before starting the 
sequencing reaction.
2.3.61; Denaturation of Template DNA(Plasmid).
Denaturation mix: DNA(3/tg), 2M NaOH(2/d), lOmM EDTA(2/d). Distilled water 
was added to a final volume of 20/d. The mix was stirred and incubated at 37°C for 
30 mins. The DNA was precipitated in ethanol and resuspended in 7/d of distilled 
water.
2.3.62; Annealing.
To the denatured template DNA (7/d), Sequenase buffer (2/d) and primer (300ng) 
were added. The total volume was 10/d. The mix was immersed in a water bath at 
65°C for 2 mins. and allowed to cool to 30°C, slowly.
While the annealing mix was cooling, 2.5/d of each termination mixtures (consisting 
of dideoxynucleotides) G,A,T,C was put in a separate tube. The labelling mix which 
consists of all four deoxynucleotides (G,A,T,C) was diluted 1:5 in water, while the 
enzyme (Sequenase version 2.0) was diluted 1:8 in cold enzyme dilution buffer. The 
four termination tubes were pre-warmed in a water bath at 37°C prior to carrying out 
the labelling reaction.
2.3.63; Sequencing Reaction.
To the annealed DNA mixture (10/d); 0.1M DTT(l/d), diluted labelling mix (2/d), 
35S dATP(l/d), diluted sequenase version 2.0 (2/d) were added. The components 
were mixed and incubated at room temperature for 4 mins. 3.5/d amounts from the 
labelling reaction was added to each of the termination tubes. The mixture was 
stirred and incubated at 37°C for 5mins. 4/d of stop solution was then added to each 
of the termination reaction tubes to stop the reaction. The samples were then stored
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at -20°C for up to three days, and were always denatured by heating at 75°C (water 
bath) prior to loading onto the gel.
2.3.64; Preparation of Sequencing Gels.
The gel consisted of the following: urea (31.5g), 10X borate buffer (7.5ml), 40% 
acrylamide, 2% bis acrylamide solution (9.3ml), water to 75ml. The urea was then 
dissolved by heating the mixture in a 37°C water bath, with occasional stirring, for 
20 mins. The volume was then adjusted to 75ml by adding more water. Just before 
pouring the gel, 420pl of 10% ammonium persulphate (AMPS), and 75/xl of TEMED 
were added and the gel preparation was mixed with a syringe and immediately poured.
2.3.65; Preparation of Glass Plates.
Two glass plates were involved in the preparation of the sequencing gel. A larger 
glass plate with a sticky surface to which the gel adhered, and a smaller glass plate 
with a non adhesive surface.
Both plates were thoroughly scrubbed with a detergent, rinsed in distilled water 
followed by a final rinse in ethanol. The gel facing side of the small plate was coated 
with 10ml dimethyl dichlorosilane and allowed to dry in a fume hood. The plate was 
then gently wiped with ethanol. This treatment provided the small plate with a 
surface to which the gel cannot adhere. The large plate was coated with a solution 
which consisted of 10ml ethanol (100%), 30/xl silane A-174, and 150/ul of 10% acetic 
acid. The plate was coated in the fume hood and allowed to dry. The surface was 
then wiped with ethanol. This treatment provided the large plate with an adhesive 
surface to which the gel can bind. Spacers were placed between both plates, 
lengthwise. Both plates were then bound together with plastic tapes along their length 
and bottom. This provided a perfect seal between which the liquid gel mixture was 
poured. Combs were inserted (in the opposite orientation) into the gel which was 
then allowed to set. The sealing tapes were removed and the gel was mounted onto 
an electrophoresis tank. The combs were then taken out and placed in the right
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orientation in the gel. The tank was filled with IX borate buffer and the gel was pre­
run at 75watts for 15 mins. before loading. The pre-run was to heat up the gel to 
the running temperature.
Both a long run and a short run was done for each sample. At the end of the run, the 
comb and spacers were taken out and the small plate was taken off. The large plate 
(having the gel) was immersed in a fixing bath for 20 mins. The fixing bath 
contained a solution of 10% methanol, 10% acetic acid. The gel was rinsed under 
gently running water for 5 mins. It was then quickly rinsed in distilled water and 
baked at 80°C for 60mins. The gel was then exposed to an X-ray film.
2.3.7; Screening of Plasmid Gene Librairies.
Plasmid gene libraries were prepared by ligating a chromosomal digest of a suitable 
strain to pUC18 cut with the same enzyme. The ligate was then employed to 
transform a suitable host (E.coli strain DH5a). The transformed cells were plated 
on L-agar plates containing a suitable antibiotic and incubated at 37°C for about 12 
hours (or until the colonies were just visible). A nylon membrane was marked at 
three points (to facilitate subsequent alignment onto film) and carefully placed on the 
culture plate for one minute. The nylon membrane was then incubated (colony side 
up) on a fresh plate at 37°C for one hour. This was to allow the colonies to firmly 
adhere to the membrane. The nylon membrane was then placed (colony side up) on 
a 3MM filter paper saturated with 10% SDS for three minutes. It was transferred 
onto another filter paper saturated with a solution made of 0.5M NaOH, 0.5M NaCl 
for five minutes. It was then placed on a 3MM filter paper saturated with 0.5M 
Tris.HCl (pH 7.5) for five minutes. The nylon membrane was finally incubated on 
a 3MM filter paper saturated with 3X SSC. It was briefly blotted between each 
treatment. After the last treatment, the nylon membrane was dried in air for five 
minutes, then baked at 80°C for two hours. After baking, it was washed in a solution 
made of 3X SSC, 0.1% SDS, at 65°C for thirty minutes. With a wet glove, the 
colonies were carefully wiped off the nylon membrane. Prehybridization,
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hybridization and detection was then carried out as already described. After 
detection, the X-ray film was aligned to the master plate. The positive colonies were 
picked and screened for possession of the right insert.
2.3.8; Transformation of DH5o: Host Cells.
These cells have already been made competent by the manufacturer. The cells were 
taken out of the freezer(-70°C) and thawed on ice. lOng (in terms of vector) of DNA 
ligate was added to 20pl of competent cells and incubated on ice for thirty minutes. 
The mixture was then heat shocked by incubating at 42°C (in a water bath) for forty 
five seconds, immediately followed by incubating on ice for two minutes. 80/xl of 
SOC medium was added to the transformation mix which was incubated at 37°C (in 
a shaker) for one hour. Aliquots were plated out on a selective medium using a 
spreader. The plates were allowed to dry after which they were incubated at 37°C for 
16 hours. The DH5a competent cell stock was immediately frozen on an ethanol/dry 
ice bath and returned to -70°C.
2.3.9; Transformation of M.smegmatis Strain MC2155 by Electroporation.
2.3.91; Preparation of competent cells.
A 10ml amount of nutrient broth containing 0.05% Tween 80, 0.2% glycerol was 
inoculated with a loopful of M.smegmatis strain me2155 from a nutrient agar plate. 
The broth culture was incubated at 37°C for two days in a shaker. 500pi of the 
culture was used to inoculate a flask containing 50ml nutrient broth, 0.05% tween 80, 
0.2% glycerol and 20pl antifoam. A spring was put around the bottom of the flask 
to facilitate aeration of the culture. The culture was incubated for two days at 37°C 
in a shaker. The broth culture was then poured into falcon tubes and incubated on 
ice for thirty minutes. It was then centrifuged at 1600g for lOminutes at 4°C. The 
supernatant was decanted and the cells were resuspended in 25ml ImM Hepes (pre-
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chilled). The cell suspension was centrifuged at 1600g, 10 minutes at 4°C. The 
supernatant was decanted and the cells were resuspended in 5 ml 10% glycerol (pre­
chilled). The suspension was centrifuged and the supernatant was decanted. The cells 
were finally resuspended in 2 ml 1 0 % glycerol (pre-chilled), and distributed in 2 0 0 /il 
amounts. The cells were then frozen on an ethanol/dry ice bath and stored at -70°C.
2.3.92; Electroporation of competent cells.
Competent M.smegmatis cells were thawed on ice. 1/ig of test DNA or 50ng of 
pYUB12 control DNA were added to 100/d of the competent cells. The cell/DNA 
mix was incubated on ice for one minute and immediately transferred into a pre­
chilled electroporation cuvette (0.1cm). The cuvette was then inserted into a chilled 
slide chamber. The chamber was pushed into position and the two pulse buttons were 
simultaneously pressed. On hearing the beeping sound, the buttons were released. 
The electroporated cells were resuspended in 2ml nutrient broth and incubated at 37°C 
for 2 hours in a shaker. This incubation was to facilitate recovery of the cells. The 
cells were then plated out on nutrient agar plates containing kanamycin (15/ig per ml) 
as the selective agent. Positive colonies were then isolated and screened for the 
possession of the required construct.
The BIO-RAD gene pulser was used for electroporation.
2.3.93; Setting The Gene Pulser For Electroporation.
Resistance 600 OHMS, Capacitance 25/iF, Voltage 2.5kV. Before commencing 
electroporation, the gene pulser was discharged by switching on and off five times. 
Face masks were worn during electroporation to protect the face from a cuvette that 
might shatter if arcing occurred.
2.4; Synthesis of Oligonucleotide Primers.
Oligonucleotide primers were synthesized using the Applied Biosystems 381A DNA 
synthesizer. All reagents and instructions for synthesis were obtained from Applied 
Biosystems.
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2.4.1; Deprotection of Oligonucleotides.
The oligonucleotides were extracted from the column in 2ml cold ammonia solution 
for two hours, using syringes. The ammonia/oligonucleotide solution was then 
incubated in a water bath set at 55°C for twelve hours. It was allowed to cool to 
room temperature before ethanol precipitation was carried out.
2.4.2; Precipitation of oligonucleotides.
This was done in three volumes 100% ethanol, 1/10 volume 3M sodium acetate. The 
suspension was mixed and incubated at -70°C for 30 minutes. It was centrifuged at 
12000g for 20 minutes at 4°C. The supernatant was discarded and the pellet was 
washed in 70% ethanol, desiccated under vacuum and resuspended in sterile distilled 
water. The concentration of the oligonucleotide was estimated using a 
spectrophotometer.
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Chapter 3.
The Employment of Gene-based Systems for Fingerprinting and 
Detection of Genomic Sequences Specific to Members of the 
Mycobacterium tuberculosis complex.
3.0; Introduction.
The fight against microorganisms of aetiological importance is a battle which requires 
strategic information acquired from different sources. The information gathered, 
which includes geographical distribution of the organism, virulence and drug 
resistance patterns, assists in the formulation of a suitable control strategy, hence 
minimising the dissemination of the pathogen.
In chapter 1, some methods employed in typing isolates were reviewed and their 
shortcomings highlighted. This chapter will be concerned with the development and 
employment of suitable typing/fingerprinting protocols which can aid in the 
localization and monitor of the spread of infections due to members of the 
M.tuberculosis complex with special emphasis on M.tuberculosis, M.bovis, 
and BCG.
3.1; DNA Fingerprinting of Members of the M.tuberculosis complex.
A substantial amount of effort has been invested on the analysis of restriction digests 
of M.tuberculosis genomic DNA during the last five years.
Initially, analysis of the genome was done by digesting the DNA with a restriction 
enzyme, separating the resultant fragments on an agarose gel, followed by staining 
the gel with ethidium bromide. By visualising the variation in the banding patterns, 
strains/species differentiation could be achieved (Collins et al, 1985., Collins et al,
1984., Patel et al, 1986). This method represents the earliest attempts to fingerprint 
the genome of members of the M.tuberculosis complex. Although species 
differentiation can be achieved with this method, the presence of partial digests will 
have a negative effect on the interpretation of the results. Due to the presence of 
hundreds of closely stacked fragments on the gel, small differences in band sizes 
might be easily missed, distorting the final interpretation of the results.
The use of total chromosomal DNA probes (Roberts et al, 1987) is much more 
sensitive and some strain differentiation can be achieved, but cross hybridization
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between species is a big problem, hence giving this approach a lower specificity.
In order to achieve clearer and more specific results, species specific DNA fragments 
have been cloned and employed as probes, including repetitive sequences (Eisenach 
et al, 1988., Hermans et al, 1990., Reddi et al, 1988., Zainuddin et al, 1989). The 
advantage of employing these repetitive sequences is their sensitivity, due to their 
presence in more than one copy. Some repetitive sequences, although capable of 
species and strain differentiation, are not highly specific (Reddi et al, 1988) whereas 
others show high species specificity (Hermans et al, 1990., Thierry et al, 1990.)
3.1.01; The Insertion Sequence IS986.
This insertion sequence was first reported in 1989 by Zainuddin and Dale after 
screening a M.tuberculosis genomic library with a probe derived from the M. 
fortuitum plasmid pUS300 which is believed to be similar to, but possibly not 
identical to another M.fortuitum plasmid known as pAL5000 (Giquel et al, 1989, 
Martin et al, 1990a). This probe highlighted restriction fragment length 
polymorphism in the genome of M.tuberculosis and is capable of distinguishing 
M.tuberculosis from M.bovis and BCG. Eisenach et al. (1988) had also reported 
a probe cloned from M.tuberculosis which highlighted the presence of a sequence 
that was repeated 10 to 15 times in the M.tuberculosis genome, indicating its 
usefulness in fingerprinting. This probe could not distinguish between 
M.tuberculosis from M.bovis or BCG, although subsequently it has been shown 
to be similar to that of Zainuddin and Dale (1989).
IS986 has been sequenced by McAdam et al (1990). A similar sequence known as 
IS6110 has also been reported by Thierry et al (1990 a,b), and IS987 for BCG 
(Hermans et al, 1991). It is specific to members of the M.tuberculosis complex 
and has been found to be a member of the IS3 family of insertion elements (McAdam 
et al, 1990). Sequence data has shown that it is 1358bp in size with 30bp inverted 
repeat sequence at the ends. It has three identifiable open reading frames (ORF). 
ORFal, ORFa2, and ORFb on one strand and ORFc on the complementary strand. 
ORFal and ORFa2 are separated by a frame shift while ORFb is believed to code for
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the transposase. IS9S<5 has a % G+C of 64% (McAdam et al, 1990).
IS <5770 has been shown to be a powerful tool in epidemiology studies of 
M.tuberculosis. It is present in one to twenty copies in the genome of members 
of the M.tuberculosis complex (Zainuddin et al, 1989., Hermans et al, 1990., 
Thierry et al, 1990), with the majority of M.tuberculosis strains harboring 6-15 
copies. Some rare but widely distributed M.tuberculosis isolates which harbor only 
a single copy of IS6110 have been recently observed (see results). M.bovis isolates 
investigated normally harbored a single copy, but a few of them have been observed 
to carry two to five copies (van Soolingen et al. 1991; this thesis). The M.bovis 
vaccine strains, M.bovis BCG, have been shown to harbor a single copy except the 
Brazilian, Japanese and Russian substrains which harbor two copies (Fomukong et al. 
1992; this thesis).
The DNA sequence of the different copies of this element are closely related but not 
identical (fig. 3.1), and the sites of insertion in the genome do vary with the different 
copies.
IS6110 exhibits a 7bp mismatch and 98.5% homology with IS986, while it shows 
a 4bp mismatch and 99.2% homology with ISPS7. But IS986 exhibits a 4bp 
mismatch and 98.6% homology with ISPS7. IS6110 and IS987 have 28bp inverted 
repeat sequences while IS986 has 30bp inverted repeat sequences at their ends. The 
inverted repeat sequences in all three elements exhibit identical 3bp mismatch. ISPSd, 
IS(5770 and IS9S7have three potential open reading frames ORFa, ORFb and ORFc. 
In the case of IS986 and IS <5770, ORFa is separated by an apparent frame shift hence 
it is divided into ORFal and ORFa2. ORFb is identical in both IS PS 7 and IS6110 
but in IS986, it differs in the first two amino acids.
Translation of the putative transposase (ORFb) is thought to occur by read through 
from ORFa by one translational frameshift in the case of IS987 and by two 
translational frameshifts in the case of IS986 and IS6110.
The fact that different copies of this element generate different target repeats 
(Mendiola et al, 1992., Hermans et al, 1991) confirms the presence of a number of 
possible insertion sites within the genome.
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Fig.3.1; Comparison of IS6110. IS986. and IS987.
Clustal multiple sequence alignment.
IS6110 CGATGAACCGCCCCGGCATGTCCGGAGACTCCAGTTCTTGGAAAGGATGGGGTCATGTCA
is986 CC-TGAACCGCCCCGGCATGTCCGGAGACTCCAGTTCTTGGAAAGGATGGGGTCATGTCA
IS987 ------ GAACCGCCCCGGCATGTCCGGAGACTCCAGTTCTTGGAAAGGATGGGGTCATGTCA********************************************************
IS6110 GGTGGTTCATCGAGGAGGTACCCGCCGGAGCTGCGTGAGCGGGCGGTGCGGATGGTCGCA
is986 GGTGGTTCATCGAGGAGGTACCCGCCGGAGCTGCGTGAGCGGGCGGTGCGGATGGTCGCA
IS987 GGTGGTTCATCGAGGAGGTACCCGCCGGAGCTGCGTGAGCGGGCGGTGCGGATGGTCGCA
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
IS6110 GAGATCCGCGGTCAGCACGATTCGGAGTGGGCAGCGATCAGTGAGGTCGCCCGTCTACTT
is986 GAGATCCGCGGTCAGCACGATTCGGAGTGGGCAGCGATCAGTGAGATCGCCCGTCTACTT
IS987 GAGATCCGCGGTCAGCACGATTCGGAGTGGGCAGCGATCAGTGAGGTCGCCCGTCTACTT
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *  * * * * * * * * * * * * * *
IS6110 GGTGTTGGCTGCGCGGAGACGGTGCGTAAGTGGGTGCGCCAGGCGCAGGTCGATGCCGGC
is986 GGTGTTG-CTGCGCGGAGACGGTGCGTAAGTGGGTGCGCCAGGCGCAGGTCGATGCCGGC
IS987 GGTGTTGGCTGCGCGGAGACGGTGCGTAAGTGGGTGCGCCAGGCGCAGGTCGATGCCGGC
* * * * * * *  * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
IS6110 GCACGGCCCGGGACCACGACCGAAGAATCCGCTGAGCTGAAGCGCTTAGCGGCGGGACAA
l's986 GCACGGCCCGGGACCACGACCGAAGAATCCGCTGAGATAAAGCGCTT-GCGGCGGGACAA
IS987 GCACGGCCCGGGACCACGACCGAAGAATCCGCTGAGCTGAAGCGCTT-GCGGCGGGACAA
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *  *  * * * * * * * *  * * * * * * * * * * * *
IS6110 CGCCGAATTGCGAAGGGCGAACGCGATTTTAAAGACCGCGTCGGCTTTCTTCGCGGCCGA
is986 CGCCGAATTGCGAAGGGCGAACGCGATTTTAAAGACCGCGTCGGCTTTCTTCGCGGCCGA
IS987 CGCCGAATTGCGAAGGGCGAACGCGATTTTAAAGACCGCGTCGGCTTTCTTCGCGGCCGA
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
IS6110 GCTCGACCGGCCAGCACGCTAATTAAC- GGTTCATCGCCGATCATCAGGGCCACCGCGAG
is986 GCTCGACCGGCCAGCACGCTAATTACCCGGTTCATCGCCGATCATCAGGGCCACCGCGAG
IS987 GCTCGACCGGCCAGCACGCTAATTACCCGGTTCATCGCCGATCATCAGGGCCACCGCGAG
* * * * * * * * * * * * * * * * * * * * * * * * *  *  * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
IS6110 GGCCCCGATGGTTTGCGGTGGGGTGTCGAGTCGATCTGCACACAGCTGACCGAGCTGGGT
i s986 GGCCCCGATGGTTTGCGGTGGGGTGTCGAGTCGATCTGCACACAGCTGACCGAGCTGGGT
IS987 GGCCCCGATGGTTTGCGGTGGGGTGTCGAGTCGATCTGCACACAGCTGACCGAGCTGGGT
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
IS6110 GTGCCGATCGCCCCATCGACCTACTACGACCACATCAACCGGGAGCCCAGCCGCCGCGAG
15986 GTGCCGATCGCCCCATCGACCTACTACGACCACATCAACCGGGAGCCCAGCCGCCGCGAG
15987 GTGCCGATCGCCCCATCGACCTACTACGACCACATCAACCGGGAGCCCAGCCGCCGCGAG 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
IS6110 CT GCGCGAT GGCGAACT CAAGGAGCACAT CAGCCGCGT CCACGCCGCCAACTACGGT GTT
15986 CTGCGCGATGGCGAACTCAAGGAGCACATCAGCCGCGTCCACGCCGCCAACTACGGTGTT
15987 CTGCGCGATGGCGAACTCAAGGAGCACATCAGCCGCGTCCACGCCGCCAACTACGGTGTT 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
IS6110 TACGGTGCCCGCAAAGTGTGGCTAACCCTGAACCGTGAGGGCATCGAGGTGGCCAGATGC
is986 T ACGGT GCCCGCAAAGT GT GGCT AACCCT GAACCGT GAGGGCATCGAGGT GGCCAGAT GC
IS987 TACGGTGCCCGCAAAGTGTGGCTAACCCTGAACCGTGAGGGCATCGAGGTGGCCAGATGC
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
IS6110 ACCGTCGAACGGCTGATGACCAAACTCGGCCTGTCCGGGACCACCCGCGGCAAAGCCCGC
i s986 ACCGTCGAACGGCTGATGACCAAACTCGGCCTGTCCGGGACCACCCGCGGCAAAGCCCGC
IS987 ACCGTCGAACGGCTGATGACCAAACTCGGCCTGTCCGGGACCACCCGCGGCAAAGCCCGC
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
IS6110 AGGACCACGATCGCTGATCCGGCCACAGCCCGTCCCGCCGATCTCGTCCAGCGCCGCTTC
15986 AGGACCACGATCGCTGATCCGGCCACAGCCCGTCCCGCCGATCTCGTCCAGCGCCGCTTC
15987 AGGACCACGATCGCTGATCCGGCCACAGCCCGTCCCGCCGATCTCGTCCAGCGCCGCTTC 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
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IS6110 GGACCACCAGCACCTAACCGGCTGTGGGTAGCAGACCTCACCTATGTGTCGACCTGGGCA
is986 GGACCACCAGCACCTAACCGGCTGTGGGTAGCAGACCTCACCTATGTGTCGACCTGGGCA
IS987 GGACCACCAGCACCTAACCGGCTGTGGGTAGCAGACCTCACCTATGTGTCGACCTGGGCA************************************************************
IS6110 GGGTTCGCCTACGTGGCCTTTGTCACCGACGCCTACG-TCGCAGGATCCTGGGCTGGCGG
i s986 GGGTTCGCCTACGTGGCCTTTGTCACCGACGCCTACGCTCGCAGGATCCTGGGCTGGCGG
IS987 GGGTTCGCCTACGTGGCCTTTGTCACCGACGCCTACGCTCGCAGGATCCTGGGCTGGCGG
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *  * * * * * * * * * * * * * * * * * * * * * *
IS6110 GTCGCTTCCACGATGGCCACCTCCATGGTCCTCGACGCGATCGAGCAAGCCATCTGGACC
is986 GTCGCTTCCACGATGGCCACCTCCATGGTCCTCGACGCGATCGAGCAAGCCATCTGGACC
IS987 GTCGCTTCCACGATGGCCACCTCCATGGTCCTCGACGCGATCGAGCAAGCCATCTGGACC
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
IS6110 CGCCAACAAGAAGGCGTACTCGACCTGAAAGACGTTATCCACCATACGGATAGGGGATCT
is986 CGCCAACAAGAAGGCGTACT CGACCT GAAAGACGTTAT CCACCAT ACGGAT AGGGGAT CT
IS987 CGCCAACAAGAAGGCGTACTCGACCTGAAAGACGTTATCCACCATACGGATAGGGGATCT
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
IS6110 CAGTACACATCGATCCGGTTCAGCGAGCGGCTCGCCGAGGCAGGCATCCAACCGTCGGTC
is986 CAGTACACATCGATCCGGTTCAGCGAGCGGCTCGCCGAGGCAGGCATCCAACCGTCGGTC
IS987 CAGTACACATCGATCCGGTTCAGCGAGCGGCTCGCCGAGGCAGGCATCCAACCGTCGGTC
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
IS6110 GGAGCGGTCGGAAGCTCCTATGACAATGCACTAGCCGAGACGATCAACGGCCTATACAAG
is986 GGAGCGGTCGGAAGCTCCTATGACAATGCACTAGCCGAGACGATCAACGGCCTATACAAG
IS987 GGAGCGGTCGGAAGCTCCTATGACAATGCACTAGCCGAGACGATCAACGGCCTATACAAG
*  ic  rtr *  *  *  *  rt ie ic 'k  i t  *  *  *  rt *  'k  *  * *  *  *  * *  *  i t *  -to -k *  *  * *  *  r t * * *  *  *  *  *  *  *  *  *  * *  * *  * *  *  *  *  *
IS6110 ACCGAGCTGATCAAACCCGGCAAGCCCTGGCGGTCCATCGAGGATGTCGAGTTGGCCACC
is986 ACCGAGCTGATCAAACCCGGCAAGCCCTGGCGGTCCATCGAGGATGTCGAGTTGGCCACC
IS987 ACCGAGCTGAT CAAACCCGGCAAGCCCT GGCGGT CCAT CGAGGAT GT CGAGTT GGCCACC
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
IS6110 GCGCGCTGGGTCGACTGGTTCAACCATCGCCGCCTCTACCAGTACTGCGGCGACGTCCCG
is986 GCGCGCTGGGTCGACTGGTTCAACCATCGCCGCCTCTACCAGTACTGCGGCGACGTCCCG
IS987 GCGCGCTGGGTCGACTGGTTCAACCATCGCCGCCTCTACCAGTACTGCGGCGACGTCCCG
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
IS6110 CCGGTCGAACTCGAGGCTGCCTACTACGCTCAACGCCAGAGACCAGCCGCCGGCTGAGGT
15986 CCGGTCGAACTCGAGGCTGCCTACTACGCTCAACGCCAGAGACCAGCCGCCGGCTGAGGT
15987 CCGGTCGAACTCGAGGCTGCCTACTACGCTCAACGCCAGAGACCAGCCGCCGGCTGAGGT 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
IS6110 CTCAGATCAGAGAGTCTCCGGACTCACCGGGGCGGTTCA CGA------
i s986 CTCAGATCAGAGAGTCTCCGGACTCACCGGGGCGGTTCAGGCCCCGATGGT
IS987 CTCAGATCAGAGAGTCTCCGGACTCACCGGGGCGGTTCA........................
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
asterisks (*) indicate matches between IS6110, IS986 IS987
^ X r r T s V s T 6"06 b0ld> are ,0Cated at the ends ° f the eleme" *  28bP fcr IS6110 and 
Putative region of framoshift, TTTTAAA (lino 6 pg. 78), for translation of ORFb can be seen in bold.
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Nomenclature.
Initially, nomenclature of the element was based on the particular copy isolated. 
McAdam et al, (1990) and Thierry et al, (1990 a,b) have called the different copies 
they isolated from different M.tuberculosis genomic libraries, IS986 and IS6110 
respectively. Hermans et al (1991) have cloned a copy of the related insertion 
sequence from BCG which they called ISPS7. A consensus has been reached to call 
all these iso-elements IS<5770 except when a specific copy is concerned (van Embden 
et al, 1993).
In this report, I will sometimes refer to ISPS<5, as it is the particular copy from which 
all the probes where derived (see fig.3.2). The site occupied by IS9S7 will be 
referred to as BCG1} while the site occupied by the copy of IS6110 found only in 
BCG Brazil, Japan and Russia will be referred to as BCG2.
Seal©
Figure 3.2. Restriction Map of ISPS6.
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Structure 
of IS986 
and 
PCR 
- 
generated 
probes
3.1.1; Differentiation of BCG Vaccine Strains By Employing Probes Based
on The Insertion Sequence IS986.
The failures and successes of BCG vaccine strains with different groups of people has 
presented a good cause to look into the genetic differences between different vaccine 
strains, and also to correlate these genetic differences to the apparent successes and 
failures of the of BCG vaccine strains. Although the vaccine is thought to be very 
safe, occasional cases of abscesses and more widespread infections have been reported 
(Lotte et al, 1984., Grange, 1988). This kind of study might also help one to 
understand why some vaccine strains cause disease.
Studies on the variation between BCG vaccine strains have mainly concentrated on 
the antigens that they secrete or express (Abou-Zeid et al, 1986., Abou-Zeid et al, 
1987a., and also on their lipid composition (Minniken et al, 1984., Abou-Zeid et al, 
1987b). The technique based on reassociation of DNA has also been employed to 
show the relationships among some mycobacterial species. M.bovis BCG was 
observed to exhibit between 8 6 % and 97% homology with M.tuberculosis and 7% 
homology was observed with M.leprae (Bradley, 1973, Grosskinsky et al. 1989). 
In this study, genetic analysis of BCG vaccine strains and M.bovis strains has been 
carried out by employing gene probes based on the insertion sequence IS986 
(McAdam et al, 1990), to establish variation among these strains.
Two sets of BCG vaccine strains were employed in this study, in addition to strains 
of clinical and veterinary isolates of M.bovis (Tables 3.2, 3.3). Since the BCG 
vaccine strains were possibly derived from M . bovis, it was necessary to have an idea 
how their IS6110 patterns are related, hence the inclusion of the M.bovis strains.
In order to realize the objective of this exercise, namely to establish genomic variation 
among BCG vaccine strains, gene probes were generated from the insertion sequence 
IS986 either by PCR or by conventional digestion and isolation of the probe fragment.
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Table 3.1: Primers Employed for the PCR Reactions.
PI: Primer employed in Generating the entire IS986 PCR Fragment. 
S’AGCTTAGGCCTGAACCGCCCCGGCATGT 3’
The underlined bases correspond to bases 1-20 of IS986, all of which 
are within the inverted region. The sequence in bold corresponds to 
the recognition site of the restriction enzyme Stul.
Primers for IS9S6 probe 2.
P2: 5’GACTCCAGTTCTTGGAAAGG 3’ (26-45) 
P3: 5’TGTGCAGATCGACTCGACAC 3’ (459-440)
Primers for IS986 probe 3.
P4: 5’CTGGCGGGTCGCTTCCACGA 3’ (891-910) 
P5: 5’TTCGACCGGCGGGACGTCGC 3’ (1266-1247)
Primers for Probe ISPS6  probe 1 (Hermans et al, 1990) 
INS I. 5’CGTGAGGGCATCGAGGTGGC 3’ (631-650) 
INS II. 5’GCGTAGGCGTCGGTGACAAA 3’ (856-875)
The numbers in brackets represent the position of each primer with respect to IS986.
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Probe Fragments were initially obtained from pRP5000 by restriction enzyme 
digestion. Subsequently, they were obtained by PCR employing the plasmid pUS330 
(see plasmids) as template.
Non PCR generated probes.
A-P : This probe is equivalent to IS986 probe 2 and occupies the region between 
20bp-459bp of IS986 (McAdam et al, 1990)
P-B : This probe is equivalent to IS986 probe 1 and occupies the region between 
460bp-880bp on IS986.
B-X : This probe is equivalent to IS986 probe 3 and occupies the region between 
881bp-1266bp on IS986.
A, B, P, and X represent the restriction sites for AccIII (BspEI), BamHI, PvuII, Xhol 
(fig.3.2). AccIII is an isoschizomer of BspEI.
3.1.11; Results of Probing Restriction Digests of DNA From BCG Vaccine 
Strains, and M.bovis Isolates.
An initial survey employed three parts of IS986 namely, P-B, A-P, B-X as probe 
fragments while employing the non-radioactive digoxigenin detection and labelling 
system to fingerprint nine BCG vaccine strains namely: Dakar, Bilthoven, Sweden, 
Tokyo, Copenhagen, Glaxo, Brazil, USSR, and Chicago. The restriction enzymes 
PvuII, BamHI, Sail, were employed in this initial survey.
PvuII was chosen because of its well known ability to digest mycobacterial DNA 
while BamHI and Sail were chosen to confirm any variations that might exist. All 
have restriction sites within IS986 (fig.3.2).
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Approach to Isolate Probe Fragments.
pRP5000 was digested with EcoRI to obtain the 4.6kb insert. The 4.6kb insert was 
digested with BamHI to give two fragments of sizes 1550bp and 3050bp. Both 
fragments were isolated and gene-cleaned. A PvuII digestion of the 1550bp fragment 
gave fragment P-B (420bp) and a 1130bp fragment. A Xhol digestion of the 3050bp 
fragment gave the B-X (385bp) fragment and a 2665bp fragment.
A BspEI digestion of the 4.6kb EcoRI fragment gave IS986 (1.36kb) and two other 
fragments. A PvuII digest of IS9&5 yielded the A-P fragment (439bp) and a 919bp 
fragment.
3.1.12; Non PCR generated probes.
The probes A-P, P-B and B-X were employed on restriction digests of genomic DNA 
obtained from BCG substrains Dakar, Bilthoven, Sweden, Japan (Tokyo), 
Copenhagen, Glaxo, Brazil, USSR, and Chicago.
The results in figure 3.4a highlight these BCG strains as having a major PvuII band 
corresponding to the single band previously observed by Hermans et al. (1990). 
However, three strains showed an additional major band, indicating these strains 
harbored a second copy of IS6110. In addition to the major bands, some minor bands 
(due to impurities in the probe) were evident.
On the basis of the major bands, the BCG strains form two groups; the Brazil, Japan 
and USSR substrains have two copies of IS6110 while Dakar, Bilthoven, Sweden, 
Copenhagen, Glaxo and Chicago only one copy. These results were confirmed using 
BamHI and Sail digests with A-P and P-B probes (figs. 3.4b and 3.4c). The 
significance of this grouping is discussed further below.
On considering the minor bands (which are thought to arise from contamination of 
probe by flanking DNA), additional polymorphism was evident which clearly 
distinguished the Dakar and Bilthoven strains from the others.
To further confirm the presence of contaminants in the probes, the unlabelled A-P,
86
and P-B fragments were blotted and detected with labelled probes. The results in 
figures 3.4b (lanes 11, 12) showed that the probes contained cross-hybridizing 
materials, some of which is likely derived from the flanking DNA.
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Figure 3.4a. PvuII digest of BCG vaccine strains probed with P-B.
The strains are seen in lanes 1-9. Dakar (1), Bilthoven (2), Sweden (3), Japan (4), 
Copenhagen (5), Glaxo (6), Brazil (7), USSR (8), and Chicago (9).
Lambda Hindlll DNA molecular markers can be seen in track 0.
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Figure 3.4b. BamHI digest (top lanes) and Sail digest (bottom lanes) of BCG vaccine 
strains probed with A-P.
The strains are seen in lanes 1-9. Dakar (1), Bilthoven (2), Sweden (3), Japan (4), 
Copenhagen (5), Glaxo (6), Brazil (7), USSR (8), and Chicago (9).
Lanes 10 and 11 contain unlabelled A-P and P-B respectively.
Figure 3.4c. Same as for fig, 3.4b but for the probe being P-B.
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3.1.13; PCR generated probes.
In order to confirm the authenticity of the results obtained with probes A-P and P-B 
(above), probes generated by PCR were therefore employed. These PCR generated 
probes are free from any contaminating flanking sequence. The results can be seen 
in figs. 3.41a, 3.41b, 3.41c.
A. Results obtained with IS9S6 probe 1.
Figure 3.41a shows the results of probing BamHI digests, Sail digests and PvuII 
digests of selected BCG vaccine strains known to have a single or two copies of 
IS 6110.
The BamHI digest gives two bands of sizes 6.6kb (highlighting BCG/ and 2.2kb 
(which represents BCG2). This pattern is identical to that obtained with IS986 probe 
2, hence this result is consistent with information obtained from the restriction map 
of IS986 (fig. 3.2).
The Sail digest gives three bands of sizes 1.3kb (BCG/, 3.3kb (BCG2), and a 0.42kb 
band due to the presence of two Sail restriction sites within IS9S<5 (fig. 3.2). This 
pattern is identical to the one obtained with ISPSri probe 2 but for the absence of the 
0.42kb band in the case of IS986 probe 2. This again is as expected from the 
restriction map because, a Sail digest will yield a fragment of about 410bp of which 
80bp will be from the region spanning IS986 probe 1.
B. Results obtained with IS986 probe 2.
Figure 3.41b highlights results obtained by probing BamHI digests, PvuII digests, and 
Sail digests of BCG vaccine strains known to have either single or two copies of 
IS 6110.
Considering the BamHI digest, two bands are apparent; A 6.6kb band in all strains 
which represents BCGt and a 2. lkb band in some strains which represents BCG2. 
Two bands are also highlighted in the PvuII digest. A 4.2kb band (which represents 
BCGQ and a 2.0kb band (representing BCG2). This confirms that the minor bands
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seen in figure 3.4a are due to contamination of the probe with extraneous DNA. 
The Sail digest also presents two bands, of sizes 1.23kb (BCG,) and 3.1kb (BCG2).
C. Results obtained with IS986 probe 3.
Figure 3.41c shows results obtained on probing BamHI, Sail, and PvuII digests of 
genomic DNA from selected BCG vaccine strains having a single or two copies of 
IS6110.
The BamHI digest gives two main bands of sizes 4.2kb (representing BCG,) and 
8.8kb (highlighting BCG2) in addition to other minor bands.
The Sail digest gives two bands of sizes 2.1kb and 0.42kb with each strain. This 
pattern is consistent with the prediction on the restriction map for the BCG, site(fig.
3.2). However, the IS copy at the BCG2 site was not detected. This may not be 
significant; the location of the internal Sail sites means that almost the whole probe 
will hybridize to the internal (0.4kb) Sail fragment. A Sail digest is therefore not 
suitable for employment in fingerprinting of BCG vaccine strains when IS986 probe 
3 is being employed.
On the other hand, IS986 probe 1 and IS986 probe 2 seem well suited in every 
situation, although best results are seen when PvuII is employed for digestion.
Each of the PCR generated probes are seen to place these vaccine strains into two 
groups. Group 1 comprises Brazil (Moreau), Japan and Russian substrains while 
group 2 comprises Dakar, Dutch (Bilthoven), Pasteur, Sweden, and Danish 
(Copenhagen) substrains.
On the other hand, the non PCR generated probes identify three groups. Group I 
comprises the Brazil, Japan, and Russian substrains, Group Ha comprises Sweden, 
Copenhagen, Glaxo and Chicago, while group lib is made up of Bilthoven and Dakar 
substrains. This shows that the sequences flanking IS986 can also be employed as a 
probe to fingerprint BCG vaccine strains. The significance of these results is 
discussed further below. The results obtained with the group 1 strains can be used 
to generate a restriction map of the region flanking the BCG2 site (fig. 3.42).
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Figure 3.41b.
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Figure 3.41a. Shows results of probing BamHI (top left), Sal I (top right) and PvuII 
(bottom) digests of BCG vaccine strains with 1S986 probe 1.
The strains are: Bilthoven (1), Pasteur (2), Dutch (3), Dakar (4), Moreau (5), Russia 
(6), Sweden (7), Japan (8), Danish (9), Japan (10).
The molecular size markers (comprising lambda Hindlll DNA marker and Phi X174 Haelll DNA 
marker) can be seen in lane 0 .
Figure 3.41b. Shows results of probing BamHI (top left), PvuII (top right) and Sal I 
(bottom) digests of BCG vaccine strains with IS9<S(5 probe 2.
The arrangement of the strains is the same as in fig. 3.41a.
The molecular size markers (comprising lambda Hindlll DNA marker and Phi X 174 Haelll DNA 
marker) can be seen in lane 0 .
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fFigure 3.41c. Shows results of probing BamHI (top left), Sal I (top right) and PvuII 
(bottom) digests of BCG vaccine strains with IS986 probe 3. The arrangement of the 
strains is the same as in fig. 3.41a.
The molecular size markers (comprising lambda Hindlll DNA marker and Phi X174 Haelll DNA 
marker) can be seen in lane 0 .
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Figure 3.42. Restriction map of the region flanking BCG2.
/
P B A P SB SXA p
1 2• 0  kb Pvu 1 1-4 kb Pvu
1 2 1 kb Bam 8-8 kb Bam
3 0  kb Sal 0 3 kb lr
Sal
p r o b e :  2
A (Acclll); B (BamHI); P (PvuII); S (Sail); X  (Xhol); 
E (EcoRI); Ps (PstI), Sp (SphI).
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3.1.14; Further Fingerprinting of BCG Vaccine Strains.
The discovery of BCG vaccine strains with two copies of IS6110 was interesting, 
indicating fundamental variation among these strains. This discovery triggered 
questions such as: Do some BCG strains harbor more than two copies of IS6110; 
What is the effect of different preparation protocols on the copy number of IS6110 
in these strains? To help answer these questions, thirty-six BCG vaccine strains 
(supplied by J.M. Grange)[see table 3.2] prepared by different manufacturers, and 
some of which had been employed in vaccine trials were screened employing IS986 
probe 3 (Hermans et al, 1990).
Figures 3.43a and 3.43b show the results obtained from blotting and probing PvuII 
digests of these vaccine strains.
Two groups of strains can again be identified. One group has only a single band 
(1.9kb) while the other group has two bands (1.9kb, 1.5kb). This result confirmed 
that the additional 1.5kb band previously seen in figure 3.4a was not due to 
contamination of the probe by flanking DNA. It was actually due to the presence of 
a second copy of an IS6770-like element in some BCG vaccine strains, namely Brazil, 
Japan and Russian substrains, confirming the consistency of these patterns.
Analysis of secreted protein patterns has shown a similar distribution (Abou-Zeid et 
al, 1986, Abou-Zeid et al, 1987a) and a similar correlation has also been observed for 
the possession of methoxymycolates (Minniken et al., 1984, Abou-Zeid et al., 1987b). 
[see discussion]
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The strains employed in figures 3.43{a,b) are BCG vaccine substrains. They have been identified 
on table 3.2 (page 97).
The strain number [ ] seen on the table corresponds to the lane number on the photograph.
The molecular size markers (comprising lambda Hindlll DNA marker and Phi X174 Haelll DNA 
marker) can be seen in lane 0 .
Figure 3.43a. PvuII Digests of BCG Vaccine Strains Probed with IS9S6 probe 3.
0 2 8 2 9 3 0 3 1 3 2 3 3 3 4 3 5 3 6  3 7 3839 4 041  4 2 4 3 4 4  45
f-351
Figure 3.43b. PvuII digests of BCG Vaccine Strains Probed with ISPS6 probe 3.
o 46 5051 52535455 565859  6 0 6 1 6 2  63 64 6 5 6 6  67
Table 3.2. BCG Vaccine Strains.
BCG vaccine strains from MGL: 
Dakar,Bilthoven,Sweden,Tokyo, 
Copenhagen, Glaxo,Brazil, Chicago.
BCG Vaccine Strains From John Grange. (36 strains.) 
Pasteur; [28]
Former Danish strain; [29]
Copenhagen(Statens.); [30].
Dutch(A-259, A-368, A-473.); [31, 32, 33], 
Dakar(B-006, B-176, B-300.); [34, 35, 36]. 
Russian(E-467, E-609, E-696, E-812.) [37, 38, 39, 40]. 
Japanese; [41]
Moreau; [42]
MFG Univ.of Illinois; [43].
Soviet; [44].
Swedish (1-067,1-141.);[45, 46].
Canadian (K-841, K-874, K-576.); [50, 51, 52].
Prague (G-47, G-142, G-956.); [53, 54, 55].
Glaxo (H-796); [56].
OSBOURNE 4-STRAIN TRIAL.
Vaccine 13(French made in France) [58].
C295(8) (French made in England) [59].
C7(1331/A) (Danish made in England) [60].
Vaccine 1 (Danish made in Denmark) [61].
Vaccine 2 (French made in Denmark) [62].
Vaccine 3 (Japanese made in Denmark) [63].
Vaccine 4 (britishmade in Denmark) [64],
Vaccine 11 (british made in Japan ) [65].
Vaccine 10(danish made in Japan ) [66].
Vaccine 9 (japanesemade in Japan) [67].
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Discussion.
In this study, BCG strains harboring two copies of ISdllOare being reported for the 
first time. The fact that other workers failed to detect BCG vaccine strains with two 
copies of 1S6110 was simply because they employed few vaccine strains, which 
excluded those strains harboring two copies.
The discovery of flanking DNA which is absent from the Dakar and Bilthoven strains 
could serve as a tool for screening other strains in the M.tuberculosis complex for 
epidemiological purposes, and also to study the effect of such a loss on the vaccine 
potential of the strains.
Apart from the employment of IS986 to identify and differentiate between members 
of the M.tuberculosis complex, one has also observed a good correlation between 
the presence of an extra copy of IS6110 and the production of a 46 kilodalton dimeric 
protein (MPB70). All the BCG vaccine strains exhibiting a second copy of IS6110 
belong to either the Tokyo, Brazil or USSR vaccine substrains. No other BCG 
vaccine substrain has exhibited an extra copy of IS6110 except these three.
Studies on secreted proteins (Abou-Zeid et al, 1986., Abou-Zeid et al, 1987a) have 
revealed the Tokyo, Brazil, and USSR substrains as producing vast amounts of the 
46kd dimeric protein while others either produce minute detectable quantities, 
undetectable amounts or nothing at all.
An explanation for the correlation between high production of MPB70 and the 
presence of a second copy of IS6110 (also known as BCG2 [this thesis]) could be that 
the insertion of the second copy of IS6110 has inactivated a repressor gene, giving 
high level expression of MPB70. The insertion of IS6110 adjacent to the MPB70 
gene might have provided a high level promoter or some other positive expression 
signal which enhances the production of the protein.
Alternatively, the Japan, Brazil, USSR substrains might simply represent a separate 
sub-family of BCG strains derived from a common ancestor in which there were two 
copies of IS6110 in addition to overexpression of MPB70. The two being 
independent characteristics of the original ancestor.
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The observation thatBrazil, Sweden and Japan substrains possessed methoxymycolates 
(Minniken et al, 1984., Abou-Zeid et al, 1987b) which were not detected in the 
Pasteur, Glaxo, Chinese, Danish and Czechoslovakian substrains of BCG indicated 
that the possession of two copies of IS 6110, the presence of characteristic 
methoxymycolates and the secretion of large amounts of MPB70 occurred together.
However, the results obtained with the two Swedish strains tested (1-067, 1-141) 
showed the presence of a single copy of the insertion sequence. Further information 
from J. Grange revealed that Sweden had discontinued the use of the original Swedish 
strains and that the current 'Swedish strain' was derived from the Copenhagen strain, 
and that 1-067 and 1-141 were infact derived from Copenhagen strain seed lot 1331. 
This does not completely resolve the discrepancy, as subsequent tests of the genuine 
Swedish strain as used by Minniken et al (1984) showed only a single copy of IS6110 
(results not shown). This could indicate that a replicative transposition of IS6110 
took place in the common ancestor of Japanese, Brazilian and Russian strains, after 
separation from the Swedish strain, as shown diagrammatically in figure 3.43c. This 
implies IS6110 was transpositionally active in this precursor, although the stability 
of the single copy in so many strains indicates an extremely low frequency of 
transposition.
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Figure 3.43c. Representation of the line of Descent of BCG strains from a common 
ancestor.
Lait Nocard strain 
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3.1.2; IS6110 typing of M.bovis.
BCG vaccine strains are popularly referred to as attenuated derivatives of the bovine 
tubercle bacillus (M.bovis). The variation observed with the BCG strains therefore 
generated an interest in the relationship between BCG and M. bovis in terms of copy 
number and location of IS6110 within the genome. This might help shed light on 
genomic changes which occurred during the attenuation process or subsequently.
ISPS6 probe 1 was employed on Southern blots of PvuII digested genomic DNA 
obtained from 28 veterinary and 5 human isolates of M.bovis. The isolates were 
received from Bilthoven, Belfast and Weybridge (table 3.4). The results can be seen 
in figs. 3.44a, 3.44b, 3.44c, table 3.3.
Results.
Most of the M.bovis strains exhibit a single band with variation in size in some 
cases. The sizes of the bands range from about 1.5kb to 8kb, but most of the strains 
are seen to harbor a single 1.9kb band, a position similar to BCG,.
Five strains are also seen to exhibit a single 1.5kb band at a position similar to BCG2. 
These strains can be seen in figures 3.44a [2, 4], 3.44b [lanes 6] and 3.44c [2, 3], 
and they are considered in more detail in a subsequent section.
One group of strains seen in figures 3.44a [10], 3.44b [10]; 3.44c [6] have a single 
band of about 1.8kb, intermediate between the BCG, and BCG2 positions. They occur 
as rare isolates from both the animal and human sources.
Only four out of thirty-three M.bovis strains tested had more than one band. Three 
of these strains had two copies while only one possessed three copies of IS6110 (table 
3.3).
These results indicate most M.bovis strains carry only a single copy of IS6110, 
which exhibits a PvuII band at the 1.9kb position, already shown to be a hotspot for 
insertion of IS6110 (Hermans et al, 1991). However, a few strains contain a single
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copy of IS6110 at the 1.8kb position. This slight variation in size could be attributed 
to deletions in the flanking sequence, hence reducing the size of the band in these 
strains. This allegation is supported by the observation of Hermans et al. (1991) that 
the flanking region of IS987 (BCG,) consists of direct repeats and intervening 
sequences which vary in number in different strains. Such a genomic composition 
predisposes the flanking region to recombination events which could lead to deletions, 
hence reducing the size of the restriction fragment. Further testing employing PCR 
and primers generated from the BCG, flanking region might help to explain this 
observation. Furthermore, inherited variation in the numbers of direct repeats and 
intervening sequences might be sufficient to attain the reduction in size observed. 
The results also indicate that fewer animal isolates (11 %) of M.bovis possessed more 
than one copy of IS6110 compared with 40% of the human isolates which exhibited 
more than one copy.
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Figure 3.44a [1-8] contains PvuII digests of genomic DNA from veterinary isolates 
from CVL Weybridge while lanes 9-13 contain human isolates from Bilthoven 
(Holland). They have been probed with IS986 probe 1.
Figures 3.44b and 3.44c show the results of probing PvuII digests of genomic DNA 
from twenty M.bovis veterinary isolates from VRL Stormont (Belfast) with IS986 
probe 1.
The sizes of the fragments can be seen on table 3.3 (page 104).
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Table 3.3. Fragment Sizes (bp) of PvuII Digests of Clinical and Veterinary Isolates
of M.bovis Probed with IS986 probe 1.
3.44a 3.44b 3.44c
1 1.9 1.9 1.9
2 1.5 1.9 1.5
3 1.9, 8.2 1.9, 8.2 1.5
4 1.5 1.9 1.9
5 1.9 1.9 1.9
6 1.9 1.5 1.8
7 1.9 1.9 1.9
8 1.9 1.9 1.9
9 1.9 1.9 1.9
10 1.8 1.8 1.9
11 1.9
12 1.9, 4.4
13 1.7, 1.9, 4.4
Columns 3.44a, 3.44b, 3.44c represent figures 3.44a, 3.44b, 3.44c respectively. 
The numbers on column I represent lane positions on the different photographs.
The strains in Table 3.3 are in the order they appear in Table 3.4{page 105).
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Table 3.4. Table of M.bovis strains.
M.bovis Strains From Wevbridge. CVL. 
4362, 4882, 5080, 5090, 5398, 5399, 
5400, 5401.
Strains From RIVM Bilthoven.
M.bovis Human Isolates.
M ycll967, Mycl2070, Mycl2095, Mycl2245, Mycl2716,.
M.bovis strains from VRL Stormont, Belfast.
T.90.1955, T.90.1957, T.90.1961, T.90.1970, T.90.1985, T.90.1994, 
T.90.2030, T.90.2031, T.90.2047, T.90.2080.
T.90.1944, T.91.2, T.91.46, T.91.63, T.91.68, T.91.76, T.91.77, T.91.78, 
T.91.79, T.91.113.
The strains from Bilthoven are clinical isolates while those from Weybridge and 
Belfast are veterinary isolates.
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Discussion.
IS6110 typing of M bovis strains has already been carried out. The investigation by 
van Soolingen et al. (1991) highlighted the presence of 1-5 copies of IS6110 in 
M.bovis strains. They tested 24 M.bovis isolates of which eight had single bands. 
Four (17%) out of twenty-four strains exhibited a single band at an identical position 
to BCG,. These strains could be distinguished from BCG strains with one copy of 
IS6110 at BCG, by employing a BssHII digest and a probe extending into the flanking 
region of IS987. All the BCG strains exhibited an identical pattern whereas the 
M.bovis strains exhibited polymorphism which were different to the pattern 
highlighted by the BCG strains.
In this study, 33 M.bovis strains have been investigated. Twenty-nine strains 
exhibited a single copy of IS6110, of which 21 strains (63%) apparently had IS6110 
inserted at the BCG, position, whereas in the investigation by van Soolingen et 
al.(1991), 17% of the single copy strains had a band at this position. In this study, 
29 out of 33 (89%) strains exhibited one copy of IS6110 whereas in the investigation 
by Soolingen et al.(1991), 8 out of 24 (33 %) of the strains had a single copy. While 
the investigation of van Soolingen et al (1991) suggests M.bovis strains harboring a 
single of copy of IS6110 are in the minority, this study indicates they are in the 
majority. This study also suggests most single copy strains preferred a site similar 
to the BCG, site as defined on a PvuII digest.
No reports on the strains with a single 1. 8kb PvuII band have been observed in any 
previous study.
The source of the M.bovis strains might hold a clue to the reason for variation in 
banding patterns. In this study, 2/5 (40%) of the human isolates had more than one 
copy of IS6110 while 2/28 (7%) of the animal isolates did so. A direct comparison 
cannot be made between these results since Hermans et al. (1990), and van Soolingen 
et al.(1991) employed only clinical isolates of M.bovis whereas in this study, 88% 
of the strains were veterinary isolates. The significance of this observation is not 
clear at this stage. It will be interesting if this observation holds true for other human 
and animal isolates of M. bovis.
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Conclusions.
IS<5ii0 is normally present as a single copy in BCG vaccine strains, but some BCG 
vaccine strains namely Brazil, Japan, and Russian substrains possess an extra copy of 
IS6110 in their genome.
A correlation exists between the possession of two copies of IS6110, the ability to 
produce large amounts of a 46Kd dimeric protein (MPB70) and the possession of 
characteristic methoxymycolates.
The presence of IS6110 at the same location in BCG vaccine strains indicates IS6110 
has a preference for particular sites in the genome of members of the 
M.tuberculosis complex. This is also an indication that IS6110 is very stable in 
BCG, having a low tendency of being lost or moved.
The presence of one or two copies of IS6110 in BCG (whereas most 
M.tuberculosis isolates have multicopies) indicates IS6110 might have a low 
frequency of transposition in BCG vaccine strains.
The presence of a single copy of IS6110 in some strains, and two copies in others 
may be an indication that IS6110 started originally at one site, and became defective 
for transposition in some strains.
Further groupings of BCG vaccine strains can be achieved by employing gene probes 
derived from genomic DNA flanking IS986.
Studies employing M.bovis isolates have revealed that IS6110 is usually present as 
a single copy, resembling BCG in this respect. A few strains were seen to harbor two 
or three copies of IS6110.
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Epidemiological studies are carried out to determine the source of an infection and to 
monitor the spread of the pathogen causing that infection. Organisms from a single 
infectious source will normally display characteristic genetic/immunological patterns. 
Since M.tuberculosis is mainly transmitted from one human to another, exercises 
like this might help in tracing the source of infection, which then leads on to 
isolating and treating the source in good time, hence arresting widespread 
dissemination of the pathogen. Epidemiological investigations will also enable health 
workers to trace other contacts of the source and screen them for tuberculosis, a 
further measure to check the spread of this debilitating organism.
A hundred and sixty four M.tuberculosis clinical isolates from Tanzania were 
obtained from Nick Kennedy (Royal Free Hospital London) for fingerprinting.
One hundred and seven isolates were successfully grown. Six isolates showed 
contamination and were discarded. Genomic DNA was isolated from 101 isolates, 
but eighteen genomic DNA extracts were highly degraded. Hence only 83 DNA 
samples from the Tanzanian M.tuberculosis isolates were employed for further 
analysis. Subsequently, twelve more isolates were processed by Salim Al Mammary 
(Univ. of Surrey) and these have also been included in this study.
Seven Malaysian M.tuberculosis isolates from Z. Zainuddin (Universiti Sains 
Malaysia) were also included, and total genomic DNA was also extracted for analysis.
Analysis of Total Genomic DNA.
Total genomic DNA was digested with the restriction enzyme PvuII and subjected to 
agarose gel electrophoresis. Southern blots of the gel were prepared and probed with 
IS9S6 probe 3. The results can be seen in figures 3.5a-3.5f; Tables 3.5 and 3.6.
3.1.3; Epidemiological Studies on Clinical Isolates of M. tuberculosis.
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Table 3.5. Representation of Southern blots of PvuII digested 
DNA of M.tuberculosis isolates.
3.5a 3.5b 3.5c 3.5d 3.5e 3.5f
A3 - A20 Kb45 A60 A105 A150
A4 A21 Kb46 A62 A106 A157
A5 A22 Kb53 A69 A109 A165
A l A23 Kb56 A70 A112 A167
A8 A24 Jb68 A77R A114a A175
A9 A25 PG200 A80 Al 14b A176
A10 A26 3623/3622 A81 A116 A179
A ll A l l A39 A83 Al 18 A182
A12 A28 A41 A85 A120 A189
A13 A29 A53 A87 A121 A192
A14 A30 A54 A88 A123 A198
A15 A32 A55R A93 A131s A200
A16(Om) A33 A57 A98 A142 A203
A16 A34 A58 A100 A144 A204
A l l A35 A59 A104 A147 A205
Columns 3.5a-3.5f correspond to figures 3.5a-3.5f (see below)
Figure 3.5c lanes 1-7 contain Malaysian M.tuberculosis isolates. The rest of the strains on table
3.5 are Tanzanian M.tuberculosis isolates.
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Figure 3.5g. M.tuberculosis Strains Processed by S. Al Mammary.
Lanes: 1 [lambda Hindlll marker], 2[151], 3[76], 4[46], 5[90], 6[92], 8[117], 
9[126], 10[130], 11 [136], 12[171], 14[161], 15[147], 16[156], 17[76], 
18[79], 20[lambda Hindlll marker], lanes 7 and 13 contain the lkb DNA 
ladder
The Malaysian M.tuberculosis isolates designated Kb45; Kb46; Kb53; Kb56; Jb68 
(table 3.5) were characterized by M. Yates (Dulwich hospital). They are of the Asian 
variety i.e TCH negative and are sensitive to streptomycin, isoniazid, ethambutol, 
rifampicin and pyrazinamide. Information received from Z. Zainuddin indicates the 
Kb strains were isolated from Kota Bharu while Jb68 was isolated from Johor Bharu 
(600km from Kota Bharu). The Malaysian isolates (Kb45, Kb46, Kb53, Kb56, Jb68) 
are seen to fall into one group, as they all have only one copy of IS6110 which 
exhibits a 1.5kb PvuII band (fig. 3.5c lanes 1-5). These strains are discussed further 
in a subsequent section.
Strains PG200, 3623/3622 (fig. 3.5c lanes 6, 7) are also Malaysian isolates. They are 
classical human strains, defined by their T C H  positive characteristic. They are 
sensitive to streptomycin, isoniazid, ethambutol, rifampicin and pyrazinamide and 
exhibit a single PvuII band of about 5kb.
In this study, the Tanzanian M.tuberculosis isolates contained 1-15 copies of the 
element, with the majority of the strains carrying between 8 and 14 copies.
Almost every strain tested exhibits a unique pattern of polymorphism, although some 
similarities were evident.
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Grouping of strains.
To facilitate analysis of the RFLP patterns generated from the Tanzanian strains, the 
Molmatch (UVP) program was employed to generate groupings of these isolates. (See 
table 3.6).
An X-ray film of the Southern blot was taped onto a sensitive surface. A sensor was 
then employed to map out the positions of the molecular weight markers, after which 
the tracks containing the test digests were read into the computer. Based on defined 
parameters namely, a similarity coefficient (S.C) greater than or equal to 78% and 
allowing for a fragment size variation less than or equal to 6%, this program was able 
to group the RFLP patterns according to the size and number of the bands present. 
The similarity coefficient allows the grouping of strains with a certain number of 
bands, and this grouping is further scrutinized by the defined fragment size variation. 
In this study an S.C of 100% indicates the banding patterns are identical.,
Table 3.6. Explanation to 'no. of bands' column as exemplified by isolate A4. 1/1 
implies A4 exhibits a single band of the same size (+ /- 6%) as that of A26, A144 or 
A176.
The 's' strains e.g. 130s where prepared by S. Al. Mammary.
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Table 3.6. Table of Tanzanian M.tuberculosis isolates showing matches 
with other isolates and some patient details.
Isolate
(A)
Tribe. Town/
Village.
Address. Region. Matches no. of 
bands
s .c
(%)
3 Mfipa Moshi Majengo Kili.
4 Chagga Moshi Shunya St. Kili. 26,
144
176
1/1
1/1
1/1
100
100
100
5 Mtende Moshi Soloeto Kili. 28
30
10/11
10/13
86
87
7 Masai Loi Tok 
Tok
Sinet Kajaro 8
22
33
53
10/10
10/5
10/12
10/10
90
80
82
90
8 Masai Kiteto Naberera Arusha 7
16
17
33
53
10/10
10/9
10/8
10/12
10/10
90
84
78
82
80
9 Msambaa Moshi Majengo Kili.
10 Mrangi Kiteto
Kondoa
Kondoa Dodom
a
11 Chagga Kibosho Kindi Kili. 121 6/8 86
12 Masai Kiteto Ngorika Arusha 13
121
10/12
10/8
91
78
13 Mrangi Moshi Majengo Kili. 12
35
123
12/10
12/11
12/10
91
78
82
14 Chagga Kibosho Umbue Kili. 85
121
10/13
10/8
78
78
15 Chagga Kibosho Manushiju
u
Kili.
16 Mpare Himo Makuyuni Kili 8
22
150
9/10
9/9
9/9
84
78
78
17 Masai Kiteto Lesinyai Arusha 8 8/10 78
116
20 Masai Loitoktok Ibron Kajaro 7
53
58
8/10
8/10
8/8
78
89
100
21 Chagga Marangu Kwameela Kili. 71s
83
13/14
13/12
82
80
22 Chagga Kilema Mana Kili. 7 5/10 80
23 Chagga Kirua Ndowi Kili.
24 Masai Rombo Rombo Kajaro 130s 4/4 75
25 Mwarusha Mondoli Kamwanga Arusha
26 Mpare Moshi Mabogini kili. 4,176 1/1/1 100
27 Masai Mondoli Gilai Arusha 16
100s
9/9
9/13
78
80
28 Mpare Hai Lawate Kili. 5
30
83
167
11/10
11/13
11/12
11/12
86
92
78
87
29 Manyema Moshi Kalimani Kili. 32 2/2 100
30 Chagga Uru Rau/Uru Kili. 5
28
167
13/10
13/11
13/12
87
92
80
32 Mngoni Moshi Sokoni
Pasua
Kili. 29 2/2 100
33 Mnyaturu Moshi Sokoni
Pasua
Kili. 7
8
53
12/10
12/10
12/10
82
82
91
34 Chagga Kirua Nduoni Kili. 35
60
90s
105
165
9/11
9/12
9/6
9/11
9/7
80
86
80
80
88
35 Chagga Moshi Dares 
Salaam St.
Kili. 13
34
80
11/12
11/9
11/9
78
80
90
39 Chagga Marangu Mamba Kili.
41 Chagga Masama Nkwawans
ira
Kili.
46s Masai Monduli Longido Arushi 126s 11/8 84
117
53 Mpare Kirua Uchira Kili. 7
8 
20 
33 
58 
116 
123
10/10
10/10
10/8
10/12
10/8
10/9
10/10
90 
80 
89
91 
78 
84 
80
54 Chagga Lomakaa Mae Kili.
55R Chagga Mashame Kyeri Kili. 92 10/8 78
57 Chagga Mwika Shokoni Kili.
58 Masai Longido Lesoi Arusha
59 Masai Rombo Rongai Kili.
60 Mkahe Kahe Ckekereni Kili. 34
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12/9
12/11
86
87
62 Chagga Hai Kwasadala Kili.
69 Masai Tulali Oldonyosa
mbu
Arusha 70
83
14/13
14/12
82
92
70 Chagga Uru Mnini Kili. 69
83
114A
13/14
13/12
13/15
82
88
79
71s Chagga Rombo Useri Kili 21
100s
189s
14/13
14/13
14/10
82
82
83
77R Chagga Masama Isuki Kili. 98,
161s
1/1
1/1
100
79s Chagga Old
Moshi
Kidia Kili 88
120
11/14
11/12
80
78
80 Chagga Uru Ongoma
Sokoni
Kili. 35 9/11 90
81 Chagga Moshi Shaban 
Robert St.
Kili. 116 14/9 78
83 Mtaita Kahe Chekereni Kili. 21
28
69
12/13
12/11
12/14
80
78
92
85 Msukuma Moshi N.H.C.
Arusha
Rd.
Kili. 14
167
13/10
13/12
78
80
118
87 Chagga Machame Lambo Kili.
88 Msambaa Moshi or 
Korogwe
Karanga Kili. or 
Tanga
79s
142
14/11
14/15
80
83
90s Chagga Hai Kashashi Kili. 34 6/9 80
92s Masai Kiteto Oiboigishu 
no. 5
Arusha 55R 8/10 78
93 Masai Kiteto Soipe Arusha
98 Chagga Old
Moshi
Mbokomu Kili. 77R 1/1 100
100s Chagga Rombo Mashati Kili. 71s
83
189
189s
13/14
13/12
13/10
13/10
82
80
78
78
100 Chagga Rombo Mashati Kili.
104 Chagga Machame Foo Kili.
105 Msambaa Moshi Kilimani
Pasua
Kili. 34
60
11/9
11/12
80
87
106 Mwarusha Kiteto Lokti Arusha
109 Mpare Hai Kikavo-
Chini
Kili.
112 Chagga Uru Kishumun
du
Kili.
114A Mpare Mwanga Kileo Kili. 70
189
15/13
15/10
79
80
114b
116 Chagga Moshi Majengo Kili. 81
147
9/14
9/9
78
89
117s Chagga Uru Kariwa
Uru
Kili. 126s 9/8 82
118 Chagga Moshi Majengo Kili.
120 79s
88
12/11
12/14
78
77
121 Mpare Moshi Mafuta St. Kili. 11
12
14
157
8/6
8/10
8/10
8/9
86
78
78
82
119
123 Masai Korogwe Kalalani Tanga 13
53
10/12
10/10
82
80
126s Masai T.P.C Magadini Kili. 46s
117s
136s
8/11
8/9
8/10
84
82
78
130s Chagga Rombo Olele Kili. 24 4/4 75
131
136s 126s 10/8 78
142 88 15/14 83
144
147 116 9/9 89
150 16 9/9 78
157
161s 77R 1/1 100
165 34 7/9 88
167 28
30
85
12/11
12/13
12/13
87
80
80
175
176 4,26 1/1/1 100
179
182 189 8/10 78
189s 100s 10/13 78
189 71s
100s
114A
182
10/14
10/13
10/15
10/8
83
78
80
78
192
198 205 8/7 93
200
203
204
120
205 198 7/8 93
Footnotes obtained from Nick Kennedy.
Information is not yet available for every isolate.
Address. Closest indication to where the patient is living. It may cover large areas (e.g. Kiteto area). 
Town/Village/Area. Name usually used by people for the place/area where they live. May be an area 
of only a few square kilometres or may cover many hundred square kilometres e.g. Kiteto.
Region. Administration region where the patient lives. It is well defined. The large Kiteto area 
extends into both Arusha and Tanga regions. Kili= Kilimanjaro.
The Masai are unique from the other tribes in not mixing with others and leading a semi-nomadic 
existence. They travel extensively in their areas (primarily Arushu region, in the Kiteto, Mbuguni and 
Longido areas and meet at the large cattle markets. The Mwarusha tribe is closely related to the Masai 
and would also go to these cattle markets.
The RFLP data for the Tanzanian isolates with the suffix "s" were obtained from Salim Al Mammary, 
University of Surrey.
Two main divisions can be identified from table 3.6. Division 1 consists of four 
groups derived by employing a similarity coefficient (S.C) of 100% while division 2 
comprises eleven groups realized by employing a similarity coefficient of between 
82% and 92% (table 3.7). This implies while members in groups under division 1 
are homogenous, the members in groups under division 2 are more varied, the extent 
of the variation increasing with decreasing S.C.(%). The occurrence of a majority 
of the isolates under division two further indicates one is dealing with a highly 
variable population of M.tuberculosis isolates.
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Table 3.7. Major Groupings of Tanzanian Isolates.
DIVISION 1. Strains (A). no. of copies 
ofIS6110.
S.C (%)
Group 1. 4, 26, 144, 176. 1 100
Group 2. 77R, 98, 161s. 1 100
Group 3. 29, 32. 2 100 |
Group 4. 20, 58. 8 100
DIVISION 2.
Group 5. 198, 205. 8, 7. 93
Group 6a. 28, 30. 11, 13. 92
Group 6b. 69, 83. 14, 12. 92
Group 7a. 12, 13. 10, 12. 91
Group 7b. 33, 53. 12, 10. 91
Group 8a. 7, 8, 53. 10, 10, 10. 90
Group 8b. 35, 80. 11,9. 90
Group 9a. 20, 53. 8, 10. 89
Group 9b. 116, 147. 9, 9. 89
Group 10a. 34, 165. 9 ,7 . 88
Group 10b. 70, 83. 13, 12. 88
Group 11a. 5, 30. 10, 13. 87
Group lib . 60, 105. 12, 11. 87
Group 12a. 5, 28. 10, 11. 86
Group 12b. 11, 121. 6, 8. 86
Group 12c. 34, 60. 9, 12. 86
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Group 13a. 8, 16. 10, 9. 84
Group 13b. 46s, 126s. 11, 8. 84
Group 13c. 53, 116. 10, 9. 84
Group 14a. 71s, 189s. 14, 10. 83
Group 14b. 88, 142. 14, 15. 83
Group 15a. 7, 33. 10, 12. 82
Group 15b. 8, 33. 10, 12. 82
Group 15c. 13, 123. 12, 10. 82
Group 15d. 21, 71s. 13, 14. 82
Group 15e. 69, 70. 14, 13. 82
Group 15f. 71s, 100s. 14, 14. 82
Group 15g. 117s, 126s. 9, 8. 82
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Table 3.8 shows some matched strains in relation to the area of domicile of their host. 
Isolates 4 and 26 have a single band each. They are related by a similarity coefficient 
of 100% and their hosts are resident in the Moshi area. A similar grouping is the 
case with strains 29 and 32. So far, such a grouping, which can be very useful 
epidemiologically, has been observed only with the strains listed in the table 3.8.
Table 3.8. Relationship between some matched isolates and the area of domicile of
patients.
Isolate. no.of bands. Similarity 
coefficient %)
Town/Village.
4 , 26 1 100 Moshi
29, 32 2 100 Moshi
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Discussion.
The Tanzanian isolates exhibit a complex array of RFLP patterns. These strains have 
come from closely related areas as well as areas far separated from each other. Most 
of the M.tuberculosis isolates came from members of the Chagga, Masai followed 
by the Mpare tribes.
Although most of the strains exhibited unique RFLP patterns, groupings could be 
effected by defining a similarity coefficient and percentage size variation (tables 3.6,
3.7).
Some correlation could be identified between the tribe of a patient and the RFLP 
pattern. Group 2 strains 77R and 98 are both from Chagga patients, group 4 strains 
20 and 58 are both from Masai, group 7a strains 7 and 8 are both Masai while group 
7b strains 35 and 80 are both from Chagga patients. Another correlation was also 
been observed between the area of domicile of the patient and the RFLP pattern (fig.
3.8). The limited numbers of these related strains indicates they are probably not 
epidemiologically significant.
Although the history of the Masai indicates they do not mix with other groups, there 
is no indication of particular types of RFLP patterns (but for the few strains 
mentioned above) associated with this group of people. The wide variations in RFLP 
patterns seen with a group of people who normally lead isolated lives would imply 
they become infected by the heterogenous population on the rare occasions they make 
contact, like on market days.
The number of bands exhibited by these strains range from 1-15, with most isolates 
exhibiting banding patterns in the 8-14 range, typical of M.tuberculosis (figs. 3.5a- 
3.5f). If one assumes the variations in banding patterns imply infection from a 
different source in each case, and takes into consideration the wide area of 
distribution of the M.tuberculosis isolates, it can therefore be said there exist a 
diverse reservoir of potential sources of M.tuberculosis infection in these regions. 
The complexity of the patterns rules out the presence of an epidemic, since there will 
be less variation or more closely related groups among isolates involved in an 
epidemic situation.
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Hermans et al.(1990) were able to show M.tuberculosis strains from nine patients 
treated by the same physician exhibited identical IS6110 RFLP patterns while non- 
epidemiologically related isolates gave diverse patterns, van Soolingen et al.(1991) 
also showed that M.tuberculosis strains from epidemiologically unrelated cases 
exhibited a high degree of variation in RFLP patterns, whereas strains from a single 
outbreak in Amsterdam exhibited identical fingerprints, indicating a common source 
of infection. Investigations on M.tuberculosis strains from regions in Central 
Africa (where tuberculosis is highly endemic), showed these strains were more related 
to each other than a more diverse group of Dutch strains ([believed to result from 
reactivation of cases of dormant infections], van Soolingen et al, 1991), despite the 
fact that the Central African isolates came from a wider geographical area.
Although both the Tanzanian and Central African isolates have come from wide 
geographical areas, the Central African isolates generally show a closer relationship 
with each other while the Tanzanian isolates are more diverse, probably highlighting 
the fact that while an epidemic situation might be associated with the Central African 
strains, the sources of infection in the Tanzanian situation are highly varied.
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3.1.31; The employment of IS6110 for investigation of potential cross 
infection.
Bronchoscopy is a technique which allows the clinician to inspect the lungs for signs 
of disease such as tuberculosis, carcinoma, infections due to Pneumocystis, and 
AIDS. It is also employed for the collection of lung washing and biopsies for further 
investigation. A bronchoscope is the instrument which is employed to carry out this 
task. It operates through fibreoptics. A feature of the bronchoscope is that it is 
reusable, implying there is that inherent risk of transfer of infection from one patient 
to another. After each exercise, the bronchoscope is disinfected in CIDEX. The 
efficacy of such a decontamination process is crucial, otherwise live organisms will 
be passed on from one patient to another.
Isolates of M. tuberculosis obtained from two patients, A and B who had 
undergone bronchoscopy at a London hospital were sent to this department for 
analysis. A case of cross infection was feared. The isolates were grown in 7H9 
broth and their genomic DNA was isolated as previously described.
The DNA was digested with the restriction enzyme PvuII, ran on a gel to separate the 
fragments. A Southern blot of the gel was probed with IS986 probe 3.
Results.
The result of the Southern blots can be seen on figure 3.6. Isolates 1-5 came from 
patient A while isolates 6-8 came from patient B. All eight isolates are apparently 
identical. Such a situation may arise in two ways; The first is that both patients 
contracted the infection independently of each other and from an external common 
source. The second thought is that one is seeing a case of cross infection, as both 
patients were subjected to examination with the same bronchoscope, van Soolingen 
et al.(1991) have also noted a possible case of cross-infection in patients undergoing 
bronchoscopy, implying cases of cross infection arising after bronchoscopy are not 
rare. Hence the need for proper sterilizing procedures for all medical equipment. 
One should also interpret such results with caution. Although the bronchoscope is the
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prime suspect as the medium involved in the cross infection, one cannot rule out the 
possibility that both patients might have caught the infection by airborne transmission 
outside the hospital, or within the hospital from another patient. There is also the 
chance that some laboratory contaminant was accidentally introduced into samples 
taken from patients A and B. But the employment of multiple isolates from each 
patient effectively eliminates the chances of contamination by a laboratory based 
isolate.
Figure 3.6. PvuII Digests of genomic DNA from M.tuberculosis Isolates from 
a Case of Suspected Cross-infection.
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Strains 1-5 came from patient A while strains 6-8 came from patient B.
The molecular size markers (comprising lambda Hindlll DNA marker and Phi X174 Haelll DNA 
marker) can be seen in lane 0.
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3.1.4; Insertion Sequence Typing of M. tuberculosis, M.bovis and BCG.
Identification of unusual strains.
Although there are other rare isolates of M.tuberculosis harboring a single copy 
of IS6110, the discovery of M.tuberculosis strains having a single band of the same 
size and apparently situated at BCG2 (Al.Mammary, Univ. of Surrey, Zainuddin et 
al. (unpublished) data) was curious and instantly generated an interest in these 
strains. These strains seemed to be widely distributed in different parts of the world, 
but they were rare isolates. In this report, I characterize some of these unusual 
M.tuberculosis isolates, and their relationship to M.bovis and BCG by employing 
Southern blots of genomic digests, and the PCR.
Hermans et al. (1991) have cloned and sequenced the region of DNA flanking either 
side ofIS987 (BCG,), while the DNA flanking BCG2 has also been sequenced (this 
thesis). This information will be employed to generate primers for PCR.
In order to realise the objectives of this part of the project, specific PCR fragments 
derived from the insertion sequence IS986 (fig.3.2) were employed as probes on 
Southern blots of restriction digests of total genomic DNA from the M.tuberculosis 
complex strains of interest.
Results and Discussion.
The unusual M.tuberculosis isolates were initially detected by probing Southern 
blots of PvuII digested genomic DNA from M.tuberculosis with IS98<5 probe 3 (fig
3.2). A single band of about 1.5kb was apparent in some of the strains tested (figs. 
3.5a lane (2), 3.5b (7), 3.5c (1-5), 3.5e (14), 3.5f (6).
Relationship to M.bovis and BCG.
The unusual nature of these strains makes them conspicuous in surveys. They seem 
to be quite widespread. This raises some interesting epidemiological questions as well
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as molecular biology ones. The question of prime interest is the relationship of the 
M.tuberculosis strains (with a single 1.5kb PvuII band) with the M.bovis and BCG 
strains.
Do the M.tuberculosis isolates represent a previously unknown subtype of the 
M.tuberculosis complex?
How close is the relationship between these M.tuberculosis isolates and either 
M.bovis or BCG. Are the copies of IS6110 actually sited at the same position or are 
the similar sized fragments due to coincidence?
These unusual M. tuberculosis strains were further analyzed together with M.bovis 
strains which exhibit a single band of about 1.5kb (fig.3.44a, 3.44b), and M. bovis 
BCG vaccine strains which exhibit one and two copies ofIS6110. Southern blots of 
restriction digests of genomic DNA from these strains were hybridized with PCR 
generated probes which correspond to the left and right ends (probes 2 and 3 
respectively) of IS986. The results are shown in figs. 3.7a, 3.7b, 3.7c, 3.7d and 
summarized in table 3.9.
In the initial test, a PvuII digest probed with IS986 3 (fig. 3.7a; table 3.9[column 
3.7a]), all the strains tested were similar, and exhibited a single band of similar size 
to that of BCG2. In a BamHI digest probed with IS986 3 (fig.3.7b)), variation was 
apparent between the strains, with a clear differentiation of the M.bovis strains from 
the M.tuberculosis isolates.
The results with the PvuII digest and ISPS<5 2 (fig. 3.7c; table 3.9[column 3.7c]) 
showed a clear variation between the strains. In particular, there was no longer a 
similarity to the BCG2 band, and the bands seen, although varying in size, were 
nearer to the BCG, fragment. This can also be seen in a BamHI digest probed with 
IS986 2 (fig. 3.7d).
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Lanes 0 and 18 contain molecular weight markers.
Lanes 1-5 contain DNA from Malaysian M.tuberculosis isolates; lanes 6,7, contain DNA from 
M.bovis veterinary isolates from Weybridge; lanes 8-10 contain DNA from M.bovis isolates from 
Stormont, Belfast; lanes 11-13 contain Tanzanian M.tuberculosis isolates, lanes 14,15 contain BCG 
substrains Dakar and Japan respectively; 16 contains an Omani M. tuberculosis isolate.
The strains are arranged in the order they appear on table 3.9. Sizes of the DNA fragments can 
be seen on table 3.9 (Page 133); Further description of these strains can be seen on page 134.
Both the digests on figs. 3.7a and 3.7b have been probed with IS986 probe 3.
Figure 3.7a. PvuII Digest of M.tuberculosis and M.bovis Isolates Exhibiting 
a Single Band of 1.5kb, Corresponding to BCG2.
Figure 3.7b. BamHI Digest of M.tuberculosis and M.bovis Isolates (as in fig. 
3.7a).
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Lanes 0 and 11 contain molecular weight markers.
Lanes 1-5 contain DNA from Malaysian M.tuberculosis isolates; lanes 6,7, contain DNA from 
M.bovis veterinary isolates from Weybridge, lanes 8-10 contain DNA from M.bovis isolates from 
Stormont, Belfast, while lanes 12-14 contain DNA from Tanzanian M.tuberculosis isolates. Lanes 
15, 16 contain DNA from BCG Dakar and Japan respectively.
The strains are arranged in the order they appear on table 3.9. Sizes of the DNA fragments can 
be seen on table 3.9 (Page 133); Further description of these strains can. be seen on page 134.
IS986 probe 2 has been employed on PvuII Digests (fig.3.7c) and BamHI digest (fig. 
3.7d) of Genomic DNA from the M.tuberculosis complex strains seen in fig. 3.7a.
Figure 3.7c. PvuII Digests Probed with IS98<5 probe 2.
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Figure 3.7d. BamHI Digests Probed with IS986 probe 2.
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Table 3.9. Band sizes of restriction digests of isolates belonging to the 
M.tuberculosis complex harboring One Copy of IS6110. (Band sizes[bp]).
3.7a 3.7b 3.7c 3.7d
Strain
Kb45 1.6 4.4 4.5 8.0
Kb46 1.6 4.4 4.3 7.8
Kb53 1.6 4.8 5.0 9.2
Kb56 1.6 4.8 4.8 8.7
Jb68 1.6 4.4 4.1 7.6
Wy2
(4882)
1.5 3.5 4.0 6.8
Wy4
(5090)
1.5 3.5 4.0 6.8
Ir73
(T.90.1994)
1.5 3.5 3.9 6.8
Ir79
(T.91.2)
1.5 3.5 4.0 6.8
Ir80
(T. 91.46)
1.5 3.5 4.0 6.8
A26 1.6 4.4 4.4 7.4
A144 1.6 4.8 4.4 7.4
A176 1.6 4.8 4.4 7.4
Dk36(BCG) 1.9 4.1 4.2 6.3
Jp67(BCG) 1.9a 4.1a 4.2a 6.3a
1.515 8.615 1.815 2.115
SL14 1.6 - -
3.7a :PvuII digest, probe IS986 probe 3 
3.7b :BamHI digest, probe IS986 probe 3 
3.7c :PvuII digest, probe IS986 probe 2 
3.7d :BamHI digest, probe IS986 probe 2 
a  :Bands relating to BCG,.
15 :Bands relating to BCG2.
(foot notes can be seen on the next page).
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Description of strains (table 3.9).
Isolates of the M.tuberculosis complex harboring a single copy of IS6110, 
exemplified by the Possession of a single 1.5kb PvuII band:
Kb45, Kb46, Kb53, Kb56, Jb68; [Malaysian M.tuberculosis isolates].
Information obtained from M. Yates (Dulwich hospital) indicates they are of the Asian 
variety i.e TCH negative. They are sensitive to streptomycin, isoniazid, ethambutol, 
rifampicin and pyrazinamide.
The Kb strains were isolated from Kota Bharu while Jb68 was isolated from Johor 
Bharu (600km from Kota Bharu).
4882, 5090. [M.bovis isolates from C.V.L. Weybridge]
Ir73; Ir79; Ir80. [M.bovis isolates from V.R.L. Stormont, Belfast]
A26; A144; A176. [Tanzanian M.tuberculosis isolates]
SL14 [Omani M. tuberculosis isolate.
DK 36 = Dakar strain 36, while Jp67=  Japan strain 67 (see table 3.2 page 97).
In all four blots, the M.bovis isolates formed a homogeneous group, while the 
Tanzanian isolates were also similar to one another but distinct from the M.bovis. 
On the other hand, the five Malaysian isolates showed a significant degree of 
heterogeneity, especially with probe 2 (fig. 3.7c).
A possible explanation of this data is that all the strains tested carry IS6110 at the 
BCG, site, identified by Hermans et al.(1990) as a 'hot spot', and that the variation 
seen is due to polymorphism in the flanking region. This could arise from the 
presence of multiple directly repeated sequences in this region. On the other hand, 
this evidence does not exclude the possibility that the insertion sequence is inserted 
at a different site in some of the strains.
The differences in band size could also be explained in terms of recombination events 
in the flanking region. These could be either insertions or deletions. Such events will 
serve to increase or decrease the length of particular restriction fragments.
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The observation by Hermans et al. (1991) that ISPS7 was inserted in a region 
containing direct repeats and intervening sequences was quite interesting. Most M. 
tuberculosis strains tested contained at least one copy of the insertion element in 
this region of direct repeats (Hermans et al. 1991, Mendiola et al.1992) while some 
even had two copies of the element inserted in this region. This showed the region 
of direct repeats was a "hotspot" for the insertion of the element. Such a genomic 
arrangement is a predisposing factor for recombination events. This statement can be 
confirmed from the fact that the length and composition of the direct repeat region 
varied among the different M. tuberculosis strains tested, implying the 
polymorphism observed with these strains might actually be due to differences in the 
size of the direct repeats.
This observation by Hermans et al. (1991) prompted a further investigation into these 
unusual M.tuberculosis isolates.
The second copy of the IS(577O-like element in BCG substrain Japan was also cloned 
and part of the flanking region sequenced. This exercise enabled a more complete 
assessment of the relationship between the unusual M.tuberculosis strains, and 
BCG to be carried out.
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Lanes 1 ,5,9,13,17 contain DNA from BCG Dakar, Lanes 2 ,6 ,10 ,14  contains DNA from BCG Glaxo. 
Lanes 3 ,7 ,11 ,15 ,18  contain DNA from BCG Brazil while Lanes 4 ,8 ,12 ,16 ,19  contain DNA from 
BCG Japan. Both Dakar and Glaxo were employed as single copy control digests while Brazil was 
employed as a two copy control digest.
The molecular size markers (comprising lambda Hindlll DNA marker and Phi X174 Haelll DNA 
marker) can be seen in lane 0.
Lanes: 1-4 contain BamHI digests; 5-8 contain EcoRI digests; 9-12 contain BstEII digests; 13-16 
contain Narl digests; 17-19 contain Nrul digests.
3.1.5. Cloning the Second Copy of IS6110 (BCG,) in BCG Japan.
This exercise was carried out to enable one to analyze the sequence flanking BCG2 
in substrain Japan, hence making it possible for one to see if IS6110 had a particular 
preference for this insertion site in the genome of M.tuberculosis, and BCG strains.
Figure 3.8 shows digests of genomic DNA (derived from BCG Japan) by some 
enzymes that are known not to digest within IS986. This was necessary as an enzyme 
not recognizing any sites within IS986 would yield fragments from which one could 
clone the copy of IS6110 in BCG2. Computer analysis of the IS986 sequence gave 
a number of enzymes, some of which digested the DNA poorly or not at all. The 
enzymes employed in the digests seen in fig.3.80 are: BamHI (lanes 1-4), EcoRI (5- 
8), BstEII (9-12), Narl (13-16) and Nrul (17-19). BamHI is the only enzyme that cuts 
within IS986, hence it is of little use when it comes to obtaining a DNA fragment 
containing a whole copy of IS6110 at BCG2. EcoRI was chosen as enzyme of choice 
and it gave a fragment of about 4.8kb which contains BCG2.
Figure 3.8. Digests of Genomic DNA from BCG strains Employing Enzymes not 
Recognizing Sites within IS986.
0 1 2  3 4  5 6 7 8 9  1 0  1 1 1 2  1 3 1 4 1 5 1 6 1 7 1 8  1 9
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Two approaches were employed to obtain the flanking DNA of BCG2.
The first approach involved employing the inverse polymerase chain reaction (IPCR) 
(Rich et al, 1990) to amplify the flanking DNA which could then be analyzed. The 
technique of IPCR has been dubbed PCR in the wrong direction, meaning the primers 
prime from within and away from the insertion sequence.
Primers P6 and P7 (see primers below) were designed for the IPCR exercise. They 
were constructed such that when the primers hybridized to the template DNA, their 
3 'end will be outward facing, enabling amplification of DNA outwards from the 
primer\template binding region.
The PCR reactions were carried out as described in methods but for the extension 
time which was three minutes.
Primers for Inverse PCR (IPCR)
P6. 5 'ATCTCTGCGACCATCCGCAC 3' (124-105)
P7. 5 'CTGCCTACTACGCTCAACGC 3' (1274-1293)
Primer P6 primes outwards to the left while primer P7 primes outwards to the right. 
Both primers anneal to sequences within IS9S6.
Preparation of Template DNA for IPCR.
The DNA template for the IPCR was prepared by carrying out an EcoRI digestion on 
genomic DNA derived from BCG Japan vaccine strain which is known to harbor 
BCG2. The EcoRI digest was then ligated with the hope that the products of the 
ligation will include the circularised 4.8kb fragment which is the template of interest. 
IPCR with this template is expected to yield a product of about 3.5kb.
The ligation reaction was carried out in a volume of 20^1 and comprised of the 
following: water(15/al), DNA(2/fl), 5X ligation buffer(2/fl), ligase(lul). The DNA 
concentration was 25ng//ri while 1 unit of ligase was employed. Five ligation 
reactions were done at the same time to increase the amount of the ligate. The 
reaction was incubated at 37°C for 15 hours. The ligate was then precipitated in
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ethanol, washed in 70% ethanol, desiccated and resuspended in 10/ul of water. 5ng 
of ligate was then employed in the PCR reaction.
Control templates that have been employed in the IPCR exercise are pRP5000 (which 
contains IS986 "plus flanking DNA" cloned into apAT153 vector and pUS330 (which 
consists of IS986 cloned into a pUC18 vector.
Both Primers PI (primer for amplification of IS986 [table 3.1])), and P6, P7 (primers 
for the IPCR) gave products of the expected sizes when employed in reactions with 
pRP5000 or pUS330 as template. This confirmed the IPCR was working 
satisfactorily with purified plasmid DNA.
When the ligated genomic DNA was employed in the IPCR, two products were 
evident. There was a band of 3.51cb and another band of 1.7kb. The 1.7 kb band 
was produced when the IPCR primer was employed to prime both the ligated (test) 
template and unligated (control) template. The 3.5kb band, which is about the 
expected size for the IPCR product of interest, was produced only when the genomic 
template DNA was ligated. This product only comprises the region flanking either 
side of IS6110, outwards from the primer binding region. The production of this 
3.5kb product was not consistent and the yield was low. This made recovery of the 
product difficult.
Since the control reactions worked first time, one reason for the bad performance of 
the test IPCR can be attributed to poor ligation. This is conceivable as routine 
ligation protocols have been tuned to effect more intermolecular than intramolecular 
products. Hence the lack of suitable templates for the IPCR reaction meant product 
yields were very low or absent. This method was therefore halted while a second 
approach was implemented.
The second approach to obtaining the flanking region of BCG2 involved cloning the 
entire 4.8kb EcoRI fragment. Repeated attempts to directly isolate this band from the 
gel followed by cloning into a pUC18 vector were met with failure. Therefore, 
shotgun cloning was employed to construct a gene library.
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Preparation and screening of pUC18 genomic library of BCG Japan.
Genomic DNA obtained from BCG Japan was digested with the restriction enzyme 
EcoRI which does not have a recognition site within ISP86. The genomic digest was 
then ligated to EcoRI cut pUC18 at 15°C for 16 hours. The ligate was then employed 
to transform DH5a competent cells.
The transformed cells were plated on L-agar plates containing ampicillin at a 
concentration of 5(£g per ml. The plates were incubated at 37°C for 12 hours. The 
library was then screened by hybridization of colony blots, employing IS986 probe 
1 and the Boehringer chemiluminescence detection system (methods).
The screening exercise highlighted thirty colonies as would be positives. These 
colonies were isolated and grown in L-broth. Minipreparation of plasmid DNA from 
the thirty colony isolates was done. The DNA was treated with RNase and digested 
with EcoRI. Only 14 out of the 30 released inserts on digestion with EcoRI, implying 
the rest were artifacts due to the detection system. Some of the colony isolates had 
multiple inserts, with the insert size ranging from 7500bp to 420bp. The average 
insert size was 1800kb. This indicates a majority of the inserts were below lkb in 
size. Only six clones yielded plasmid extracts with a 4.8kb EcoRI insert. Southern 
blots of these six plasmid clones probed with IS 986 probe 3 revealed only four clones 
were positive, one of which was christened 332. A stock culture of 332 was 
prepared and stored at -70°C while working cultures were stored on sealed L-agar 
plates at 4°C.
A large scale plasmid preparation of pUS332 was made. Template DNA for 
sequencing was subsequently obtained from this plasmid stock.
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Sequencing the Region of DNA Flanking BCG2.
Sequence analysis of the flanking DNA was achieved by employing the dideoxy chain 
termination method as advised by United States Biochemicals (See methods).
The initial primers for sequencing (Cl.i and C2.i) were derived from within IS986. 
Based on the known sequence, other primers (Cl.ii, C2.ii, C2iii) were employed in 
further sequencing, while primers C l.r, C2.r were then employed to sequence the 
complementary strands. The sequencing strategy was "chromosome walking".
C l.i : 5' ATC,TCT,GCG,ACC,ATC,CGC,AC 3' 20mer
C l.ii : 5 ’ GTC,GGT,GAG,CCT,CAA,GT 31 17mer
C l.r  : 5' GAT,CCA,GCG,CCT,GTG,CC 31 17mer
C2.i : 5' CTG,CCT,ACT,ACG,CTC,AAC,GC 3* 20mer
C2.ii : 5’ TGG,GTA,TTG,CGA,CCT,GG 3' 17mer
C2iii : 5' CTG,GGA,ATC,GAT,GAC,AC 3 ' 17mer
C2.r : 5 ’ GTG,TCA,TCG,ATT,CCC,AG 3 ' 17mer
C l.i, C l.ii are the leftwards oriented primers while primer C2.i, C2.ii, C2.iii are the 
rightwards oriented primers, with both sets of primers effecting extensions away from 
IS986. C l.r  and C2.r both effect extensions (from the left and right respectively) 
towards IS9&5.
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Figure 3.90. Flanking sequence of BCG2.
CCTT CCAACCTTCG TGGTCTCCTC GTCGAGCTCG ATATCGGLGA CGTCAGTCGA
ACATACGTGG TTCCTTGTTG CCCTTGCCGL TCGCAGATGA CCGCAGCCTG GCCACGACCT
CCTCCAAACT GAAGGGCTTT GTCACATAGT CG T CACCAC C CAGGGTCAGA CCCGATCTTG
TCCTGTAGCG AGTCACGGGC CGTCAGGAAC AACGGCCGGG GCATCGATGC CGTCCCGCGC
GCAGCCGGLG CAGCACCCCA AAGCCGTCCA TCCCGGGCAT CATCACATCG AGGATCACCG
CGTCCGGCGG GTTTCCCGGG CCCGATCCAG CGCCTGTGCC CCGTTGGTCG CGGTGTAGAC
TTCAAAGCCC TGGAACTTGA GGCTCACCGA CAGCAGTTCA ACGATGTTGG CCTCATCATC
GACCACGAGG ACACGAGCTC CGGTGTGGTG TTTTCGCCTG GGTTCCCGCC GTCACGAGAT
CAACCCCTTT CCGCATTGGT TGAACGTTAC CTTCTGAACC GCCCCGGCAT GTCCGGAGAC
TCCAGTTCTT GGAAAGGATG GGGTCATGT C AGTGTGGTTC ATCGAGGAGG TACCCGCCGG
AGCTGCGTGA GCGGGCGGTG 'CGGATGQTCQ CAGAQAT*** CTGCCTACTAC GCTCAACGCCAG
AGACCAGCCG CCGCGTGAGG TCTCAGATCA GAGAGTCTCC GGACTCACCG GGGCGGTTCATTCAC
AGTCATTGTG TAATTCCTGA AAGCTTGTTG CCAGTAGTCT GCTAACAGTC TGCCAGGAAT
CGCCAAATCA GCTTGGACCG TTGCCGCTCA ATCCACGGCM CGCCGTGAAT ACACTCGCAG
AATGAACCTC GGCCAAACCC TCGTGGGTAT TGCGACCTGG CCCGCACGAG CGGCTCGCCG
CCGCCGACAC CGGTTTGAAC ATGGCCGGCM CCMGGTTGAC ATGGCCAAAC AAGCGTTGGG
TGMATGCCGG CGGCGCAAGC GGACGACCTC AATGGCCAAC ATGCTGGGAA TCGATGACAC
GATTGCCCGC MCAACCGGCT GGCCAGGCTA TTGGACGACG ATATGCCGCT GGGACGCGCC
ATCGCCGCCA ACGGCGCGAT GGACCGGATG CTGCGGCCCG GCGGGGTGGT CGACCTGCTG
ACCCAGCCCG GCGGCTTACT CGACCGCCTG ACCGCTGAAG GCGCGCCATG CAGCGCGCAC
TGCAACCGGG CGGACTGGCC GACCAGCTGC TCGCCGAGGA CGGACTTATC GAGCGGGTGC
TCTCCGAAGA CGGGCTGGCC GACCGGCTGC TGGCCGAACG GGACTGATCG ACAAGATAAC
GGCCAAGGAC GGACCGCTCG .AACAGCTCGC CGACGTCGTC CGACACGTTG GC
Target duplication (TTC) is double underlined.
IS986 sequence is in bold with the inverted repeat sequence(left to right) in bold, 
underlined.
*** represents the remainder of IS98<5 sequence.
The positions of the primers C l.i, C l.ii are in shadow italics while that of primers 
C2.i, ii, iii are in italics and underlined. Primer C l.r is in italics and double 
underline while C2.r is the complementary strand of C2.iii.
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Results from flanking sequence.
The region of flanking sequence analyzed in this study bore no resemblance to any 
IS6110 flanking sequence analyzed. It exhibits a three base target duplication of 
TTC, whereas IS986 (McAdam et al, 1990) shows no duplication of target DNA. 
Thierry et al (1990) have shown IS6110 exhibits a three base target duplication 
(CGA) while Hermans et al. (1991) have also shown IS987 exhibits a three base 
duplication (CCC) of target DNA. Mendiola et al.(1992) have sequenced the region 
of DNA flanking four copies of the insertion sequence in one M. tuberculosis 
isolate. Each copy of the insertion sequence exhibited a different target duplication 
(CCC, AGG, CCA, CTC). The variation in target duplications indicates a random 
insertion of IS6110 into sites within the genome of members of the M.tuberculosis 
complex.
A knowledge of the flanking sequences of both BCG, (Hermans et al, 1991) and BCG2 
(this thesis) enabled further analysis of the position of insertion 1S6110-like, elements 
in the unusual M.tuberculosis strains, and M.bovis strains to be carried out by 
employing PCR.
PCR tests for the site of insertion of IS6110.
This exercise was realized by employing primers derived from the DNA sequence 
flanking BCG, (primers 1 and 2) and the sequence flanking BCG2 (primers 3 and 4).
Primer sequences.
Primer 1. 5’ TCGACGATCGCGTCGAT 3' 17mer 
Primer 2. 5' TGATCGCTAAACGCCGG 3' 17mer 
Primer 3. 5 ’ GCCGTCCATCCCGGGCATC 3' 19mer 
Primer 4. 5’ CCATGTTCAAACCGGTGTC 3* 19mer
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Figure 3.91. Diagram showing positioning of primers for PCR.
BCG, primers.
263bp IS986
The binding positions of primers 1 and 2 ore indicated by the orroujs.
The distance (bp) betuueen primer binding site and inverted repeat sequence has also been indicated.
A (AccIII); B (BamHI); P (PvuII); Ps (Pst I); Sp (Sphl); € (EcoRI).
Left inverted repeat sequence (irl); Right inverted repeat sequence (irR).
IS986 (shaded in grey) is located betuueen the inverted repeats.
BCG2 primers.
^  233b p  IS986
The binding positions of primers 3 and ^ore indicated by the aiTOUJS.
The distance (bp) betuueen primer binding site and inverted repeat sequence has also been Indicated.
A (AccIII); B (BamHI); P (PvuII); Ps (Pst I); Sp (Sphl); E (EcoRI).
Left inverted repeat sequence (irl); Right inverted repeat sequence (irR).
IS986 (shaded in grey) is located betuueen the inverted repeats.
Scale
200bp
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On employing primers 1 and 2 in a PCR reaction, the presence of a product of size 
1898bp would indicate IS6110 is present at the same position as BCG,, while the 
presence of a band of size 540bp would indicate this site is present in the genome but 
lacks an IS6110 insert.
Figure 3.92 shows results obtained on employing primers 1 and 2 in a PCR reaction. 
All the BCG strains employed gave a band of about 1800bp as expected (top lane 11, 
bottom lane 11), and this result was always reproducible.
Interestingly, some Malaysian, Tanzanian, and Omani M.tuberculosis isolates tested 
also gave a band of about 1800bp (top lanes 2, 4, 5., bottom lanes 1, 3, 4, 5, 10,), 
which is identical in size to that obtained with the BCG strains. These strains also 
produced three other minor bands of sizes 750bp, 500bp and 270bp, indicating the 
presence of other primer binding sites.
No PCR products are apparent in the case of the M.bovis strains (top lanes 6-10), 
except in the case of Wy2 (top lane 6) which gave three bands of sizes 750bp, 500bp, 
and 270bp. This probably indicates the absence of IS6110 at the BCG, site, or lack 
of a BCG, site in the M.bovis strains. It also indicates the possible presence of 
primer binding sites at least in the case of Wy2 (lane 6)
The presence of a 1800bp PCR product in some M.tuberculosis strains suggests 
IS6110 is present at the same position as BCG,.
Some unexpected PCR products were apparent. This could be due to non specific 
binding of primer to template. An annealing temperature of 65°C is likely to 
eliminate non specific binding of primer to template. Its failure to do so implied there 
could be more than one suitable binding site for the primers despite the fact that the 
primers were derived from non repetitive DNA sequence.
Whereas the results were reproducible in the case of BCG, repeated PCR tests with 
the M.tuberculosis isolates did not give consistent results. The result in fig. 3.92 
could therefore be due to contamination with BCG DNA.
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Figure 3.92. PCR Products Employing Primers Flanking BCG,
Top lanes: 1-5 contain Malaysian M.tuberculosis isolates Kb45,Kb46,Kb53,Kb56,Jb68
respectively; 6,7 contain M.bovis isolates Wy2, Wy4 from Weybridge; 8-10 contain M.bovis 
isolates Ir73, Ir79,lr80; 11 contains BCG Dakar strain 36.
Bottom lanes: 1 -4 contain Tanzanian M.tuberculosis isolates A144 ,A150,A176,A26; 5-10 contain 
M.tuberculosis strains from Oman; 11 contains BCG Japan strain 67.
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When primers 3 and 4 are involved in a PCR reaction, the presence of a product of 
size 1819bp would indicate the presence of IS6110 at a site similar to that occupied 
by BCG2, while the presence of a 461bp band would show that the genome lacks an 
IS6110 insert at this site. The results obtained on employing primers 3 and 4 are 
clearly exemplified by figures 3.93a and 3.93b.
All the M.tuberculosis and M.bovis (except Ir79) strains tested exhibited a band 
at 461bp rather than 1819bp, indicating that in no case was IS6110 inserted at the 
BCG2 site.
In the case of the unique M. bovis strain (Ir79), no amplification occurred even after 
repeated attempts (figs. 3.93a [13], 3.93b [11]. Southern blot analysis identified this 
strain as being similar to the other M.bovis isolates. This might indicate the strain 
does not have an available primer binding site, presumably due to mutation or deletion 
of this region.
Only with the BCG vaccine strains having two copies of IS6110 was a band of about 
1781bp amplified. This observation might indicate the unique nature of the insertion 
of IS6110 at this site, which so far has been shown to be restricted to BCG vaccine 
strains having two copies of IS6110. Due to the limited number of strains tested, one 
has to view this uniqueness with caution.
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Top lanes: 1 -5 contain Malaysian M.tuberculosis isolates Kb45,Kb46,Kb53,Kb56,Jb68; 6-9 contain 
Tanzanian M.tuberculosis isolates A144,A150,A176,A198;
Strains A150 and A198 contain multiple copies of IS6110.
Bottom lane: 10,11 contain M.bovis strains Wy2,Wy4; 12-14 contains M.bovis strains 
Ir73,lr79,lr80; 15 contains Tanzanian M.tuberculosis isolate A26.
Lambda Hindlll + phi X174 Hae III DNA size markers can be seen in lane 0.
All the strains tested (except Ir79 Jane 13) gave a single band of 461 bp.
Top lanes: 1 -5 contain Malaysian M.tuberculosis isolates Kb45,Kb46,Kb53,Kb56,Jb68; 6,7 contain 
M.bovis strains Wy2,Wy4 from Weybridge; 8,9 contain BCG Dakar (strain 36) and Russia (strain 
37) respectively.
Bottom lanes: 10,11,12 contain Ir73,lr79,lr80; 13 contains M.tuberculosis isolate 1 (from a case 
of cross infection) which contains multiple copies of IS6110; 14-17 contain Tanzanian 
M.tuberculosis isolates A144,A150,A176,A26; 18,19 contain BCG British strain 65,
Japan strain 67 respectively.
Lambda Hindlll + phi X174 Hae 111 DNA size markers can be seen in lane 0.
All the strains tested (except Kb45, lane 1;lr79 Jane 11) gave a single band of 461 bp. But BCG 
Russia (top lane 9) and BCG Japan (bottom lane 19) all give two bands of sizes 1.8kb and 400bp.
Figure 3.93a and 3.93b. PCR Products Employing the Primers Flanking BCG2
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Implication of Results/Conclusions.
BCG vaccine strains with two copies of IS6110 are further confirmed as a unique 
entity in that not only do they have two copies of IS6110, but also the insertion of 
IS6110 at the BCG2 site is unique to these strains. This finding implies these strains 
can be easily detected by PCR, employing primers generated from the BCG2 flanking 
region. However, due to the limited number of strains tested, more screening is 
called for to confirm this finding.
Other members of the M.tuberculosis complex tested contain the BCG2 flanking 
region but without an IS6110 insert. This has been confirmed by employing PCR. 
The complete failure of the PCR in one of the M.bovis isolates while employing the 
BCG2 flanking primers further supports the idea that a complete loss of the primer 
binding site can occur.
The results suggest IS6110 is probably present at the BCG, site in some Malaysian, 
Tanzanian and Omani M.tuberculosis isolates. But the inconsistency of the results 
indicate there exist constraints to binding of the primer to template. It could either 
be structural constraints, implying the primer binding site is not properly exposed to 
the primer. It might also be that these M. tuberculosis strains have simply lost the 
primer binding site. The peculiar nature of the ISPS7 flanking sequence (Hermans 
et al, 1991) suggests recombination and rearrangements are likely to occur in the 
region flanking BCG, . This could lead to loss of the primer binding site, or the 
creation of secondary structures which may shield this site. Alternatively, the 
possibility of contamination by BCG DNA cannot be excluded.
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Chapter 4.
TRANSPOSITION OF IS986 .
4.0; INTRODUCTION.
The discovery of transposable elements.
"Elements carried in maize chromosomes ... serve to control gene action and to 
induce at the site of the gene, heritable modifications affecting this action... They can 
appear at new locations and disappear from previously determined locations. The 
presence of one such element at or near the locus of a known gene may affect the 
action of this gene. In so doing, it need not alter the action potential of the genic 
substances at the locus. Therefore, these elements were called controlling elements... 
It might be considered that a controlling element represents some kind of 
extrachromosomal substance that can attach itself or impress its influence in some 
manner at various positions in the chromosome complement and so affect the action 
of the genic substances at these positions ... Transposition of controlling elements 
either arise from some yet unknown mechanism or occur during the chromosomal 
reduplication process itself and are a consequence of it1 (Barbara McClintock, 1956). 
This observation made by Barbara McClintock, albeit on a eucaryotic system, namely 
maize, showed that there was some dynamism going on within the genomic system. 
This genome dynamism, known as transposition, is now known to take place in 
procaryotic chromosomes as well. The elements involved in the transposition process 
are known as insertion sequences or transposons.
One such element known as IS98<5, was initially discovered in the genome of 
Mycobacterium tuberculosis as a repetitive sequence. This implicated the element 
as being capable of carrying out transposition, probably via a replicative pathway. 
IS986 is the transposable element on which this work is based. Further discussions 
on IS986 will be realized after a general overview of procaryotic transposable 
elements.
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4.1; Procaryotic Transposable elements.
These are genetic entities capable of inserting as discrete, unchanged segments of 
DNA at different sites in the genome. Some transposable elements are capable of 
duplicating and inserting a daughter copy at a new location in the genome, while the 
transposition activity of others can be suicidal for the donor replicon. The enzyme 
activity involved in the insertion of a transposable element at a new site is the 
transposase.
By virtue of their ability to insert into new locations in the genome, transposable 
elements effect genomic changes through mutations and rearrangements. Their ability 
to translocate within the host's genome coupled with the ability of some elements to 
autonomously replicate, could be viewed as properties which might enable 
transposable elements to escape the host' mechanism that could eliminate DNA 
sequences.
4.1.1; Divisions of procaryotic transposable elements.
Transposable elements have been identified under two main headings namely, 
insertion sequences and transposons.
Insertion sequences. These are the simplest known transposable elements. They 
encode only functions involved in transposition hence, they have been branded as 
selfish genes. Since they do not carry any selectable markers, preliminary knowledge 
about insertion sequences is usually derived from their effect on surrounding genes. 
Their presence can also be detected at the recombination junctions of two replicons, 
where they are seen to provide homologous sites for recombination.
Transposons. These are larger and more complex transposable elements. In 
addition to transposition functions, transposons encode additional genetic determinants 
as well as functions which regulate transposition.
The transposition functions are known to act at the ends of the element. In addition
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to transposon encoded functions, there are also some host encoded functions involved 
in transposition which include DNA polymerase I, DNA gyrase and ligase.
Classification of transposable elements.
Despite attempts to classify transposable elements, current classification schemes do 
not incorporate all the known elements. This is because classification schemes are 
based on the knowledge derived from known elements, hence the discovery of new 
elements with novel properties always calls for a reclassification. The classification 
scheme for procaryotic transposable elements mainly focused on elements found in 
Escherichia coli and the classification was based on the DNA sequence 
homologies, arrangement of the different gene segments and the perceived mode of 
transposition. However, some transposable elements found in gram positive bacteria 
which include Streptomyces, Staphylococci and Streptococci, and some 
elements from Mycobacteria, (see tables 4.13, 4.14) do not fit into the current 
classification scheme. However, based on studies involving transposable elements 
found in E.coli, these elements have been conveniently grouped into three classes.
Class I elements. This class is made up of insertion sequences (class I A)
and composite transposons (class I B).
Class II elements. This class comprises the Tn3-family of transposons.
Class m  elements. It is made up of the transposing bacteriophage Mu and
related phages.
Class I elements.
The members in this group are either simple insertion sequences, or composite 
transposons. They all share a similar mode of recombination and genetic organization 
of the transposable units.
The insertion sequence IS6110 is a typical class I A transposable element (insertion 
sequence). The members of class I A (table 4.10) exhibit a compact system as they
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contain one or more structural genes, regulatory information, transposition 
determinants, all within a limited coding capacity. This is made possible due to 
overlap of some coding regions. Most insertion sequences carry inverted repeat 
sequences at their ends (tables 4.10, 4.11, 4.14), but there are known insertion 
sequence elements which have a similar genetic arrangement but they lack inverted 
repeats (table 4.13).
Composite transposons (table 4.11) are segments of DNA that carry insertion 
sequences at their ends. This implies that a composite transposon has four ends that 
can potentially be used for transpositional recombination, whereas simple insertion 
sequences have only two such ends. The insertion sequence at the ends of composite 
transposons could either be in direct or inverted repeat orientation. The entire 
composite transposon may be transposable or the individual insertion sequences may 
transpose independently (Reif,1980, Rosner and Guyer, 1980, Foster et al, 1981). 
Insertion sequences range in size from 750bp to 1600bp while the size of composite 
transposons varies from 2100bp to 40000bp. (see tables 4.10, 4.11).
The Transposase.
Genetic evidence and DNA sequence analysis shows insertion sequences encode a 
protein (transposase) that is required for transpositional recombination. It is actually 
a core function involved in the transposition process. For IS 10, IS50 and IS903, the 
transposase gene occupies about 90% of the coding capacity of the transposon 
(Hailing et al, 1982., Grindley et al, 1980 a,b., Grindley et al, 1985), clearly 
highlighting the importance of this protein in transposition. In the case of Tn 10, it 
has been shown that the transposase acts at the ends of the insertion elements (Foster 
et al,1981., Grindley et al, 1980 a,b., Rothstein et al, 1981). This is understandable 
as most insertion sequences are known to possess inverted repeats at their ends. 
The inverted repeats probably serve as recognition sites for the transposase. If the 
inverted repeats do serve as recognition sites for the transposase, how do other 
elements which lack terminal repeats, like IS900 and IS907 (table 4.13), carry out the 
transposition exercise?
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The transposase of class I elements functions efficiently in cis, i.e on transposon ends 
on the same DNA molecule as the transposase gene (Machida et al,1982, Grindley et 
al,1985, Morisato et al, 1983). Complementation in trans occurs with an efficiency 
of 1 % or less. The non complementability of the transposase of class I elements has 
been studied using point or deletion mutants which fail to be complemented in trans 
by a homologous element. Cis action has also been proposed for the action of Tn903 
functions on the insertion elements (Foster et al, 1981). A possible explanation for 
the cis preference by the transposase of insertion sequences is that on synthesis, the 
transposase binds non specifically to DNA close to the transposase gene. The 
transposase then goes on to search for the transposon ends by one dimensional 
diffusion along the DNA (Berg et al, 1981).
It has been shown for IS50 that in addition to coding for a transposase, there is also 
another product which is derived from a sequence with an initiation site different to 
that for the transposase. This product is thought to function as an inhibitor to 
transposition (Johnson et al, 1981, Johnson et al, 1982, Isberg et al, 1982). This can 
be seen as a way in which nature protects the host's genomic DNA from degeneration 
through increase in numbers of the transposable element.
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Table 4.10. Class I A. Insertion Sequences(IS elements.)
Element Size(bp) Target Repeat 
(bp)
N° of Copies 
in E.coli K12.
Terminal 
Inverted 
Repeat (bp)
ISi 768 8 or 9 6 to 10 18/23
IS2 1327 5 5 32/41
I S3 -1 4 0 0 3 or 4 5 32/38
IS 4 1426 11 or 12 1 16/18
IS5 1195 4 11 15/16
ISiO-R 1329 9 17/22
IS50-R 1531 9 8/9
IS9(95-R,L 1050 9 18/18
IS 102 -1 0 0 0 9 18/18
151 is very deletogenic.
152 exhibits a strong orientation II promoter activity.
(Cullum, P., 1985., Grindley, et al, 1985., N. Kleckner, 1981.)
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Table 4.11. Class I B. Composite Transposons.
Transposons Markers Ends Length(bp)
Tn5 Km IS50 IR 5700
Tn9;Tn981 Cm IS7 DR 2500
TnlO Tc IS10 IR 9300
Tn 903 Km IS903IR 3100
Tn1681 Stable enterotoxin ISi IR 2100
Tn2901 Arg. biosyth. IS7 DR 11000
Tn2571 Cm,Sm,Hg,Su,
Fus.
ISi DR 23000
Tn-raf Raffinose
utilization
ISi DR 40000
TnD Tc IS10 IR 9300
TnD::TnA Tc,Amp. IS70 IR 14300
Comments.
TnD::TnA - Insertion of Tni-lilce element into TnD.
TnD - Closely related to Tni0
IR - Inverted repeat.
DR - Direct repeat.
Amp - Ampicillin resistance
Su - Sulphonamide resistance
Hg - Resistance to mercury.
Arg. - Biosynthesis of arginine.
Tc - Tetracycline resistance
Km - Kanamycin resistance
Cm - Chloramphenicol resistance
Sm - Streptomycin resistance
Bennett, P., 1985., Grindley et al, 1985.)
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Class II Elements (The TnA family).
These elements differ from insertion sequences by possessing at least one gene (which 
is not involved in transposition) that confers a heritable property on the host 
bacterium. Such a property could either be antibiotic resistance, resistance to heavy 
metals (mercury, cadmium), the ability to utilize certain substrates (fermentation of 
lactose) [table 4.12].
The TnA elements are commonly known as transposons, although this term is 
sometimes employed to describe other transposable elements. Their genetic 
organization has earned them the name of complex transposons. They are exemplified 
by the transposon Tni.
The TnA elements share some properties which help classify them as a family. 
They are flanked by inverted repeat sequences of between 30bp to 40bp, between 
which are found genes coding for drug resistance, and/or other genetic markers in 
addition to transposition functions. The genetic markers are not segregated from the 
transposition functions and sites, but together, they form the body of a basic 
transposing element.
The inverted repeats are of a similar size and show a considerable degree of 
homology, suggesting they are related, but they may not be perfect inverted repeats 
as seen in the case of Tnl721 and Tn501 where 35bp out of 38bp are identical [table 
4.12]. The TnA elements also generate a characteristic 5bp target duplication on 
insertion. The element always transposes as a unit, which differs from composite 
transposons whereby either insertion sequence or the entire unit may transpose. 
Transposition of TnA elements appears to be a two step process comprising 
cointegrate formation and resolution.
Transposition of class II elements is effected by two gene products, namely, the tnpA 
and the tnpR gene products. The tnpA gene encodes the transposase while tnpR 
encodes the resolvase (a site specific recombinase). In contrast to the transposase of 
insertion elements, the tnpA (in some cases) and tnpR gene products are trans-acting.
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Grouping of members of the T 11A.
Members of the TnA family of transposons can be divided into two groups. This 
division is based on genetic organisation and the ability of recombination functions 
to complement each other.
Group I.
This is represented by transposons Tn3 and gamma-delta. In these elements, the tnpA 
and tnpR genes are divergently transcribed from a common regulatory region (Heffron 
et al, 1979., Grindley et al, 1985), and the tnpR (but not the tnpA) functions can be 
complemented in trans. The resolution site lies within the intergenic region. The 
tnpR gene product functions both as a transcriptional repressor (of both tnpA and 
tnpR) and a site specific recombinase.
Group II.
This is represented by Tn501. The tnpR sequences are inverted relative to the 
orientation in Tn3. Both the tnpA and tnpR functions are complemented in trans 
among these transposons, and both genes are transcribed in the same direction.
Transposition Immunity.
Members of the Tn3-family exercise a property called transposition immunity. This 
implies the target DNA has a reduced ability to accept a new copy of the same 
transposon. Transposition immunity is conferred on the replicon by the presence of 
the inverted repeats (Bishop et al, 1984., Grindley et al, 1985). It is a cis-acting 
process which appears to affect only intermolecular transposition events. The non 
immunity of intramolecular transposition is consistent with the notion that both 
transposon ends are complexed with the transposase before the search for a target site 
(which lacks a free inverted repeat). This is presumably distinct from the mechanisms 
that limit the number of IS/Tn copies by reducing the frequency of transposition as 
copy number increases.
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Table 4.12. Class II Transposons. TnA family
Element Markers(s) Terminal 
Inverted 
Repeats (bp)
Size
(bp)
Target
Repeat(bp)
Tn3 Amp 38 4957 5
TnI,Tn901,Tnl701. Amp 38 5000 5
Tn501 Hg 35/38 8200 5
Tn551 Ery 35 5300 5
Tnl721,Tnl771 Tc 35/38 11400 5
Tn951 Lactose
utilization
40 16600 5
TnlOOO None 37 5800 5
lerg et al, 1989., Kleckner, 1981., Grindley et al, 1985. — ———— — ———
Ery - Resistance to erythromycin.
35/38: This implies the inverted repeat is imperfect as matches can be seen with 35 
out of 38 bases.
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Class III elements. Bacteriophage Mu.
The genome of phage Mu is attached to host sequences at all stages in its life cycle 
(including when packaged into the phage heads). In the phage particle, its DNA is 
a linear molecule of approximately 38kb. It has about 1.5kb of host DNA at one end 
and 50 to 150bp of host DNA at the other end.
It undergoes repeated cycles of transposition within the cell, followed by packaging 
along with adjacent host sequences. There is a 5bp target duplication on integration. 
Bacteriophage Mu does not have inverted repeat ends, but there exist sites of 
recombination which are bound by purified Mu transposase in vitro.
Two gene products are involved in transpositional activity. The A gene product 
which is the transposase, and the B gene product which is probably an accessory 
protein necessary for replication and full transpositional activity. Both the A and B 
gene products are complemented in trans. There is no evidence of a Mu resolvase, 
hence resolution is probably by host encoded functions.
Mu transpositional activity is greatest during the lytic cycle and is mainly by the 
replicative cointegrate pathway (simple insertions are rare) and Mu cointegrates are 
stable. Transposition products include: inversion insertions, adjacent deletions, and 
intermolecular cointegrates. One of the two transposons copies retains the original 
host left end (Mu att-L junction) while it derives a new junction with host sequences 
at the right end. The other copy has the original host Mu att-R junction while it gains 
a new host junction at the left end. For Mu to transpose, defined left and right ends 
are required.
Although simple insertions are rare, it is the case when Mu first forms a lysogen 
(Grindley et al, 1985).
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Other transposable elements
Elements in mycobacteria. These can be seen on table 4.13. They include IS6110 
which exhibits the same basic structure as class I A insertion sequences and IS900 
(Green et al, 1989., England et al, 1991), IS901 (Kunze et al, 1991) which lacks the 
terminal inverted repeats characteristic of most insertion elements. These elements 
will be further discussed later.
Elements in gram positive bacteria. These can be seen on table 4.14 and cover a 
wide range of transposons including; IS 110 which is a simple insertion sequence, 
Tn917 which is typical of the TnA family, Tn554 which lacks terminal inverted 
repeats and Tn916 which is a conjugative transposon. This implies replicons having 
Tn916 may be transferred to the recipient host during Tn916 mediated conjugation.
Unclassified transposons.
Transposons could vary widely in arrangement and content of their DNA as 
highlighted in Table 4.15, implying there is the need for reclassifying known 
transposons or creating groups to accommodate newly discovered elements. These 
unclassified elements are generally large transposons with very long inverted repeats. 
They generally encode more than one marker.
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Table 4.13 Transposable Elements in Mycobacteria.
Element Size(bp) Inverted 
Repeat (bp)
TD(bp) Source
IS6110 1,355 28 3 M.tuberculosis
IS 986 1,358 30 nil M.tuberculosis
IS 987 1,355 28 3 M.bovis BCG
IS1081 1,324 15 nil M.bovis
IS900 1,451 nil nil M.paratuberculo
sis
IS 901 1,472 nil nil M. avium
IS6100 880 14 nil M.fortuitum FC1
IS1096 2,274 25 8 M.smegmatis
TD = Target duplication.
IS6110, IS98<5, ISPS7 are related to the IS3 family of the enterobacteriaceae (Thierry 
et al, 1990 a,b; McAdam et al, 1990; Hermans et al, 1991.)
IS 1081: related to IS25<5 of Staphylococcus aereus (Collins et al, 1991).
IS900, IS 901 are both related to I SI 10 of Streptomyces coelicolor ( Collins et 
al, 1989; Green et al, 1989; Kunze et al, 1991).
IS6100: Related to the ISti family of insertion sequences which is found in both gram 
positive and gram negative bacteria. It flanks either side of the sulphonamide 
resistance transposon Tn610 (Martin et al, 1990b).
IS1096: Has a low homology with Tn552, Tn3926, Tn1000. (Cirillo et al, 1991.)
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Table 4.14. Transposable elements in gram positive bacteria.
Element Size
(bp)
IR(bp) TD
(bp)
Markers. Related
element
Source
IS110 1.55 10/15 ? Streptomyces
coelicolor
IS 466 - 2 .5 S. coelicolor
Tn4556 6.8 38 Neomycin Tn3 Streptomyces
fi'adicie.
Tn916 16.4 20/26 nil Tetracycline,
conjugal
transfer.
Streptococcus
faecalis.
Tn917 5605 5 Erythromycin Tn 3 Streptococci
IS 256 1350 nd nd Staphylococus{
TN4001ir)
IS 257 0.9 nd nd Staphylococcus
Tn4003dr
Tn551 5300 40 5 Erythromycin Tn 3, 
Tn917.
Staphylococus.
Tn554 6691 nil nil Erythromycin,
spectinomycin.
Staphylococcus.
nd - not done; Murphy, E. (1988), Chater K.F. et al, (1988), Clewell, D.B. et al, (1988). 
Hartl, D.L., and S.A. Sawyer (1988).
TD = target duplication.
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Table 4.15. Some unclassified elements.
Element Marker(s) Size(bp). Terminal 
repeats, (bp)
Tn 4 Ap,Sm,Su,Hg. 20500 140 IR
Tn 6 Km 4200 ? DR
Tn7,Tn7/,Tn72 Tp,Sm,Spc. 13500 19 IR
Tn2603 Sm,Su,Hg, Type II 
Penicillinase
19600 < 140 IR
Tnl691 Gent,Sm,Su,
Cm,Hg.
13500 < 100 IR
Gent. - Resistance to gentamycin. 
dr= Flanking insertion sequences are in direct repeat. 
ir=Flanking insertion sequences are in inverted repeat. 
(N.kleckner, 1981).
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4.1.2; Rearrangements mediated by transposable elements.
a) Intermolecular (replicative) transposition. In this reaction, the donor and the 
target molecules are initially genetically unlinked. The donor and target replicons 
fuse in a replicative process and in the presence of the transposase to form a 
cointegrate. The cointegrate is described as a transient intermediate having a copy of 
the transposable element at each donor-recipient junction. Stable intermediates can 
also be formed in some cases.
The cointegrate may be resolved into its two constituent molecules by host encoded 
functions, or by site specific recombination at the two resolution (res) sites which is 
mediated via a specific resolvase. Both the regenerated donor and target replicons 
now have a copy of the transposable element.
b) Intramolecular transposition. This reaction occurs when a copy of the insertion 
element transposes to another site within the same replicon, giving a cointegrate 
structure. This implies the donor and target molecules are initially genetically linked. 
The cointegrate structure now proceeds to carry out recombination and rearrangements 
such as adjacent deletions, and inversion-insertions. The cointegrate may be resolved 
by host encoded functions.
Simple insertion (non-replicative transposition).
Instead of, or in addition to, a replicative cointegrate pathway, some transposable 
elements carry out simple insertions. It does not involve replication of the element, 
but dictates sole insertion of the transposable element into the target. The donor 
replicon is then degraded. However, if the donor replicon is a multicopy plasmid, 
it can be replaced by replication of the remaining plasmid(s), hence it is often difficult 
to distinguish from a true replicative transposition. Furthermore, some transposable 
elements appear to use both pathways.
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4.1.21; Some functions and uses of transposable elements in nature.
IS elements are known to facilitate the formation of Hfr strains, thus enabling 
chromosome transfer via high efficiency plasmid conjugation system. The Hfr strains 
are a result of homologous recombination between an IS on the F plasmid and 
homologous sequences 011 the chromosome (Cullum et al, 1979). The F plasmid is 
known to carry one copy of ISi and two copies of I S3. The transposon Tn 916 is 
known to mediate conjugation, hence the genes that are linked to this transposon 
become potentially transferrabie. These conjugation systems can be important 
vehicles involved in the spread of antibiotic resistance (Clewell et al, 1988). 
Transposable elements can serve as movable regions of homology, providing sites for 
recA-mediated reciprocal recombination events. In this wise, those elements that 
encode a resolvase/internal resolution site system can also provide sites for recA- 
independent site specific recombination events.
The insertion of transposable elements in the genome can result in a detectable 
mutational effect which can be appreciated as the inactivation of a gene, increased 
expression of a gene, (or the production of an inactive peptide). Hence these elements 
can be employed as mutagens to study gene expression and peptide activity. 
Transposable elements are known to effect deletions of neighboring genes, hence 
deletions in a given region of DNA may make their presence suspect.
Insertion sequences may be employed to provide a strong promoter in the event of 
poor transcription. An example is seen in the case of yeast genes which are not 
always well expressed in E.coli. The presence of an IS promoter may result in the 
expression of the yeast gene from this promoter, hence leading to increased expression 
of the yeast gene (Cullum, 1985). In addition, IS2 is seen to exhibit strong promoter 
activity in orientation II, hence if IS2 is involved, increased expression of the gene 
will also indicate the orientation of the promoter.
IS elements can also be involved in the spread of chromosomal markers like antibiotic 
resistance, by creating a composite transposon comprising two elements flanking the 
marker genes. The whole unit becomes transposable. Similar composite structures
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can be employed as couriers for introducing foreign genetic material into the cell or 
genome of a suitable host. This report seeks to describe such a system which is based 
on the insertion sequence ISPSti.
4.2; Demonstration of Transposition of IS986
Up till now, evidence for transpositional activity of IS<5I7(Mike elements (which 
includes IS98<5) has largely been indirect, mainly based on the presence of multiple 
copies of the element in some members of the M.tuberculosis complex. This 
report describes a series of exercises aimed at experimentally demonstrating the 
transposition of IS986. The results obtained will be critically assessed and relevant 
conclusions will be drawn.
4.2.1; Preparation of plasmid clones for transposition exercises.
In order to realize the aims of this exercise, pUC18 based plasmid clones were 
constructed to cater for the specific needs of this experiment.
A. Clone I. (pUS 330).
Construction of pUS330.
This clone comprises IS986 cloned into the Smal site of the plasmid vector pUC18. 
Preparation of the IS9&5 insert.
The IS9&5 insert was prepared by employing the polymerase chain reaction (per) on 
a pRP5000 template. pRP5000 is a plasmid clone that contains a copy of IS986 plus 
its flanking sequences (MeAdam et al, 1990), cloned into the plasmid vector pAT153. 
The size of the insert in pRP5000 is about 4800bp.
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The Primer. The primer used to amplify IS986 is 28 bases long. From the 5’end 
of the primer, the first ten bases do not match the sequence of pRP5000 but provide 
a StuI recognition site for easy recovery of a blunt end fragment for cloning.
Since this primer anneals to the inverted repeat ends, only one primer was needed for 
PCR.
While the left and right IR ends of IS986 (including IS987 and IS6110) have a three 
base mismatch, this PCR strategy creates a derivative of IS986 with identical IR ends.
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Table 4.20. PCR primer for the construction of pUS 330.
Sequence of left inverted repeat.
5 ’CCT,GAA,CCG,CCC,CGG,CAT,GTC,CGG,AGA,CTC 3’ 
3’GGA.CTT.GGC.GGG.GCC.GTA.CAG.GCC.TCT.GAG 5’
Double underline: Region of template to which primer anneals. 
Sequence of primer.
5 ’AGC.TTA.GGC.CTG.AAC.CGC.CCC.GGC.ATG.T3>
The over-hang sequence is underlined.
The StuI recognition sequence is in bold.
Double underline: Region of primer that anneals to the template.
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Reaction conditions for the PCR.
The reaction mixes were prepared as described in methods section. The only 
variation was the annealing temperature which was set at 50°C. This low annealing 
temperature can be explained from the fact that there is an overhang primer sequence 
on hybridization of the primer to the template. This overhang sequence might have 
contributed to the instability of the hybrid structure.
The product was subsequently separated from the residual primers on a 1.5 % agarose 
gel and the band was extracted and purified using the Geneclean II kit.
The purified PCR fragment was digested with the restriction enzyme StuI to create 
blunt ends. The vector pUC18 was digested with the enzyme Smal, creating blunt 
ends. The pUC18 vector and the IS986 insert were then ligated at 12°C for 15
hours. More ligase was added and the ligation reaction allowed to carry on for
another four hours. The ligase was then inactivated by heating the reaction at 65°C 
for 7 minutes and the ligate was employed to transform competent E.coli JM109 
cells.
The transformed cells were plated on L-agar plates having 50mg per ml of ampicillin, 
0.05mM IPTG, 0.02mg per ml of X-gal. The plates were incubated for 16 hours. 
White colonies were screened for the presence of the right insert by extracting the 
plasmid, digesting it with EcoRI/Xbal (double digest) to release the insert, running 
the digest on a gel followed by blotting the gel. The blot was then probed with IS9S<5 
probe 1. Positive clones were isolated and stock cultures were stored at -70°C in 15 % 
glycerol. A large scale plasmid preparation was made from one of the positive 
clones, pUS330, and this preparation was employed in further exercises.
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S.Ps.X.B
Figure 4.10. Structure of pUS330
pUS330 comprises a copy of IS986 (grey section) cloned into the Smal site of pUC18. 
Restriction sites: S = Sal I; Ps = Pst I, X = Xho I, B = BamHI, P = PvuII, E = EcoRI
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B. Clone II. (pUS331).
Preparation of pUS331.
pUS331 comprises a kanamycin resistance gene inserted into pUS330 at the Pstl site. 
Preparation of insert (Kan1) and vector (pUS330).
The kanamycin resistance gene (Kan') which encodes the enzyme aminoglycoside 3’- 
phosphotransferase, conferring resistance to neomycin, G-148 in addition to 
kanamycin, (derived from the transposon Tn903) was obtained from the plasmid 
pUC4K (Pharmacia). It is 1300bp long. Kari was obtained from pUC4K by digesting 
the plasmid with the restriction enzyme Pstl.
The vector pUS330 was linearized by digesting with Pstl. The linearized pUS330 
was then treated with calf intestine alkaline phosphatase to prevent re-ligation.
The vector and insert were then ligated at 16°C for 16 hours and the ligate was then 
used to transform competent E.coli cells. Positive transformants were selected on 
an L-agar plate having kanamycin at a concentration of 50mg per ml. Stock cultures 
were stored at -70°C in 15% glycerol. A large scale plasmid preparation from a 
single colony was also done.
A single 5.4kb band was apparent on digestion with EcoRI which linearizes pUS331. 
A Pstl digest of the plasmid revealed a band of about 1300bp, equivalent to Kari, and 
the vector band of about 4100bp as expected. The plasmid stock was stored at -20°C.
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Figure 4.11. Structure of pUS331.
S.Ps
pUS331 comprises a copy of IS986 and aph gene cloned into the plasmid vector pUC18. IS986 
is seen in light grey while the aph gene is in a dark shade of grey.
Restriction sites: S = Sal I; Ps = Pst I, X = Xho I, B = BamHI, P = PvuII, E = EcoRI
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C. Clone III. (pUS333).
Preparation of pUS333.
pUS333 was made from pUS331 by adding a second copy of IS986 to pUS331 such 
that the copies of IS986 flanked Karf.
Preparation of the vector.
The plasmid pUS331 was linearized by digesting with the enzyme Sphl. The 
linearized plasmid was then treated with calf intestine alkaline phosphatase to prevent 
the vector from religating onto itself.
Preparation of insert.
The insert is IS986. The insert was obtained by carrying out an EcoRI/Xbal double 
digest on plasmid pUS330. This digestion released the insert which was separated 
from the rest of the plasmid by running the digest on a 1 % agarose gel. The ISPSti 
fragment was isolated and purified.
End filling of the IS986 insert.
This exercise was carried out to blunt the ends of IS986. A detailed description of the 
procedure can be seen in section 2.2.61.
Ligation of end filled IS PS6 to Sphl linkers.
Sphl linkers were "blunt end" ligated to the end filled IS986 such that one could 
create sticky Sphl ends on digestion of the ligate.
Reaction mixture.
The reaction mixture contained 600ng of blunt ended ISPS6, 400ng of Sphl linker, 
2jul 5X ligase buffer and Ipl of ligase. The volume was made up to 10/xl using sterile 
distilled water.
173
The Contents were mixed by pipetting and incubated at 12°C for 18 hours, ljul of 
ligase was added and the ligation reaction was incubated for a further 5 hours. The 
ligation mixture was extracted in phenol/chloroform, precipitated in ethanol, washed 
in 70% ethanol and desiccated under vacuum. The DNA pellet was then resuspended 
in water.
SphI digestion of linker-ISPSd ligation product.
The product of the ligation was digested with Sphl. The restriction fragments were 
separated on a 1 % agarose gel and the band of interest was extracted and purified. 
The DNA was then ethanol precipitated, washed, desiccated and resuspended in water.
Ligation of IS 986-linker Sphl digest to the vector pUS331 (linearized with Sphl and 
treated with calf intestine alkaline phosphatase).
Ligation mixture. Linearized vector (ljug) was added to insert (3yug). 4/xl of 5X 
ligase buffer and water to make the volume up to 19/xl were added. After the addition 
of 1/fi of ligase, the ligation mixture was mixed and incubated at 16°C for 16 hours. 
The ligate was then used to transform competent E.coli cells. Four positive colonies 
were isolated and plasmids from these clones gave identical restriction digest patterns, 
indicating they were similar. The plasmid from one of these colonies was called 
pUS333, and a large scale plasmid preparation of pUS333 was done.
Digestion of pUS333 with EcoRI gave a single band of 6.81cb as expected. 
Sequence data of pUS331 and restriction digests of pUS333 indicated the two copies 
of IS986 in pUS333 are direct repeats.
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Figure. 4.12. Structure of pUS333.
S.B p
pUS333 comprises two copies of IS986 flanking the aph gene, the entire construct is cloned into 
the vector pUC18. IS986 is seen in light grey while the aph gene is in a dark shade of grey.
Restriction sites: S = Sal I; Ps = Pst I, X = Xho I, B = BamHI, P = PvuII, E = EcoRI
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The ultimate aim of this study is to create transposition systems based on ISPS6 which 
can serve in the capacity of mutagens and couriers of genetic information.
Two approaches were employed to study the transposability of IS986. The first 
approach involved a conjugation pathway, with E.coli strains playing host at various 
stages of the exercise. The second approach involved electroporation of an 
M.smegmatis host strain with plasmid clones containing IS986.
4.2.21; Approach I.
Exercises to Demonstrate Transposition of ISPS6. Employing a Conjugation System.
The exercises carried out in this study to demonstrate the transposition of IS986 are 
an adaptation based on the findings of A.K. Turner et al (1990). They based their 
work on reports stating class II transposons were temperature sensitive to 
transposition, with the frequency of transposition of Tn3 at 37°C being only 1 % of 
the frequency at 30°C. Although IS986 is a class I transposon, this protocol was 
employed to see if a similar observation could be made.
The plasmid pUC18 lacks the mob and tra genes implying it is a non conjugative 
plasmid, hence it cannot effect its own transfer into a recipient cell, nor is it 
mobilizable by a second conjugative plasmid. Hence transfer of a pUC18-based 
replicon to a recipient cell will involve recombination (probably by the formation of 
a cointegrate) between pUC18 and a sex factor/conjugative plasmid, the new replicon 
being transferable as a unit. A similar phenomenon occurs in the formation of Hfr 
strains through the integration of the fertilityQQ factor into the genome of the host 
bacterium, conferring on the genome the potential to carry out conjugation (Cullum 
et al, 1979).
4.2.2; Exercises to Demonstrate Transposition of the Insertion Sequence IS986.
176
Materials and Methods.
Strains Employed.
JD103 (Tp,Su,Tra+) This is a donor clone derived from E.coli strain J53. It 
contains the conjugative plasmid R388 which encodes markers conferring resistance 
to trimethoprim and sulphonamide.
JD127 (Sm,Tc,Tra+) This is a donor clone derived from strain 162 which possesses 
the conjugative plasmid R64 drd, conferring resistance to streptomycin and 
tetracycline.
JD157 (Nal1) This is the recipient clone also derived from strain J62. It carries a 
chromosomal mutation conferring resistance to nalidixic acid.
Method.
The donor clones JD103 and ID 127 were transformed with the plasmids pUC18, 
pUS330 and pUS331. The transformants were screened on nutrient agar plates 
(containing ampicillin at a concentration of 50^g per ml) which were incubated at 
37°C.
Single colonies of JD103 transformants were further screened on nutrient agar plates 
containing trimethoprim at a concentration of 25pg per ml while JD127 transformants 
were further screened on plates containing streptomycin at a concentration of 25pg per 
ml. A further screening of the transformants was necessary to confirm the actual 
identities of the host colonies. The identity of the recipient host ID 157 was 
confirmed by plating on nutrient agar plates (containing nalidixic acid at a 
concentration of lOO/ug per ml) followed by incubation at 37°C for overnight.
Single colonies of the transformed donor strains and the recipient strain were isolated 
and plated on nutrient agar plates, selecting for all the antibiotic markers present in
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the clones (table 4.30). The plates were pre-incubated for 3 hours at the test 
temperature before plating, followed by incubation at the test temperature for 16 hours 
or until the colonies were visible. Colonies from these plates were then used for 
cross-streaking to effect conjugation.
Table 4.30. Inhibitory Effect of Test Antibiotics on the Recipient and Donor Strains.
Strain Selecting agent(s) Observation
JD157 TpjAp + -
JD157 Nal +  +  +  +
JD103 Tp,Ap + -
JD103 Tp + +  +  +
JD103 Nal -
Cl Nal -
Cl Tp,Ap + +  +  +
C2 Nal -
C2 Tp,Ap +  +  +  +
C3 Nal -
C3 Tp,Ap +  +  +  +
a. (+ -) : Growth hig lly inhibited with colonies resembling satellite colonies.
b. (-) : Total inhibition of growth.
c. (+  +  +  +): Good growth.
A similar result was observed with both JD103 and JD127 clones.
Clones C l, C2, C3 were obtained by transforming JD103 with pUC18, pUS330, 
pUS331 respectively.
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Crossing. Nutrient agar plates without selecting agents were incubated at the test 
temperature for at least 3 hours. A colony from each of the transformed donor clones 
was then cross-streaked with the recipient host JD157. The cross-streaked plates were 
then incubated at the test temperature for 16 hours. The colonies were then harvested 
in 1.5ml of distilled water.
In order to screen for transconjugants which were presumptive cointegrates, diluted 
cultures were plated on nutrient agar plates containing ampicillin, trimethoprim, and 
nalidixic acid. To select for the transfer of the conjugation plasmid (with or without 
the second plasmid), the cultures were plated on nutrient agar containing trimethoprim 
and nalidixic acid only.
The antibiotic concentrations in the nutrient agar were as follows; trimethoprim 
(25jUg/ml), ampicillin (50^g/ml), and nalidixic acid (lOO^g/ml).
Results.
a. Selection for JD103 (R388) based clones.
Transformants.
On transforming JD103 with the different plasmids pUC18, pUS 330, pUS 331, the 
resultant transformants C l, C2, C3 respectively, were obtained. They all exhibited 
ampicillin resistance in addition to resistance to trimethoprim (table 4.30). In the case 
of C3 transformants, resistance to kanamycin was also observed as expected (result 
not shown).
Transconjugants.
The results of crossing donors with the recipient can be seen on tables 4.31 and 4.32. 
The results indicate the presence of transconjugants which may be due to 
recombination between the R388 and pUC plasmids. If this were the case, the fact 
that the number of ampicillin resistant transconjugants is about 10% that of R388
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transconjugants would indicate that the recombination/cointegrate reaction between 
R388 and the test plasmid construct is an efficient process. However, the number of 
apparent transconjugants was as high with the negative control (pUC18) as with either 
pUS330 or pUS331, indicating that the presence of IS986 was not required for this 
effect.
There was no apparent difference in the number of transconjugants regardless of the 
temperature at which the exercises were carried out (30°C or 37°C).
b. Screening for JD127(R64 drd) transconjugants.
The same explanations and procedures employed in the case of selecting for JD103 
transconjugants were applied here. The only difference was replacing trimethoprim 
(incorporated to screen for R388) with streptomycin (incorporated to screen for R64 
drd). The concentration of streptomycin employed to screen for R64 drd was 
25/xg/ml. Initial experiments gave results very similar to those in tables 4.31 and 
4.32 (not shown).
181
Table 4.31. Selecting agents/N° of Transconjugants (103)
Tp,Ap Nal,Tp Nal,Ap
Strain Crossed with 
JD157.
Cl 76 90 3
C2 33 55 12
C3 50 66 • 5
Incubation was carried out at 30°C.
Tp,Ap selects for donors; Nal,Tp selects for recipient and R388 while Nal, Ap selects 
for recipient and pUC 18/pUS.
Table 4.32. Selecting agents/Number of Transconjugant(103).
Tp,Ap Nal,Tp Nal,Ap
Strains Crossed with 
JD157.
Cl 60 65 7
C2 75 80 4
C3 55 60 1
Incubation temperature was 37°C.
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DNA analysis of Recombination/Cointegrate-based Transconjugants.
Southern blot analysis of PvuII digested total genomic DNA derived from C2 and C3 
transconjugants gave positive signals with IS986 probe 3, highlighting the presence 
of IS986 in these transconjugants. This can occur if IS986 was transferred by 
mobilization or integrated into R388 by general recombination (or by the formation 
of a cointegrate), followed by R388 mediated transfer of the cointegrate/recombinant 
plasmid into the recipient strain. On the other hand, one might be seeing NalR 
mutants of the donor.
However, since pUC18 was transferred by about the same order as the ISP85-pUC18 
(pUS) clones, it is likely that the transconjugants positive for IS986 are simply due 
to products of recombination between pUC18 sequences and R388, not IS986 
mediated transposition.
The difficulty involved in detecting cointegrates, coupled with failure of the negative 
control experiment with pUC18, called for the termination of the conjugation based 
exercises, while the electroporation approach was implemented.
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4.2.22; Approach II.
This is the second pathway employed to study the transposition activity of IS986. It 
involves electroporation of a pUC18-based IS986 containing plasmid into the 
M.smegmatis host me2155 (Snapper et al, 1990). The exercises carried out are based 
on the knowledge that pUC-based vectors do not replicate in M.smegmatis (England 
et al, 1991., this project). The pUC18-IS986 clones all contain the kanamycin 
resistance gene which can serve as a marker during screening for integration of the 
IS986-kanr clones into the genome of M.smegmatis.
Electroporation. The electroporated cells were handled as described in the methods 
section 2.3.92. The resultant colonies exhibiting resistance to kanamycin were 
isolated and grown in nutrient broth at 37°C for three days, in a shaking incubator. 
Total genomic DNA was extracted from the cells as described for mycobacteria 
(methods section 2.3.2). The DNA was stored at -20°C prior to use while stock 
cultures of the transformants were stored in 15% glycerol at -70°C.
Analysis of Genomic DNA.
Four different plasmid clones were involved in the electroporation exercise.
The mycobacterial shuttle vector pYUB12 (Snapper et al, 1990) was employed as a 
positive control of the frequency of transformation. This was found to be between 
103 and 105 transformants per gg of DNA.
pUC4K (which is a pUC-derivative containing the kanamycin resistance gene) was 
employed as a control to test for the frequency of integration of pUC18 (minus IS986) 
into the genome of M.smegmatis. All the pUC4K controls gave an integration 
frequency of zero. No pUC integration products were obtained in the absence of 
IS 986.
The two test clones are pUS331 and pUS333. pUS331 comprises a single copy of 
IS986 and the kanamycin resistance gene (aph) cloned into a pUC18 plasmid vector 
(fig. 4.11).
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pUS333 comprises two copies of IS986 flanking the kanamycin resistance gene, with 
the entire construct inserted into a pUC18 plasmid vector (fig. 4.12). '
The events that have occurred after electroporation and subsequent integration of the 
putative transposon cassette into the chromosome were analyzed employing Southern 
blots of restriction digests.
Description of Positive Clones.
A total of ten clones which showed resistance to kanamycin were isolated. On 
probing restriction digests of DNA from these clones with IS986 probe 3 (Fomukong 
et al, 1992), two clones turned out to be negative for IS986, implying they might be 
spontaneous kanamycin resistant mutants. Further investigation was not carried out 
on the IS986 negative clones.
Two clones positive for IS986 (333a and 3338) appeared to be identical, hence only 
333a (renamed D5) was employed for further investigation. The rest of the clones 
turned out to be unique entities on initial screening with the IS986 probe 3.
Each of the isolates (except D5 and 333B) were derived from individual 
electroporation events.
The frequency of integration for each electroporation event yielding a positive clone 
was 1-2 per /ug of input DNA. The percentage efficiency of integration (relative to 
the frequency of transformation with pYUB12) ranged from 0.002% to 0.0002% 
(table 4.40).
In a similar set of exercises carried out to demonstrate the transposition of IS900 in 
M.smegmatiSy England et al.(1991) obtained l-5xl04 transformants per pg  of 
pYUB12 input DNA and 1-10 transformants per fxg of input test DNA. They also 
obtained nil transformants with the Kanr-pUC18 construct. Their results are of the 
order obtained in this study.
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Table 4.40. Percentage efficiency of integration.
Exercise 331 333 pUC4K pYUB12
I 0 0 - 1.0 x 104 
(100%)
II 0 0 - 6.1 x 103 
(100%)
III 0.002% 0.004% - 5.0 x 104 
(100%)
IV 0 0 0 6.1 x 104 
(100%)
V 0 0 0 2.1 x 105 
(100%)
VI 0 0.0003% 0 3.7 x 105 
(100%)
VII 0.0002% 0.0002% 0 6.6 x 105 
(100%)
pYUB 12(control) values only depict transformation efficiency per microgram of DNA 
employed, and are here employed as 100% efficient.
pUC4K(control), 331 and 333 indicate the efficiency of integration into the genome 
of M.smegmatis.
% efficiency of integration =  100 x N° of integration products/N° of pYUB12
transformants.
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Analysis of Southern blots of genomic digests.
The pictures of the Southern blots can be seen on figures 4.20-4.25 while the sizes 
of the restriction fragments can be seen on tables 4.50-4.52.
Southern blots of restriction digests of total genomic DNA obtained from pUS331 and 
pUS333 based clones were analyzed in order to elucidate the mode of transposition 
that occurred in each of the clones. The same blots were employed with all three 
probes, hence reducing the problem of products of partial digestion affecting any 
single result. The restriction enzymes BamHI, and PvuII were employed for 
digestion. Both BamHI and PvuII have only a single restriction site within ISP85, 
(MeAdam et al, 1990) [fig.3.2].
Three probes namely; the kanamycin resistance gene fragment (KanR), pUC18 
plasmid and IS986 probe 3 were labelled by the nonradioactive detection system 
protocol (Boehringer) and employed to probe the Southern blots.
The seven M. smegmatis clones are S2, S3, S4, D5, D6, D7, D8 (tables 4.50, 4.51, 
4.52). Clones S2, S3, S4 were obtained by electroporating M.smegmatis mc2155 
with pUS331 (a pUC18 replicon containing a kanamycin resistance gene and a single 
copy of IS9&5) while clones D5, D6, D7, D8 were similarly derived from pUS333 
(a pUC18 vector containing a kanamycin resistance gene flanked by two directly 
repeated copies of ISPS6).
In order to help analyze these clones, restriction digests of pUS331 and pUS333 were 
also included as controls. The term ’expected result’ employed to describe these 
results will refer to the observation that will be apparent when restriction digests of 
the wild type plasmids pUS331 or pUS333 were probed with either IS9&5 probe 3, 
the aph gene or pUC18. The ’observed’ result is that seen with the M.smegmatis 
clones, and it may be different from the expected result, in which case the fragment 
seen with the wild type test plasmid has been interfered with. This interference 
could either be an insertion or a deletion event. The same result for both ’observed’ 
and ’expected’ implies the fragment is internal (conserved) and not a junction 
fragment. The expected results have been deduced from figures 4.11 and 4.12.
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Lanes 2*4 contain strains 52 ,83 ,84  obtained by transforming M.smegmatis strain mc2155 with the 
plasmid pUS331.
Lanes 5-8 contain strains D5,D6,D7,D8 obtained by transforming M.smegmatis strain mcz155 with 
the plasmid pUS333.
Lanes 9,10 contain the plasmids pUS331 and pUS333 repectively.
Lanes 1,11 contain molecular size markers Lambda Hindlll + Phi X174 and Lambda Hindlll only, 
respectively.
Sizes detected are listed on tables 4 .50-4.52 (pages 197-199).
Figure 4.20. BamHI Digests of Recombinants probed with aph gene.
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Figure 4.21. PvuII Digests of Recombinants probed with aph gene.
Lanes 2-4 contain strains S2,S3,S4 obtained by transforming M.smegmatis strain mc2155 with the 
plasmid pUS331.
Lanes 5-8 contain strains D5,D6,D7,D8 obtained by transforming M.smegmatis strain mc2155 with 
the plasmid pUS333.
Lanes 9,10 contain the plasmids pUS331 and pUS333 repectively.
Lanes 1,11 contain molecular size markers Lambda Hindlll + Phi X174 and Lambda Hindlll only, 
respectively.
Sizes detected are listed on tables 4.50-4.52 (pages 197-199).
Figure 4.22. BamHI Digests of Recombinants Probed with IS986 probe 3.
Figure 4.23. PvuII Digests of Recombinants Probed with IS986 probe 3.
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Lanes 2-4 contain strains S2,S3,S4 obtained by transforming M.smegmatis strain mc2155 with the 
plasmid pUS331.
Lanes 5-8 contain strains 0 5 ,0 6 ,0 7 ,0 8  obtained by transforming M.smegmatis strain mc2155 with 
the plasmid pUS333.
Lanes 9,10 contain the plasmids pUS331 and pUS333 repectively.
Lanes 1,11 contain molecular size markers Lambda Hindlll + Phi X174 and Lambda Hindlll only, 
respectively.
Sizes detected are listed on tables 4 .50-4 .52 (pages 197-199).
Figure 4.24. BamHI Digests of Recombinants Probed with pUC18.
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Figure 4.25. PvuII Digests of Transformants Probed with pUC18.
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Clone D6. The transposition activity of ISP86 in this clone can be explained by 
employing the model A (fig. 4.26). This model indicates a replicative transposition 
with D6 where one copy of IS986 has been duplicated and the daughter copy inserted 
at a position such that the resultant lS986-KanR-lS986-p\5Q structure is flanked by 
genome. Such a model originated from the observation in figures 4.22 and 4.23. 
Clone D6 gives three bands when BamHI digests of genomic DNA were probed with 
IS986 probe 3 instead of the expected two bands (table 4.51). Two of these bands 
(1.8, 3.2) could be related to the ’expected’ bands, hence they are conserved 
fragments. The presence of a 1.9kb band indicated the presence of an extra copy of 
IS986, which can arise by a duplication of one parent copy.
The orientation of this new copy of IS986 can be described as being in a direct repeat 
with both original copies. This can be explained from the BamHI digest probed with 
IS986 3. In an inverted repeat orientation, BamHI (making use of the mcs on pUC) 
will give a 453bp (conserved) fragment, whereas in a direct repeat orientation, a 
1.9kb (variable) fragment can occur (assuming the use of a BamHI site on the genome 
[fig. 4.26]). This interpretation is supported by the PvuII digest (fig. 4.23).
The pUC18 probe (fig. 4.24, 4.25) gave positive signals with both blots indicating the 
presence of pUC18.
These results also suggest integration of the entire pUS333 construct into the genome. 
Such an arrangement is consistent with a cointegrate structure.
191
Clones D7. D8. Model B (fig. 4.27) has been employed to help explain the
transpositional activity occurring in clones D7 and D8. This model supposes a simple 
(non-replicative) transposition event involving the entire 1S986 composite transposon 
or a replicative transposition leading to a cointegrate as in model A, followed by 
recombination/resolution eliminating pUC18.
These clones all have KanR sequences (figs. 4.20, 4.21) as well as IS986 sequences 
(figs. 4.22, 4.23), but have lost pUC18 sequences as seen on figures 4.24 and 4.25. 
Both the BamHI and the PvuII digests probed with KanR gave the expected result, 
implying this region remains an internal (conserved) fragment.
Employment of either enzyme and probe 3 gave two bands as predicted by model B 
(figs. 4.22, 4.23), one internal and one variable fragment (which depends on the 
position of the next restriction site on the genome [table 4.51]). The D7 PvuII band 
(fig. 4.23) is a doublet.
Figure 4.27. Transposition model B.
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In the map highlighting the sizes of the DNA restriction fragments, the fragments seen on top were 
obtained with PvuII while the bottom fragments were obtained with BamHI.
The 6.6Kb fragment is from D7 while the 3.5Kb fragment is from D8.
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Clone D5. Model C (fig. 4.28) has been employed to explain the reactions that 
occurred in clone D5. This model supposes the presence of the entire pUS333 
construct integrated into the genome, possibly within the region spanning the pair of 
PvuII sites on pUC18, and very close to the PvuII site nearest IS986 copy A. There 
is no duplication of the insertion sequence, and this model is not consistent with 
conventional transposition models.
This clone gave a single internal fragment with both the PvuII and BamHI digests 
when probed with the aph (KanR) gene as expected (figs. 4.20, 4.21). The PvuII 
digest probed with IS986 probe 3 gave two internal fragments while the BamHI digest 
gave a constant (internal) fragment and a junction (variable) fragment (2.2kb), (figs. 
4.22, 4.23; table 4.51). ' '
On probing the PvuII digest with pUC18, a junction fragment (2.8kb) was evident. 
In addition to the 2.8kb fragment, two internal fragments of sizes l.lk b  and 0.6kb 
(not visible on picture) could be seen on the X-ray film. The variable fragment seems 
to have resulted from the region between the PvuII sites on pUC18 since the constant 
fragments are the small ones.
As pUC18 lacks an internal BamHI site, the presence of two variable fragments 
(instead of one fragment) (fig. 4.24) implies these are now junction fragments 
resulting from a split of the pUC18 sequence, most probably due to integration of the 
genome within this region.
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Clone S3. Model D (fig.4.29) has been employed to interpret the results with 
S3, and it is similar to model C (described for D5). Model D indicates integration 
of the plasmid by recombination with the chromosome at a point within the P-P region 
of the pUC18 sequence. This model is suggested in the results obtained with PvuII 
and BamHI digests probed with pUC18 (fig. 4.24, 4.25), and this inference is further 
supported by results of probing PvuII and BamHI digests with the aph gene and 
IS986 probe 3. No replication of IS986 is indicated.
The BamHI digest probed with pUC18 highlights two fragments instead of a single 
4.5kb fragment, indicating an insertion within the basic pUS331 construct.
A PvuII digest of pUS 331 probed with pUC18 gave two minor bands (1.8kb and 
l.lkb) and a major 2.4kb band (derived from P-P region of pUC18 found on the pUS 
331 construct). The observed result (fig.4.25; table 4.52) indicate the two minor 
bands are conserved while the major 2.4kb band is split into two bands of sizes 
18.5kb and 1.5kb, indicating the 18.51cb and the 1.5kb bands are junction fragments. 
The internal (conserved) fragments seen with the PvuII digest probed with the aph 
gene (fig. 4.21) together with the two small conserved fragments seen with the pUC18 
probe all indicate the region of integration into the genome is within P-P (pUC18).
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Clone S4. Model E (fig. 4.30) has been employed to explain the results obtained 
with S4. It is similar to that adopted for clone S3, involving integration of genomic 
sequences within P-P (pUC18), but the precise points of integration on both replicons 
differ.
Figure 4.30. MOD6L €.
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The position of IS986 probe 3 is seen in bold .
In the map highlighting the sizes of the DNA restriction fragments, the fragments seen on top were 
obtained w ith PvuII while the bottom fragments were obtained w ith BamHI.
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Clone S2. Employing the KanR probe on PvuII and BamHI digests gave one 
conserved fragment (1.8kb, and 4.5kb respectively) in each case as expected. A PvuII 
digest probed with IS986 3 gave a conserved l.lkb  band (fig. 4.23) while a BamHI 
digest gave two bands of sizes 4.5kb (equivalent to the expected fragment) and a 
2.3kb band in addition (fig. 4.22). The presence of two BamHI fragments detected 
with IS986 3 suggests they are either junction fragments or the presence of a second 
copy of IS986. But these suggestions are not supported by other results obtained with 
S2, and no suitable model could be employed to explain the result.
Conclusions.
Clones D6, D7 and D8 are seen to represent conventional transposition events 
whereas D5, S2, S3, and S4 suggest patterns not related to conventional transposition. 
The pattern of D6 is consistent with a cointegrate structure while D7 and D8 depict 
simple transposition events, or the result of resolution of a cointegrate structure.
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Table 4.50. Band Sizes of Restriction Digests(kb) of Recombinants on Probing with 
KanR (aph).
Clone BamHI PvuII
S2 4.5 1.8
S3 14.0 1.8
S4 4.5 1.8
D5 1.8 2.7
D6 1.8 2.7
D7 1.8 2.7
D8 1.8 2.7
331 4.5 1.8
333 1.8 2.7
The probe is the entire kanamycin resistance gene.
Table 4.51. Sizes of Restriction Fragments(kb) of Recombinants on Probing with
IS986 probe 3.
Clone BamHI PvuII
S2 4.5, 2.3 1.1
S3 3.8 1.1
S4 2.2 1.1
D5 2.2, 1.8 2.7, 1.1
D6 3.2, 1.9, 1.8 16.5, 2.7, 1.1
D7 6.6, 1.8 2.7
D8 3.5, 1.8 4.8, 2.7
331 4.5 1.1.
333 3.2, 1.8. 2.7, 1.1
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Table 4.52. Sizes of Restriction Fragments(kb) of Recombinants on Probing with
pUC18.
Clone. BamHI PvuII
S2 4.5, 2.3 2.7, 2.4, 1.8f
S3 15.0, 4.0 18.5, 1.5, 1.8r, l . l f
S4 4.5, 2.2 2.3, 1.8, 1.1
D5 3.3, 2.2 2.8, 1.1*, 0.6*
D6 3.3 2.4
D7 nil nil
D8 nil nil
331 4.5 2.4, 1.8, 1.1
333 3.2 2.4, 1.1, 0.55*
The probe is pUC18.
* Bands not visible on photograph (but seen on the original X-ray film). 
f faint band.
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Discussion.
Introduction of foreign DNA into a new host requires an efficient means of 
introducing the recombinant DNA into the cell, a system to ensure the gene of interest 
is stably maintained in the new host and another system to select for transformants. 
For the first time, a transposon cassette has been constructed from an 
M.tuberculosis insertion sequence, namely IS986. This cassette has been 
electroporated into M.smegmatis and transformants have been selected via kanamycin 
resistance expressed on the cassette. So far the system is found to be stable. 
Although the efficiency of integration is low, it comparable to those obtained by 
other workers.
Insertion of foreign DNA into M.smegmatis has been described before. Zainuddin 
et al, (1989i) were able to transform M.smegmatis to chloramphenicol resistance 
employing a mycobacteria-E.coli shuttle vector. They also showed some E.coli 
plasmids could be maintained extrachromosomally in M.smegmatis, albeit with 
varying stability.
A similar set of exercises carried out in this study had been covered by England et 
al. (1991). They demonstrated simple insertion and cointegrate formation employing 
an IS900 composite transposon. Martin et al (1991) have succeeded in introducing 
foreign DNA into M.smegmatis by employing a site specific integration vector. 
From the results in this report, one can look at the transposon cassettes as a class of 
integrative vectors which do not show site specificity of integration.
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Chapter 5.
General discussion.
5.0; General discussion.
This report is based on a two part project comprising:
A. DNA fingerprinting of members of the M.tuberculosis complex employing 
probes derived from the insertion sequence IS986.
B. Demonstration of the transposability of IS986 in the M.smegmatis strain me2155. 
5.1; DNA fingerprinting
DNA fingerprinting is a technique based on the concept that on employing a suitable 
restriction enzyme, characteristic DNA banding patterns will be generated and these 
patterns can be detected on hybridizing with a suitable probe. Each individual may 
exhibit a characteristic pattern while the similarity between patterns generated from 
two individuals will indicate their relatedness to each other. The technique of DNA 
fingerprinting has been employed to confirm the parental status of individuals, to 
identify humans with abnormal genes as in the case of Huntington’s chorea (Gusella 
et al. 1983) and myotonic dystrophy, employed in forensic investigations as well as 
in typing schemes involving procaryotes as well as eucaryotes.
One class of DNA commonly employed as probes are repetitive sequences, implying 
they occur many times in the genome. They provide greater sensitivity by virtue of 
their numbers, and more variation due to insertion at different sites in the genome. 
Some of these elements are capable of transposition (transposable elements), while 
others cannot mediate their movement within the genome and are simply known as 
dispersed repeats (Williams et al, 1990, Clarke-Curtiss et al, 1989). Some dispersed 
repeated DNA sequences, like those found in M. leprae (Williams et al, 1990, 
Clarke-Curtiss et al, 1989) appear to be stable and incapable of self transposition. 
Deninger (1989) has highlighted that at least in eucaryotes, such dispersed repeats 
arose through a process known as retroposition. Retroposition is a phenomenon 
describing the reverse transcription of an RNA molecule into DNA which is 
subsequently inserted into staggered chromosomal breaks. There is no conclusive
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evidence of such an event in procaryotes.
A few mycobacterial species have been involved in different fingerprinting schemes, 
employing transposable elements (insertion sequences) as probes.
McFadden et al.(1990) employing a probe which comprised the insertion sequence 
\S900 plus flanking DNA, were able to generate characteristic RFLP patterns with 
particular M. avium isolates, implying these strains possessed a repetitive element 
lacking in others. Kunze et al. (1991) have sequenced this repetitive element which 
is called IS901. It lacks terminal inverted repeat sequences and does not generate 
duplication of target on insertion. IS901 was absent in M.avium isolates from AIDS 
patients. Strains harboring IS901 were animal isolates and showed increased 
virulence for mice, hence IS901 could be employed as an indicator of virulent 
M. avium strains.
The insertion sequence IS900 (McFadden et al, 1987a) is highly specific to 
M.paratuberculosis and present in multiple copies in the genome. It shows a 60% 
DNA homology with the M. avium insertion sequence IS901. Like IS901, it is an 
atypical insertion sequence lacking terminal inverted repeats and does not generate 
duplication of target sequence (Green et al, 1989). It has been employed to 
differentiate between M. avium and M.paratuberculosis through RFLP typing and 
PCR (Vary, et al, 1990), and has also been shown to be transposable (England et al, 
1991) when introduced into M.smegmatis, although stable in M.paratuberculosis. 
McFadden et al. (1987b) showed RFLP patterns can identify two groups within the 
M. avium complex and they were able to correlate this grouping to previously 
identified serotypes within the M.avium complex. One group consisted of M.avium 
strains comprising serotypes 2V 22, 5 , 6, 8,, 82, M.paratuberculosis,
M. lepraemurium., and exhibited a base substitution of less than 3 %. The second 
group comprised M. intracellulare strains consisting of serotypes 7, 11, 16, 27. 
This is a more heterogenous group showing a base substitution greater than 13%. 
No such correlations have been found in the case of the M.tuberculosis isolates 
screened in this study. However, the BCG substrains Brazil, Japan and Russia which 
have been shown to harbor two copies of the insertion sequence IS6110, also produce
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large amounts of the 46kd protein MPB70 (Abou-Zeid et al, 1986), in addition to 
possessing characteristic lipids [methoxymycolates] (Minniken et al, 1984).
Williams et al. (1990) have shown M.leprae are a genetically homogenous species. 
They generated RFLP patterns from genomic DNA obtained from M. leprae isolates 
from different parts of the world and from different hosts. Despite employing 
different restriction enzymes and probes derived from different genes (including a 
repetitive sequence), no polymorphism was detected, indicating a remarkable degree 
of conservation of nucleotide sequences among M.leprae isolates. Other M.leprae 
specific repeated sequences have also been reported (Woods et al, 1990, Clarke- 
Curtiss et al, 1989) but none of these would differentiate between different M.leprae 
isolates.
A highly repetitive element (Ross et al, 1992) was cloned from M.tuberculosis and 
shown to be useful as an epidemiological tool. But this element, which is thought to 
be similar to that of Reddi et al. (1988) is also found in mycobacteria other than 
members of the M tuberculosis complex .
The insertion sequence ISI081 is present only in members of the M.tuberculosis 
complex and in five or six copies (Collins et al, 1991). Although it shows a limited 
RFLP pattern in these strains, it has been shown to distinguish M.tuberculosis from 
M.bovis by only one band (van Soolingen et al, 1992).
Pulsed field gel electrophoresis has been employed to separate large restriction 
fragments of DNA resulting from digestion with an infrequent-cutting endonuclease, 
facilitating direct viewing of restriction patterns on the gel. This allowed RFLP 
typing of M.tuberculosis isolates without the need for probes or a detection system. 
But more than two enzymes are employed to effect separation of strains in some cases 
(Zhang et al, 1992a).
Due to the high success of employing IS6110 in the fingerprinting and epidemiology 
of members of M.tuberculosis complex, van Embden et al.(1993) have laid down 
a standard protocol for the fingerprinting of M.tuberculosis DNA, as this will 
enable comparison of data on an international basis, therefore facilitating the 
monitoring of the distribution and spread of M.tuberculosis worldwide. The
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protocol includes digestion of the DNA with the restriction enzyme PvuII, and 
employing probes derived from the right of the single PvuII site on IS6110 (fig.3.2). 
Ruling out partial digests, this will ensure each band will depict one copy of 1S6110. 
They also recommended the inclusion of molecular size markers (which do not 
hybridize with IS6110) into the wells together with the test M.tuberculosis DNA. 
This is to facilitate computer analysis of different gels.
5.2; Transposition and Genetic manipulation.
Genetic manipulation of species of the M.tuberculosis complex is quite difficult, 
a situation made worse by the slow growth of the organism, and the fact that standard 
techniques employed in the manipulation of other organisms function inefficiently or 
not at all. The problem of slow growth and virulence associated with studies 
involving M.tuberculosis can be alleviated by employing alternate hosts. 
M.smegmatis is one such host which is employed in studying certain aspects of the 
M.tuberculosis complex. This implies genes from a slow growing mycobacterial 
species can be studied in a mycobacterial host (in which they are more likely to be 
expressed), hence there is no need for cloning specific promoters with the gene of 
interest.
Although transposable elements were initially discovered in a eucaryotic system, 
namely maize, much of our understanding of the molecular basis of transposition has 
emerged from work done on procaryotic systems, mainly gram negative bacteria, 
with E.coli being the main example. Presently, gram positive systems including 
Streptococcus, Staphylococcus, and Streptomyces feature highly in 
transposition studies. (Murphy, 1988., Clewell et al, 1988).
Transposable elements can be employed in mutagenic studies where they are involved 
in insertion mutations or polar mutations. They can also be employed as vehicles or 
couriers for the transfer of genetic material to a new host (England et al, 1991., 
Fomukong and Dale, 1993., this thesis). As couriers, they can be employed in
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vaccine production where they carry particular genes for expression in a new host. 
They could be employed to study transposon mediated drug resistance transfer. As 
some transposons carry drug resistance genes, it will be interesting to study whether 
these are naturally occurring agents or they are due to selective pressures like 
excessive use of a particular drug.
A number of models have been put forward to help explain the transposition event. 
These models are based on observations of particular transposable elements. While 
these models explain some activities of transposable elements, the current models do 
not cover the behavior of all known transposable elements.
Suggested transposition models include :
The replication recombination model. In this case, cointegrates are a required 
intermediate and both ends of the element are selected at the initiation. It is also 
thought that in certain situations, only one end of the transposable element is selected 
at initiation (Reznikoff, 1983).
Non replicative transposition is also thought to occur, and it is inferred in the absence 
of a cointegrate. Yet one should not forget that the observation of a cointegrate 
structure, hence confirming the presence of a replicative process will depend on the 
stability of the cointegrate structure, and suitable methods for identifying cointegrates. 
Although not yet proven, the transposase may double as a resolvase and transposase, 
hence the rapid resolution of the cointegrate structure in some cases, while the host’s 
recombination system may also be involved in the resolution of cointegrates.
Hotspots and warm spots have been employed to describe areas of preference for 
insertion by transposable elements. IS6110 has been shown to insert randomly, 
although a particular region consisting of an arrangement of direct repeats and 
intervening sequences is most favored and has been described as a ’hotspot’ (Hermans 
et al, 1991). An alternative interpretation is that when IS6110 was first acquired, by 
a precursor of M.tuberculosis/M.bovis/BCG, it was inserted at this site, and the 
stability of the element is such that most descendants still have it.
Recently, genome flux due to IS6110 has been detected in some isolates of
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M.tuberculosis (Das et al, 1993). They compared RFLP patterns from strains 
isolated before and after chemotherapy, and from relapse cases. They were able to 
detect fingerprint instability in a few strains, and this instability was either exhibited 
as a loss or gain of a copy of IS 6110. However, these results are contrary to that of 
van Soolingen et al.(1991) which demonstrated stability of IS6110 in 
M.tuberculosis isolates after weekly passages for six months in the presence or 
absence of antituberculous drugs.
Transposons seem to be as varied as the mode in which they mediate transposition. 
Some distinct differences can be seen with highly similar transposons.
A feature of most transposons is the presence of terminal inverted repeats and the 
duplication of target DNA on insertion. The terminal repeats are thought to be 
recognition sites for the transposase.
England et al.(1991) demonstrated simple insertion and the formation of a cointegrate 
employing a ISiW-composite transposon. IS900 and other elements such as IS901, 
Tn554 and Tn916 (Murphy, 1988., Clewell et al, 1988.) are known not to have 
inverted repeat sequences at their ends. If the inverted repeat sequences actually 
function as recognition sites for the transposase, how do these elements effect 
transposition ?. This either defeats the current transposition models or implies a 
model not yet described.
A group of highly promiscuous transposons are the conjugative transposons depicted 
by Tn916 (found in Streptococci (Clewell et al, 1988). Mating promoted by these 
transposons is not limited to a single species or genus, hence they pose a threat as 
agents for the transfer of drug resistance traits. Tn916, can transpose independently 
or together with associated DNA, and transposition is through a minicircle 
intermediate (Scott, 1992).
Transpositional activity of IS986 has been correlated to the activity in ISi (McAdam 
et al, 1990). The insertion sequence ISi has been shown to have two open reading 
frames (insA and insB) involved in transposition. mRNA for insA and insB
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proteins is synthesized polycistronically from a common promoter located upstream 
of the InsA coding frame (Machida et al, 1982). Sekine et al, (1989) have indicated 
ribosomal frameshifting in the -1 direction generating a fusion protein which functions 
as the transposase. They showed a third ORF (B ’) which overlaps both insA and 
irnB was employed in the formation of the fusion protein InsA-B’-InsB which served 
as the transposase. They indicated a sequence of mainly purine residues 
(AAAAAAC) in the region of overlap between insA and B1 as being the site for 
ribosomal frameshifting, and also showed that insertion of a purine into this site 
increased the frequency of cointegrate formation. Such a sequence has also been 
indicated for IS98<5 and its possible involvement in ribosomal frameshifting during 
synthesis of ORFb has already been discussed (McAdam et al, 1990). Insertions or 
deletions in this putative region of frameshift in IS986 might throw light on its 
significance in the transpositional activity of IS98d
Duplication of target sequence was shown to be lacking in the case of IS986 
(McAdam et al, 1990) whereas other copies of IS6110 have been shown to generate 
target duplications. This indicates sequencing one copy of an insertion sequence may 
not give a full picture of the group.
A number of methods have been employed to achieve integration of foreign DNA 
fragments into M.smegmatis. Martin et al.(1991) employed an integrative vector 
containing the integrative element pSAM2 (which contains the int gene and the attB 
site) from Streptomyces ambofaciens, achieving a site specific integration of the 
construct into the attB site in the M.smegmatis genome. Other integrative vectors 
based on pUC19 have been constructed by Husson et al.(1990). They employed the 
M.smegmatis pyrF gene (encoding orotidine monophosphate decarboxylase) as the 
region of integration into the chromosome. They cloned the kanamycin resistance 
gene (aph) from Tn903 into the unique EcoRl site of pyrF, inactivating the gene.
A functional pyrF gene allows cells to grow in a medium lacking uracil but is lethal 
to cells grown in the presence of 5-FOA, hence allowing differentiation of 
recombinants due to single cross-overs and those which were gene replacements.
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Integrative vectors based on the temperate mycobacteriophage L5 have been 
constructed and shown to effect stable integration of plasmid sequences into 
M.smegmatis, M .tuberculosis and BCG, giving efficiencies of integration of 105 
per gg (Lee et al. 1991). They constructed such a vector by cloning the att-P-int 
region from phage L5 into the plasmid pUC119. On transforming a suitable 
mycobacterial strain with this construct, they were able to achieve site specific 
integration at the att-B site in the chromosome.
The products of recombination seen with some IS986 constructs employed in 
transposition studies (Fomukong and Dale, 1993., this thesis) indicate the constructs 
can also be described as integrative vectors.
Strains of BCG have been successfully transformed with E.coli-mycobacteria shuttle 
plasmid (Lugosi et al, 1989). This shuttle plasmid was constructed from the E.coli 
plasmid pU666 and the M.fortuitum plasmid pAL5000. The plasmid pIJ666 was 
unable to effect transformation of BCG alone, implying the sequences on the 
M.fortuitum plasmid were required to provide an origin of replication in BCG. 
They also showed there was an increase in the transformation efficiency on 
transforming BCG strains with the re-isolated plasmids.
Jacobs et al. (1989) employed a shuttle phasmid to introduce genetic material into the 
mycobacterial cell. These phasmids are constructed by inserting E.coli cosmids 
(plasmid vectors containing phage lambda cohesive ends) into a non-essential region 
of a temperate mycobacteriophage genome, implying it will replicate in E.coli as a 
plasmid and in mycobacteria as a phage.
Zainuddin et al. (19891) were able to transform M.smegmatis to chloramphenicol 
resistance employing pAL5000-based recombinants of the E.coli plasmids pIJ666 
and pSGMU37. They found that both the wild-type plasmids and the recombinants 
could be detected as extrachromosomal elements at a low copy number in 
M.smegmatis. This highlights the fact the fact that some E.coli plasmids can be 
maintained as plasmids in M.smegmatis, contrary to the observations by Lugosi et 
al (1989).
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This report has shown for the first time that some BCG strains, namely substrains 
Brazil, Japan and Russia contain two copies of IS6110, instead of one copy as 
previously reported (Hermans et al, 1990., van Soolingen et al, 1991).
It has also been indicated that BCG2 contains an IS6110 insert only in substrains 
Brazil, Japan, and Russia, while PCR evidence suggests the BCG2 site is also found 
in other members of M.bovis BCG, some M. bovis and strains of M.tuberculosis, 
but without a copy of IS 67 70.
The complex nature of the BCG, insertion site was further highlighted in failed 
experiments to amplify IS6770 by PCR, employing primers obtained from the 
flanking region of BCG,.
IS6770 typing of M.tuberculosis isolates from Tanzania has revealed the strains are 
polymorphic, contrary to other studies covering similarly wide areas which indicate 
a closer relationship among the isolates. This indicates a diverse reservoir of 
potential sources of M.tuberculosis infection in Tanzania.
The transposition of a Mycobacterium tuberculosis insertion sequence (IS986) has 
been demonstrated for the first time, despite failed attempts by other workers 
(Mendiola et al. 1992). These failed attempts could be attributed to the sequence 
variations between the different copies of IS6770 employed. The fact that the IS986 
construct employed in this study had perfect inverted repeat sequences (instead of the 
imperfect inverted repeat sequences seen with the wild type) may have been significant 
in determining the success of the transposition exercise.
A number of possible recombination events have been highlighted, ranging from 
events which indicate cointegrate formation to transposition, and those which cannot 
be explained employing current models.
This report also shows the IS986-based plasmid constructs can be employed as 
couriers of genetic information into M.smegmatis.
209
Further work.
IS986 has been shown experimentally to be transposable. It would be interesting to 
study the mechanisms controlling this process, employing site-directed mutagenesis 
and gene fusions.
Another area for study is the employment of the IS986 composite transposon as a 
courier of genetic material to manipulate BCG (as in vaccine development) and to use 
these constructs as insertional mutants to study the effects of both polar and 
insertional mutations in BCG. But these studies will require higher transposition 
frequencies and more efficient electroporation systems.
The failure of the PCR to amplify IS6110 employing primers derived from the region 
flanking BCGj indicates some major structural and sequence variations with respect 
to the unusual M.tuberculosis strains. Sequence analysis of the BCGt flanking 
region in one of these strains might be helpful in studying the reason for the PCR 
failure. The preliminary observation that M.bovis strains from a veterinary source 
are more likely to have a single copy of IS6110 than those from clinical origins may 
be confirmed by further screening of M.bovis strains from the different sources.
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